Publications du CNR en 2014

1368488 2014 1 heidelberg-university-faculty-of-medicine 50 creator asc year 1 229 https://cnrmyrma.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22K9G9PRET%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Atallah%20et%20al.%22%2C%22parsedDate%22%3A%222014%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAtallah%2C%20D.%2C%20El%20Kassis%2C%20N.%2C%20Araj%2C%20G.%2C%20Nasr%2C%20M.%2C%20Nasnas%2C%20R.%2C%20Veziris%2C%20N.%20and%20Sarkis%2C%20D.%20%282014%29.%20%26lt%3Bb%26gt%3BMycobacterial%20infection%20of%20breast%20prosthesis%20%26%23x2013%3B%20a%20conservative%20treatment%3A%20a%20case%20report%26lt%3B%5C%2Fb%26gt%3B.%20BMC%20Infectious%20Diseases%20%26lt%3Bi%26gt%3B14%26lt%3B%5C%2Fi%26gt%3B%2C%20238%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2F1471-2334-14-238%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2F1471-2334-14-238%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mycobacterial%20infection%20of%20breast%20prosthesis%20%5Cu2013%20a%20conservative%20treatment%3A%20a%20case%20report%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Atallah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadine%22%2C%22lastName%22%3A%22El%20Kassis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Araj%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marwan%22%2C%22lastName%22%3A%22Nasr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roy%22%2C%22lastName%22%3A%22Nasnas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dolla%22%2C%22lastName%22%3A%22Sarkis%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222014%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1186%5C%2F1471-2334-14-238%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.biomedcentral.com%5C%2F1471-2334%5C%2F14%5C%2F238%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221471-2334%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-02-26T17%3A51%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22TEJ5T7ZD%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Aubry%20et%20al.%22%2C%22parsedDate%22%3A%222014-04-17%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAubry%2C%20A.%2C%20Sougakoff%2C%20W.%2C%20Bodzongo%2C%20P.%2C%20Delcroix%2C%20G.%2C%20Armand%2C%20S.%2C%20Millot%2C%20G.%2C%20Jarlier%2C%20V.%2C%20Courcol%2C%20R.%20and%20Lema%26%23xEE%3Btre%2C%20N.%20%282014%29.%20%26lt%3Bb%26gt%3BFirst%20Evaluation%20of%20Drug-Resistant%20Mycobacterium%20tuberculosis%20Clinical%20Isolates%20from%20Congo%20Revealed%20Misdetection%20of%20Fluoroquinolone%20Resistance%20by%20Line%20Probe%20Assay%20Due%20to%20a%20Double%20Substitution%20T80A-A90G%20in%20GyrA%26lt%3B%5C%2Fb%26gt%3B.%20PLoS%20ONE%20%26lt%3Bi%26gt%3B9%26lt%3B%5C%2Fi%26gt%3B%2C%20e95083%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0095083%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0095083%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22First%20Evaluation%20of%20Drug-Resistant%20Mycobacterium%20tuberculosis%20Clinical%20Isolates%20from%20Congo%20Revealed%20Misdetection%20of%20Fluoroquinolone%20Resistance%20by%20Line%20Probe%20Assay%20Due%20to%20a%20Double%20Substitution%20T80A-A90G%20in%20GyrA%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%22%2C%22lastName%22%3A%22Bodzongo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guy%22%2C%22lastName%22%3A%22Delcroix%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvie%22%2C%22lastName%22%3A%22Armand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G%5Cu00e9rald%22%2C%22lastName%22%3A%22Millot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ren%5Cu00e9%22%2C%22lastName%22%3A%22Courcol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadine%22%2C%22lastName%22%3A%22Lema%5Cu00eetre%22%7D%5D%2C%22abstractNote%22%3A%22Background%20Tuberculosis%20%28TB%29%20is%20one%20of%20the%20major%20public%20health%20problems%20in%20Congo.%20However%2C%20data%20concerning%20Mycobacterium%20tuberculosis%20drug%20resistance%20are%20lacking%20because%20of%20the%20insufficient%20processing%20capacity.%20So%2C%20the%20aim%20of%20this%20study%20was%20to%20investigate%20for%20the%20first%20time%20the%20resistance%20patterns%20and%20the%20strain%20lineages%20of%20a%20sample%20of%20M.%20tuberculosis%20complex%20%28MTBC%29%20isolates%20collected%20in%20the%20two%20main%20cities%20of%20Congo.%20Methods%20Over%20a%209-day%20period%2C%20114%20smear-positive%20sputa%20isolated%20from%20114%20patients%20attending%20centers%20for%20the%20diagnosis%20and%20treatment%20of%20TB%20in%20Brazzaville%20and%20Pointe%20Noire%20were%20collected%20for%20culture%20and%20drug%20susceptibility%20testing%20%28DST%29.%20Detection%20of%20mutations%20conferring%20drug%20resistance%20was%20performed%20by%20using%20line%20probe%20assays%20%28GenoType%20MTBDRplus%20and%20MTBDRsl%29%20and%20DNA%20sequencing.%20Strain%20lineages%20were%20determined%20by%20MIRU-VNTR%20genotyping.%20Results%20Of%20the%20114%20sputa%2C%2046%20were%20culture%20positive%20for%20MTBC.%20Twenty-one%20%2846%25%29%20were%20resistant%20to%20one%20or%20more%20first-line%20antiTB%20drugs.%20Of%20these%2C%2015%20%2871%25%29%20were%20multidrug%20resistant%20%28MDR%29.%20The%20most%20prevalent%20mutations%20involved%20in%20rifampin%20and%20isoniazid%20resistance%2C%20D516V%20%2860%25%29%20in%20rpoB%20and%20S315T%20%2887%25%29%20in%20katG%20respectively%2C%20were%20well%20detected%20by%20MTBDRplus%20assay.%20All%20the%2015%20MDR%20strains%20were%20susceptible%20to%20fluoroquinolone%20and%20injectable%20second-line%20drug.%20No%20mutation%20was%20detected%20in%20the%20rrs%20locus%20involved%20in%20resistance%20to%20amikacin%20and%20capreomycin%20by%20both%20the%20MTBDRsl%20assay%20and%20DNA%20sequencing.%20By%20contrast%2C%209%20MDR%20strains%20belonging%20to%20the%20same%20cluster%20related%20to%20T-family%20were%20identified%20as%20being%20falsely%20resistant%20to%20fluoroquinolone%20by%20the%20MTBDRsl%20assay%20due%20to%20the%20presence%20of%20a%20double%20substitution%20T80A-A90G%20in%20GyrA.%20Conclusions%20Taken%20together%2C%20these%20data%20revealed%20a%20possible%20spread%20of%20a%20particular%20MDR%20clone%20in%20Congo%2C%20misidentified%20as%20fluoroquinolone%20resistant%20by%20MTBDRsl%20assay.%20Thus%2C%20this%20test%20cannot%20replace%20gold-standard%20culture%20method%20and%20should%20be%20interpreted%20carefully%20in%20view%20of%20the%20patient%26%23039%3Bs%20native%20land.%22%2C%22date%22%3A%22April%2017%2C%202014%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0095083%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fdx.doi.org%5C%2F10.1371%5C%2Fjournal.pone.0095083%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-02-26T18%3A04%3A00Z%22%7D%7D%2C%7B%22key%22%3A%226XTASPN7%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bastos%20et%20al.%22%2C%22parsedDate%22%3A%222014-11-15%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBastos%2C%20M.%20L.%2C%20Hussain%2C%20H.%2C%20Weyer%2C%20K.%2C%20Garcia-Garcia%2C%20Lourdes%2C%20Leimane%2C%20Vaira%2C%20Leung%2C%20Chi%20Chiu%2C%20Narita%2C%20Masahiro%2C%20Pen%26%23xE3%3B%2C%20J.%20M.%2C%20Ponce-de-Leon%2C%20Alfredo%2C%20Seung%2C%20Kwonjune%20J.%2C%20Shean%2C%20Karen%2C%20Sifuentes-Osornio%2C%20Jos%26%23xE9%3B%2C%20Walt%2C%20M.%20V.%20der%2C%20Werf%2C%20T.%20S.%20V.%20der%2C%20Yew%2C%20Wing%20Wai%2C%20Menzies%2C%20Dick%2C%20Ahuja%2C%20S.%2C%20Ashkin%2C%20D.%2C%20Avenda%26%23xF1%3Bo%2C%20M.%2C%20Banerjee%2C%20R.%2C%20Bauer%2C%20M.%2C%20Becerra%2C%20M.%2C%20Benedetti%2C%20A.%2C%20Burgos%2C%20M.%2C%20Centis%2C%20R.%2C%20Chan%2C%20E.%20D.%2C%20Chiang%2C%20C.%20Y.%2C%20Cobelens%2C%20F.%2C%20Cox%2C%20H.%2C%20D%26%23x2019%3BAmbrosio%2C%20L.%2C%20Lange%2C%20W.%20C.%20M.%20de%2C%20DeRiemer%2C%20K.%2C%20Enarson%2C%20D.%2C%20Falzon%2C%20D.%2C%20Flanagan%2C%20K.%2C%20Flood%2C%20J.%2C%20Gandhi%2C%20N.%2C%20Garcia-Garcia%2C%20L.%2C%20Granich%2C%20R.%20M.%2C%20Hollm-Delgado%2C%20M.%20G.%2C%20Holtz%2C%20T.%20H.%2C%20Hopewell%2C%20P.%2C%20Iseman%2C%20M.%2C%20Jarlsberg%2C%20L.%20G.%2C%20Keshavjee%2C%20S.%2C%20Kim%2C%20H.%20R.%2C%20Koh%2C%20W.%20J.%2C%20Lancaster%2C%20J.%2C%20Lange%2C%20C.%2C%20Leimane%2C%20V.%2C%20Leung%2C%20C.%20C.%2C%20Li%2C%20J.%2C%20Menzies%2C%20D.%2C%20Migliori%2C%20G.%20B.%2C%20Mitnick%2C%20C.%20M.%2C%20Narita%2C%20M.%2C%20Nathanson%2C%20E.%2C%20Odendaal%2C%20R.%2C%20O%26%23x2019%3BRiordan%2C%20P.%2C%20Pai%2C%20M.%2C%20Palmero%2C%20D.%2C%20Park%2C%20S.%20K.%2C%20Pasvol%2C%20G.%2C%20Pena%2C%20J.%2C%20P%26%23xE9%3Brez-Guzm%26%23xE1%3Bn%2C%20C.%2C%20Ponce-de-Leon%2C%20A.%2C%20Quelapio%2C%20M.%20I.%20D.%2C%20Quy%2C%20H.%20T.%2C%20Riekstina%2C%20V.%2C%20Robert%2C%20J.%2C%20Royce%2C%20S.%2C%20Salim%2C%20M.%2C%20Schaaf%2C%20H.%20S.%2C%20Seung%2C%20K.%20J.%2C%20Shah%2C%20L.%2C%20Shean%2C%20K.%2C%20Shim%2C%20T.%20S.%2C%20Shin%2C%20S.%20S.%2C%20Shiraishi%2C%20Y.%2C%20Sifuentes-Osornio%2C%20J.%2C%20Sotgiu%2C%20G.%2C%20Strand%2C%20M.%20J.%2C%20Sung%2C%20S.%20W.%2C%20Tabarsi%2C%20P.%2C%20Tupasi%2C%20T.%20E.%2C%20Vargas%2C%20M.%20H.%2C%20Altena%2C%20R.%20van%2C%20Walt%2C%20M.%20van%20der%2C%20Werf%2C%20T.%20S.%20van%20der%2C%20Viiklepp%2C%20P.%2C%20Westenhouse%2C%20J.%2C%20Yew%2C%20W.%20W.%20and%20Yim%2C%20J.%20J.%20%282014%29.%20%26lt%3Bb%26gt%3BTreatment%20Outcomes%20of%20Patients%20With%20Multidrug-Resistant%20and%20Extensively%20Drug-Resistant%20Tuberculosis%20According%20to%20Drug%20Susceptibility%20Testing%20to%20First-%20and%20Second-line%20Drugs%3A%20An%20Individual%20Patient%20Data%20Meta-analysis%26lt%3B%5C%2Fb%26gt%3B.%20Clin%20Infect%20Dis%20%26lt%3Bi%26gt%3B59%26lt%3B%5C%2Fi%26gt%3B%2C%201364%26%23x2013%3B1374%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciu619%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciu619%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Treatment%20Outcomes%20of%20Patients%20With%20Multidrug-Resistant%20and%20Extensively%20Drug-Resistant%20Tuberculosis%20According%20to%20Drug%20Susceptibility%20Testing%20to%20First-%20and%20Second-line%20Drugs%3A%20An%20Individual%20Patient%20Data%20Meta-analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mayara%20L.%22%2C%22lastName%22%3A%22Bastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hamidah%22%2C%22lastName%22%3A%22Hussain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karin%22%2C%22lastName%22%3A%22Weyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lourdes%22%2C%22lastName%22%3A%22Garcia-Garcia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vaira%22%2C%22lastName%22%3A%22Leimane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chi%20Chiu%22%2C%22lastName%22%3A%22Leung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masahiro%22%2C%22lastName%22%3A%22Narita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%20M.%22%2C%22lastName%22%3A%22Pen%5Cu00e3%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alfredo%22%2C%22lastName%22%3A%22Ponce-de-Leon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kwonjune%20J.%22%2C%22lastName%22%3A%22Seung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%22%2C%22lastName%22%3A%22Shean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%22%2C%22lastName%22%3A%22Sifuentes-Osornio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martie%20Van%20der%22%2C%22lastName%22%3A%22Walt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tjip%20S.%20Van%20der%22%2C%22lastName%22%3A%22Werf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wing%20Wai%22%2C%22lastName%22%3A%22Yew%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dick%22%2C%22lastName%22%3A%22Menzies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Ahuja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Ashkin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Avenda%5Cu00f1o%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Banerjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Bauer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Becerra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Benedetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Burgos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Centis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20D.%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20Y.%22%2C%22lastName%22%3A%22Chiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Cobelens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22D%27Ambrosio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%20C.%20M.%20de%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22DeRiemer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Enarson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Falzon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Flanagan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Flood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Gandhi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Garcia-Garcia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20M.%22%2C%22lastName%22%3A%22Granich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20G.%22%2C%22lastName%22%3A%22Hollm-Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%20H.%22%2C%22lastName%22%3A%22Holtz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Hopewell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Iseman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20G.%22%2C%22lastName%22%3A%22Jarlsberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Keshavjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%20R.%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%20J.%22%2C%22lastName%22%3A%22Koh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Lancaster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Leimane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20C.%22%2C%22lastName%22%3A%22Leung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Menzies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20B.%22%2C%22lastName%22%3A%22Migliori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20M.%22%2C%22lastName%22%3A%22Mitnick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Narita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Nathanson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Odendaal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22O%27Riordan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Pai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Palmero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20K.%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Pasvol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Pena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22P%5Cu00e9rez-Guzm%5Cu00e1n%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Ponce-de-Leon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20I.%20D.%22%2C%22lastName%22%3A%22Quelapio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%20T.%22%2C%22lastName%22%3A%22Quy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Riekstina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Royce%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Salim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%20S.%22%2C%22lastName%22%3A%22Schaaf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20J.%22%2C%22lastName%22%3A%22Seung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Shean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%20S.%22%2C%22lastName%22%3A%22Shim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20S.%22%2C%22lastName%22%3A%22Shin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Y.%22%2C%22lastName%22%3A%22Shiraishi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Sifuentes-Osornio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Sotgiu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20J.%22%2C%22lastName%22%3A%22Strand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20W.%22%2C%22lastName%22%3A%22Sung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Tabarsi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%20E.%22%2C%22lastName%22%3A%22Tupasi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20H.%22%2C%22lastName%22%3A%22Vargas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20van%22%2C%22lastName%22%3A%22Altena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20van%20der%22%2C%22lastName%22%3A%22Walt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%20S.%20van%20der%22%2C%22lastName%22%3A%22Werf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Viiklepp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Westenhouse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%20W.%22%2C%22lastName%22%3A%22Yew%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20J.%22%2C%22lastName%22%3A%22Yim%22%7D%5D%2C%22abstractNote%22%3A%22Background.%20Individualized%20treatment%20for%20multidrug-resistant%20%28MDR%29%20tuberculosis%20and%20extensively%20drug-resistant%20%28XDR%29%20tuberculosis%20depends%20upon%20reliable%20and%20valid%20drug%20susceptibility%20testing%20%28DST%29%20for%20pyrazinamide%2C%20ethambutol%2C%20and%20second-line%20tuberculosis%20drugs.%20However%2C%20the%20reliability%20of%20these%20tests%20is%20uncertain%2C%20due%20to%20unresolved%20methodological%20issues.%20We%20estimated%20the%20association%20of%20DST%20results%20for%20pyrazinamide%2C%20ethambutol%2C%20and%20second-line%20drugs%20with%20treatment%20outcomes%20in%20patients%20with%20MDR%20tuberculosis%20and%20XDR%20tuberculosis.%5CnMethods.%20We%20conducted%20an%20analysis%20of%20individual%20patient%20data%20assembled%20from%2031%20previously%20published%20cohort%20studies%20of%20patients%20with%20MDR%20and%20XDR%20tuberculosis.%20We%20used%20data%20on%20patients%26%23039%3B%20clinical%20characteristics%20including%20DST%20results%2C%20treatment%20received%2C%20outcomes%2C%20and%20laboratory%20methods%20in%20each%20center.%5CnResults.%20DST%20methods%20and%20treatment%20regimens%20used%20in%20different%20centers%20varied%20considerably.%20Among%208955%20analyzed%20patients%2C%20in%20vitro%20susceptibility%20to%20individual%20drugs%20was%20consistently%20and%20significantly%20associated%20with%20higher%20odds%20of%20treatment%20success%20%28compared%20with%20resistance%20to%20the%20drug%29%2C%20if%20that%20drug%20was%20used%20in%20the%20treatment%20regimen.%20Various%20adjusted%20and%20sensitivity%20analyses%20suggest%20that%20this%20was%20not%20explained%20by%20confounding.%20The%20adjusted%20odds%20of%20treatment%20success%20for%20ethambutol%2C%20pyrazinamide%2C%20and%20the%20group%204%20drugs%20ranged%20from%201.7%20to%202.3%2C%20whereas%20for%20second-line%20injectables%20and%20fluoroquinolones%2C%20odds%20ranged%20from%202.4%20to%204.6.%5CnConclusions.%20DST%20for%20ethambutol%2C%20pyrazinamide%2C%20and%20second-line%20tuberculosis%20drugs%20appears%20to%20provide%20clinically%20useful%20information%20to%20guide%20selection%20of%20treatment%20regimens%20for%20MDR%20and%20XDR%20tuberculosis.%22%2C%22date%22%3A%222014-11-15%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciu619%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fcid.oxfordjournals.org%5C%2Fcontent%5C%2F59%5C%2F10%5C%2F1364%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221058-4838%2C%201537-6591%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-03-26T17%3A57%3A15Z%22%7D%7D%2C%7B%22key%22%3A%22C89M4NXG%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bernard%20et%20al.%22%2C%22parsedDate%22%3A%222014%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBernard%2C%20C.%2C%20Brossier%2C%20F.%2C%20Fr%26%23xE9%3Bchet-Jachym%2C%20M.%2C%20Morand%2C%20P.%20C.%2C%20Coignard%2C%20S.%2C%20Aslangul%2C%20E.%2C%20Aubry%2C%20A.%2C%20Jarlier%2C%20V.%2C%20Sougakoff%2C%20W.%20and%20Veziris%2C%20N.%20%282014%29.%20%26lt%3Bb%26gt%3BConcomitant%20Multidrug-resistant%20Pulmonary%20Tuberculosis%20and%20Susceptible%20Tuberculous%20Meningitis%26lt%3B%5C%2Fb%26gt%3B.%20Emerging%20Infectious%20Diseases%20%26lt%3Bi%26gt%3B20%26lt%3B%5C%2Fi%26gt%3B%2C%20506%26%23x2013%3B507%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3201%5C%2Feid2003.131205%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3201%5C%2Feid2003.131205%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Concomitant%20Multidrug-resistant%20Pulmonary%20Tuberculosis%20and%20Susceptible%20Tuberculous%20Meningitis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathilde%22%2C%22lastName%22%3A%22Fr%5Cu00e9chet-Jachym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%20C.%22%2C%22lastName%22%3A%22Morand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophie%22%2C%22lastName%22%3A%22Coignard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisabeth%22%2C%22lastName%22%3A%22Aslangul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2203%5C%2F2014%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.3201%5C%2Feid2003.131205%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwwwnc.cdc.gov%5C%2Feid%5C%2Farticle%5C%2F20%5C%2F3%5C%2F13-1205_article%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221080-6040%2C%201080-6059%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-02-26T18%3A04%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22F23JKI8Q%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brossier%20et%20al.%22%2C%22parsedDate%22%3A%222014-11-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBrossier%2C%20F.%2C%20Sola%2C%20C.%2C%20Millot%2C%20G.%2C%20Jarlier%2C%20V.%2C%20Veziris%2C%20N.%20and%20Sougakoff%2C%20W.%20%282014%29.%20%26lt%3Bb%26gt%3BComparison%20of%20a%20Semiautomated%20Commercial%20Repetitive-Sequence-Based%20PCR%20Method%20with%20Spoligotyping%2C%2024-Locus%20Mycobacterial%20Interspersed%20Repetitive-Unit%26%23x2013%3BVariable-Number%20Tandem-Repeat%20Typing%2C%20and%20Restriction%20Fragment%20Length%20Polymorphism-Based%20Analysis%20of%20IS6110%20for%20Mycobacterium%20tuberculosis%20Typing%26lt%3B%5C%2Fb%26gt%3B.%20J%20Clin%20Microbiol%20%26lt%3Bi%26gt%3B52%26lt%3B%5C%2Fi%26gt%3B%2C%204082%26%23x2013%3B4086%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.02226-14%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.02226-14%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Comparison%20of%20a%20Semiautomated%20Commercial%20Repetitive-Sequence-Based%20PCR%20Method%20with%20Spoligotyping%2C%2024-Locus%20Mycobacterial%20Interspersed%20Repetitive-Unit%5Cu2013Variable-Number%20Tandem-Repeat%20Typing%2C%20and%20Restriction%20Fragment%20Length%20Polymorphism-Based%20Analysis%20of%20IS6110%20for%20Mycobacterium%20tuberculosis%20Typing%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Sola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Millot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%22%2C%22lastName%22%3A%22Sougakoff%22%7D%5D%2C%22abstractNote%22%3A%22Fifty-two%20multidrug-resistant%20isolates%20of%20Mycobacterium%20tuberculosis%20representative%20of%20the%20currently%20predominant%20lineages%20in%20France%20were%20analyzed%20using%20repetitive-sequence-based%20PCR%20%28rep-PCR%29%20DiversiLab%20%28DL%29%2C%20spoligotyping%2C%2024-locus%20mycobacterial%20interspersed%20repetitive-unit%5Cu2013variable-number%20tandem-repeat%20typing%20%28MIRU-VNTR%29%2C%20and%20restriction%20fragment%20length%20polymorphism%20of%20IS6110%20%28IS6110-RFLP%29.%20DL%2C%20as%20opposed%20to%20MIRU-VNTR%20and%20IS6110-RFLP%20analysis%2C%20did%20not%20allow%20discrimination%20among%20half%20of%20the%20isolates%2C%20an%20indication%20of%20comparatively%20lower%20resolving%20power.%22%2C%22date%22%3A%2211%5C%2F01%5C%2F2014%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2FJCM.02226-14%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjcm.asm.org%5C%2Fcontent%5C%2F52%5C%2F11%5C%2F4082%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220095-1137%2C%201098-660X%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-04-27T17%3A08%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22SXN9ZPK4%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cambau%20and%20Drancourt%22%2C%22parsedDate%22%3A%222014-03-01%22%2C%22numChildren%22%3A6%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCambau%2C%20E.%20and%20Drancourt%2C%20M.%20%282014%29.%20%26lt%3Bb%26gt%3BSteps%20towards%20the%20discovery%20of%20Mycobacterium%20tuberculosis%20by%20Robert%20Koch%2C%201882%26lt%3B%5C%2Fb%26gt%3B.%20Clin%20Microbiol%20Infect%20%26lt%3Bi%26gt%3B20%26lt%3B%5C%2Fi%26gt%3B%2C%20196%26%23x2013%3B201%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2F1469-0691.12555%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2F1469-0691.12555%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Steps%20towards%20the%20discovery%20of%20Mycobacterium%20tuberculosis%20by%20Robert%20Koch%2C%201882%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Drancourt%22%7D%5D%2C%22abstractNote%22%3A%22Palaeomicrobiology%20has%20detected%20the%20tuberculosis%20agent%20in%20animal%20and%20human%20skeletons%20that%20are%20thousands%20of%20years%20old.%20The%20German%20doctor%20Robert%20Koch%20was%20the%20first%20microbiologist%20to%20report%20in%201882%20the%20successful%20isolation%20of%20the%20causative%20agent%20of%20tuberculosis%2C%20named%201%5Cu00a0year%20later%20as%20Mycobacterium%20tuberculosis.%20This%20immense%20discovery%2C%20however%2C%20was%20not%20made%20from%20scratch%2C%20but%20involved%20the%20combining%20of%20previous%20scientific%20knowledge%2C%20chiefly%20the%20previous%20demonstration%20by%20the%20French%20doctor%20Jean-Antoine%20Villemin%20that%20tuberculosis%20was%20a%20transmissible%20disease%2C%20and%20two%20innovations%5Cu2014a%20new%20staining%20procedure%20that%20allowed%20R.%20Koch%20to%20consistently%20observe%20the%20new%20organism%20in%20tuberculous%20lesions%2C%20and%20use%20of%20a%20solidified%2C%20serum-based%20medium%20instead%20of%20broths%20for%20the%20culture.%20These%20innovations%20allowed%20R.%20Koch%20not%20only%20to%20isolate%20M.%5Cu00a0tuberculosis%20from%20animal%20and%20patient%20specimens%20for%20the%20first%20time%2C%20but%20also%20to%20reproduce%20the%20disease%20in%20experimentally%20inoculated%20guinea%20pigs.%20It%20is%20thanks%20to%20R.%20Koch%20that%20one%20of%20the%20most%20lethal%20diseases%20in%20human%20history%20could%20be%20diagnosed%2C%20could%20be%20treated%20and%20cured%20after%20the%20discovery%20of%20streptomycin%2065%5Cu00a0years%20later%2C%20and%20could%20be%20efficiently%20prevented%20by%20isolation%20of%20cases.%20His%20microbiological%20innovations%20are%20now%20being%20renewed%20with%20molecular%20and%20improved%20culture-based%20detection%20being%20the%20twenty-first%20century%20weapons%20in%20the%20fight%20against%20this%20disease%2C%20which%20remains%20a%20major%20killer.%22%2C%22date%22%3A%22March%201%2C%202014%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1111%5C%2F1469-0691.12555%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fonlinelibrary.wiley.com%5C%2Fdoi%5C%2F10.1111%5C%2F1469-0691.12555%5C%2Fabstract%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221469-0691%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-01-08T18%3A02%3A08Z%22%7D%7D%2C%7B%22key%22%3A%22CZENVP6G%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22de%20Beer%20et%20al.%22%2C%22parsedDate%22%3A%222014-05-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3Bde%20Beer%2C%20J.%20L.%2C%20K%26%23xF6%3Bdm%26%23xF6%3Bn%2C%20C.%2C%20van%20Ingen%2C%20J.%2C%20Supply%2C%20P.%2C%20van%20Soolingen%2C%20D.%20and%20The%20Global%20Network%20for%20the%20Molecular%20Surveillance%20of%20Tuberculosis%202010%20%282014%29.%20%26lt%3Bb%26gt%3BSecond%20worldwide%20proficiency%20study%20on%20variable%20number%20of%20tandem%20repeats%20typing%20of%20Mycobacterium%20tuberculosis%20complex%26lt%3B%5C%2Fb%26gt%3B.%20The%20International%20Journal%20of%20Tuberculosis%20and%20Lung%20Disease%20%26lt%3Bi%26gt%3B18%26lt%3B%5C%2Fi%26gt%3B%2C%20594%26%23x2013%3B600%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.13.0531%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.13.0531%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Second%20worldwide%20proficiency%20study%20on%20variable%20number%20of%20tandem%20repeats%20typing%20of%20Mycobacterium%20tuberculosis%20complex%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20L.%22%2C%22lastName%22%3A%22de%20Beer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22K%5Cu00f6dm%5Cu00f6n%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22van%20Ingen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Supply%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22van%20Soolingen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22The%20Global%20Network%20for%20the%20Molecular%20Surveillance%20of%20Tuberculosis%202010%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20quality%20of%20variable%20number%20of%20tandem%20repeats%20%28VNTR%29%20typing%20of%20Mycobacterium%20tuberculosis%20was%20first%20investigated%20in%202009%20in%2037%20laboratories%20worldwide.%20The%20results%20revealed%20an%20inter-%20and%20intra-laboratory%20reproducibility%20of%20respectively%2060%25%20and%2072%25.%20These%20data%20spurred%20an%20improvement%20in%20laboratory-specific%20assays%20and%20global%20standardisation%20of%20VNTR%20typing.%20OBJECTIVE%3A%20To%20measure%20the%20effects%20of%20the%20technical%20improvements%20and%20increased%20standardisation%2C%20a%20test%20panel%20consisting%20of%2030%20M.%20tuberculosis%20complex%20DNA%20samples%20was%20distributed%20for%20VNTR%20typing%20in%2041%20participating%20laboratories%20from%2036%20countries.%20RESULTS%3A%20The%20inter-%20and%20intra-laboratory%20reproducibility%20increased%20overall%20to%20respectively%2078%25%20and%2088%25.%20The%2033%20laboratories%20that%20participated%20in%20both%20the%20first%20and%20second%20proficiency%20studies%20improved%20their%20inter-%20and%20intra-laboratory%20reproducibility%20from%2062%25%20and%2072%25%20to%20respectively%2079%25%20and%2088%25.%20The%20largest%20improvement%20in%20reproducibility%20was%20detected%20in%2010%20laboratories%20that%20use%20an%20in-house%20polymerase%20chain%20reaction%20technique%20and%20perform%20amplicon%20sizing%20using%20gel%20electrophoresis.%20Detailed%20error%20analysis%20revealed%20a%20reduction%20in%20the%20number%20of%20systematic%20errors%2C%20sample%20exchange%20events%20and%20non-amplifiable%20loci.%20CONCLUSION%3A%20This%20second%20worldwide%20proficiency%20study%20indicates%20a%20substantial%20increase%20in%20the%20reproducibility%20of%20VNTR%20typing%20of%20M.%20tuberculosis.%20This%20will%20contribute%20to%20a%20more%20meaningful%20interpretation%20of%20molecular%20epidemiological%20and%20phylogenetic%20studies%20on%20the%20M.%20tuberculosis%20complex.%22%2C%22date%22%3A%222014-05-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.5588%5C%2Fijtld.13.0531%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222015-07-20T16%3A39%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22FVC9ASTH%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22De%20Beer%20et%20al.%22%2C%22parsedDate%22%3A%222014%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDe%20Beer%2C%20J.%20L.%2C%20Kodmon%2C%20C.%2C%20van%20der%20Werf%2C%20M.%20J.%2C%20van%20Ingen%2C%20J.%2C%20van%20Soolingen%2C%20D.%20and%20ECDC%20MDR-TB%20Molecular%20Surveillance%20Project%20Participants%20%282014%29.%20%26lt%3Bb%26gt%3BMolecular%20surveillance%20of%20multi-%20and%20extensively%20drug-resistant%20tuberculosis%20transmission%20in%20the%20European%20Union%20from%202003%20to%202011%26lt%3B%5C%2Fb%26gt%3B.%20Euro%20Surveill%20%26lt%3Bi%26gt%3B19%26lt%3B%5C%2Fi%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Molecular%20surveillance%20of%20multi-%20and%20extensively%20drug-resistant%20tuberculosis%20transmission%20in%20the%20European%20Union%20from%202003%20to%202011%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20L.%22%2C%22lastName%22%3A%22De%20Beer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Kodmon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20J.%22%2C%22lastName%22%3A%22van%20der%20Werf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22van%20Ingen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22van%20Soolingen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22ECDC%20MDR-TB%20Molecular%20Surveillance%20Project%20Participants%22%7D%5D%2C%22abstractNote%22%3A%22The%20European%20Centre%20for%20Disease%20Prevention%20and%20Control%20%28ECDC%29%20initiated%20a%20project%20on%20the%20molecular%20surveillance%20of%20multi-%20and%20extensively%20drug-resistant%20tuberculosis%20%28MDR-%5C%2FXDR-TB%29%20transmission%20in%20the%20European%20Union%20%28EU%29%20in%20the%20period%20from%202009%20to%202011.%20In%20total%2C%202%2C092%20variable%20number%20of%20tandem%20repeat%20%28VNTR%29%20patterns%20of%20MDR-%5C%2FXDR-TB%20Mycobacterium%20tuberculosis%20isolates%20were%20collected%2C%20originating%20from%2024%20different%20countries%20in%20the%20period%202003%20to%202011.%20Of%20the%20collected%20VNTR%20patterns%2C%2045%25%20%28n%3D941%29%20could%20be%20assigned%20to%20one%20of%20the%2079%20European%20multiple-country%20molecular%20fingerprint%20clusters%20and%2050%25%20of%20those%20%28n%3D470%29%20belonged%20to%20one%20extremely%20large%20cluster%20caused%20by%20Beijing%20strains%20of%20one%20genotype.%20We%20conclude%20that%20international%20transmission%20of%20MDR-%5C%2FXDR-TB%20plays%20an%20important%20role%20in%20the%20EU%2C%20especially%20in%20the%20eastern%20part%2C%20and%20is%20significantly%20related%20to%20the%20spread%20of%20one%20strain%20or%20clone%20of%20the%20Beijing%20genotype.%20Implementation%20of%20international%20cluster%20investigation%20in%20EU%20countries%20should%20reveal%20underlying%20factors%20of%20transmission%2C%20and%20show%20how%20TB%20control%20can%20be%20improved%20regarding%20case%20finding%2C%20contact%20tracing%2C%20infection%20control%20and%20treatment%20in%20order%20to%20prevent%20further%20spread%20of%20MDR-%5C%2FXDR-TB%20in%20the%20EU.%22%2C%22date%22%3A%222014%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221560-7917%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222015-07-20T16%3A41%3A45Z%22%7D%7D%2C%7B%22key%22%3A%223H39HRSJ%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22de%20Masson%20et%20al.%22%2C%22parsedDate%22%3A%222014%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3Bde%20Masson%2C%20A.%2C%20Maillart%2C%20E.%2C%20Veziris%2C%20N.%2C%20Meyssonnier%2C%20V.%2C%20Papeix%2C%20C.%20and%20Caumes%2C%20E.%20%282014%29.%20%26lt%3Bb%26gt%3BCavitary%20pulmonary%20disease%20in%20a%20patient%20treated%20with%20natalizumab%26lt%3B%5C%2Fb%26gt%3B.%20La%20Presse%20M%26%23xE9%3Bdicale%20%26lt%3Bi%26gt%3B43%26lt%3B%5C%2Fi%26gt%3B%2C%201009%26%23x2013%3B1012%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lpm.2013.12.012%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.lpm.2013.12.012%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Cavitary%20pulmonary%20disease%20in%20a%20patient%20treated%20with%20natalizumab%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ad%5Cu00e8le%22%2C%22lastName%22%3A%22de%20Masson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisabeth%22%2C%22lastName%22%3A%22Maillart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanina%22%2C%22lastName%22%3A%22Meyssonnier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%22%2C%22lastName%22%3A%22Papeix%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Caumes%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2209%5C%2F2014%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.lpm.2013.12.012%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS0755498214001377%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%2207554982%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-02-27T14%3A10%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22NHCWA8HP%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Delafont%20et%20al.%22%2C%22parsedDate%22%3A%222014-09-23%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDelafont%2C%20V.%2C%20Mougaris%2C%20F.%2C%20Cambau%2C%20E.%2C%20Joyeux%2C%20%20michel%2C%20Bouchon%2C%20D.%2C%20Hechard%2C%20Y.%20and%20Moulin%2C%20L.%20%282014%29.%20%26lt%3Bb%26gt%3BFirst%20evidence%20of%20amoebae%20%26%23x2013%3B%20mycobacteria%20association%20in%20drinking%20water%20network%26lt%3B%5C%2Fb%26gt%3B.%20Environ%20Sci%20Technol%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Fes5036255%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1021%5C%2Fes5036255%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22First%20evidence%20of%20amoebae%20%5Cu2013%20mycobacteria%20association%20in%20drinking%20water%20network%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Delafont%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faiza%22%2C%22lastName%22%3A%22Mougaris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22michel%22%2C%22lastName%22%3A%22Joyeux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dider%22%2C%22lastName%22%3A%22Bouchon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yann%22%2C%22lastName%22%3A%22Hechard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Moulin%22%7D%5D%2C%22abstractNote%22%3A%22Free-living%20amoebae%20are%20protozoa%20ubiquitously%20found%20in%20water%20systems.%20They%20mainly%20feed%20on%20bacteria%20by%20phagocytosis%2C%20but%20some%20bacterial%20species%20are%20able%20to%20resist%20or%20even%20escape%20this%20lethal%20process.%20Among%20these%20amoeba%20resistant%20bacteria%20are%20numerous%20members%20of%20the%20genus%20Mycobacterium.%20Nontuberculous%20Mycobacteria%20%28NTM%29%20are%20opportunistic%20pathogens%20that%20share%20the%20same%20ecological%20niches%20as%20amoebae.%20While%20several%20studies%20have%20demonstrated%20the%20ability%20of%20these%20bacteria%20to%20colonise%20and%20persist%20within%20drinking%20water%20networks%2C%20there%20is%20also%20strong%20suspicion%20that%20mycobacteria%20could%20use%20amoebae%20as%20a%20vehicle%20for%20protection%20and%20even%20replication.%20We%20investigated%20here%20the%20presence%20of%20NTM%20and%20FLA%20on%20a%20drinking%20water%20network%20during%20an%20all%20year%20round%20sampling%20campaign.%20We%20observed%20that%2087.6%25%20of%20recovered%20amoebal%20cultures%20carried%20high%20numbers%20of%20NTM.%20Identification%20of%20these%20amoeba%20and%20mycobacteria%20strains%20indicated%20that%20the%20main%20genera%20found%20in%20drinking%20water%20networks%2C%20i.e.%20Acanthamoeba%2C%20Vermamoeba%2C%20Echinamoeba%20and%20Protacanthamoeba%20are%20able%20to%20carry%20and%20likely%20to%20allow%20replication%20of%20several%20environmental%20and%20potentially%20pathogenic%20mycobacteria%20including%20M.%20llatzerense%20and%20M.%20chelonae.%20Direct%20Sanger%20sequencing%20as%20well%20as%20pyrosequencing%20of%20environmental%20isolates%20demonstrated%20the%20frequent%20association%20of%20mycobacteria%20and%20FLA%2C%20as%20they%20are%20part%20of%20the%20most%20represented%20genera%20composing%20amoebae%26%23039%3Bs%20microbiome.%20This%20is%20the%20first%20time%20that%20an%20association%20between%20FLA%20and%20NTM%20is%20observed%20in%20water%20networks%2C%20highlighting%20the%20importance%20of%20FLA%20in%20the%20ecology%20of%20NTM.%22%2C%22date%22%3A%22September%2023%2C%202014%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1021%5C%2Fes5036255%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fdx.doi.org%5C%2F10.1021%5C%2Fes5036255%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220013-936X%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-03-26T17%3A51%3A27Z%22%7D%7D%2C%7B%22key%22%3A%22VHRV75TG%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fangous%20et%20al.%22%2C%22parsedDate%22%3A%222014-09-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BFangous%2C%20M.-S.%2C%20Mougari%2C%20F.%2C%20Gouriou%2C%20S.%2C%20Calvez%2C%20E.%2C%20Raskine%2C%20L.%2C%20Cambau%2C%20E.%2C%20Payan%2C%20C.%20and%20H%26%23xE9%3Bry-Arnaud%2C%20G.%20%282014%29.%20%26lt%3Bb%26gt%3BClassification%20Algorithm%20for%20Subspecies%20Identification%20within%20the%20Mycobacterium%20abscessus%20Species%2C%20Based%20on%20Matrix-Assisted%20Laser%20Desorption%20Ionization%26%23x2013%3BTime%20of%20Flight%20Mass%20Spectrometry%26lt%3B%5C%2Fb%26gt%3B.%20J%20Clin%20Microbiol%20%26lt%3Bi%26gt%3B52%26lt%3B%5C%2Fi%26gt%3B%2C%203362%26%23x2013%3B3369%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.00788-14%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.00788-14%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Classification%20Algorithm%20for%20Subspecies%20Identification%20within%20the%20Mycobacterium%20abscessus%20Species%2C%20Based%20on%20Matrix-Assisted%20Laser%20Desorption%20Ionization%5Cu2013Time%20of%20Flight%20Mass%20Spectrometry%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Sarah%22%2C%22lastName%22%3A%22Fangous%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faiza%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phanie%22%2C%22lastName%22%3A%22Gouriou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elodie%22%2C%22lastName%22%3A%22Calvez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Raskine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Payan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Genevi%5Cu00e8ve%22%2C%22lastName%22%3A%22H%5Cu00e9ry-Arnaud%22%7D%5D%2C%22abstractNote%22%3A%22Mycobacterium%20abscessus%2C%20as%20a%20species%2C%20has%20been%20increasingly%20implicated%20in%20respiratory%20infections%2C%20notably%20in%20cystic%20fibrosis%20patients.%20The%20species%20comprises%203%20subspecies%2C%20which%20can%20be%20difficult%20to%20identify.%20Since%20they%20differ%20in%20antibiotic%20susceptibility%20and%20clinical%20relevance%2C%20developing%20a%20routine%20diagnostic%20tool%20discriminating%20Mycobacterium%20abscessus%20at%20the%20subspecies%20level%20is%20a%20real%20challenge.%20Forty-three%20Mycobacterium%20abscessus%20species%20isolates%2C%20previously%20identified%20by%20multilocus%20sequence%20typing%2C%20were%20analyzed%20by%20matrix-assisted%20laser%20desorption%20ionization%5Cu2013time%20of%20flight%20mass%20spectrometry%20%28MALDI-TOF%20MS%29.%20A%20subspecies%20identification%20algorithm%2C%20based%20on%20five%20discriminating%20peaks%2C%20was%20drawn%20up%20and%20validated%20by%20blind%20identification%20of%20a%20further%2049%20strains%2C%2094%25%20of%20which%20%28n%20%3D%2046%29%20were%20correctly%20identified.%20Two%20M.%20abscessus%20subsp.%20massiliense%20strains%20were%20misidentified%20as%20M.%20abscessus%20subsp.%20abscessus%2C%20and%20for%201%20other%20strain%20identification%20failed.%20Inter-%20and%20intralaboratory%20reproducibility%20tests%20were%20conclusive.%20This%20study%20presents%2C%20for%20the%20first%20time%2C%20a%20classification%20algorithm%20for%20MALDI-TOF%20MS%20identification%20of%20the%203%20M.%20abscessus%20subspecies.%20MALDI-TOF%20MS%20proved%20effective%20in%20discriminating%20within%20the%20M.%20abscessus%20species%20and%20might%20be%20easily%20integrated%20into%20the%20workflow%20of%20microbiology%20labs.%22%2C%22date%22%3A%2209%5C%2F01%5C%2F2014%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2FJCM.00788-14%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjcm.asm.org%5C%2Fcontent%5C%2F52%5C%2F9%5C%2F3362%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220095-1137%2C%201098-660X%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-04-27T17%3A05%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22XAZXMGAD%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Godreuil%20et%20al.%22%2C%22parsedDate%22%3A%222014-08-27%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGodreuil%2C%20S.%2C%20Leban%2C%20N.%2C%20Padilla%2C%20A.%2C%20Hamel%2C%20R.%2C%20Luplertlop%2C%20N.%2C%20Chauffour%2C%20A.%2C%20Vittecoq%2C%20M.%2C%20Hoh%2C%20F.%2C%20Thomas%2C%20F.%2C%20Sougakoff%2C%20W.%2C%20Lionne%2C%20C.%2C%20Yssel%2C%20H.%20and%20Miss%26%23xE9%3B%2C%20D.%20%282014%29.%20%26lt%3Bb%26gt%3BAedesin%3A%20Structure%20and%20Antimicrobial%20Activity%20against%20Multidrug%20Resistant%20Bacterial%20Strains%26lt%3B%5C%2Fb%26gt%3B%20Ed.%20Shih%2C%20C.%20PLoS%20ONE%20%26lt%3Bi%26gt%3B9%26lt%3B%5C%2Fi%26gt%3B%2C%20e105441%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0105441%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0105441%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Aedesin%3A%20Structure%20and%20Antimicrobial%20Activity%20against%20Multidrug%20Resistant%20Bacterial%20Strains%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvain%22%2C%22lastName%22%3A%22Godreuil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadia%22%2C%22lastName%22%3A%22Leban%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andr%5Cu00e9%22%2C%22lastName%22%3A%22Padilla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rodolphe%22%2C%22lastName%22%3A%22Hamel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natthanej%22%2C%22lastName%22%3A%22Luplertlop%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marion%22%2C%22lastName%22%3A%22Vittecoq%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7ois%22%2C%22lastName%22%3A%22Hoh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fr%5Cu00e9d%5Cu00e9ric%22%2C%22lastName%22%3A%22Thomas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corinne%22%2C%22lastName%22%3A%22Lionne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hans%22%2C%22lastName%22%3A%22Yssel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Doroth%5Cu00e9e%22%2C%22lastName%22%3A%22Miss%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Chiaho%22%2C%22lastName%22%3A%22Shih%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222014-8-27%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0105441%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fdx.plos.org%5C%2F10.1371%5C%2Fjournal.pone.0105441%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221932-6203%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-02-27T14%3A13%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22E38XJ99U%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lerat%20et%20al.%22%2C%22parsedDate%22%3A%222014-03-15%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLerat%2C%20I.%2C%20Cambau%2C%20E.%2C%20Bettoni%2C%20R.%20R.%20dit%2C%20Gaillard%2C%20J.-L.%2C%20Jarlier%2C%20V.%2C%20Truffot%2C%20C.%20and%20Veziris%2C%20N.%20%282014%29.%20%26lt%3Bb%26gt%3BIn%20Vivo%20Evaluation%20of%20Antibiotic%20Activity%20Against%20Mycobacterium%20abscessus%26lt%3B%5C%2Fb%26gt%3B.%20J%20Infect%20Dis%20%26lt%3Bi%26gt%3B209%26lt%3B%5C%2Fi%26gt%3B%2C%20905%26%23x2013%3B912%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Finfdis%5C%2Fjit614%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Finfdis%5C%2Fjit614%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22In%20Vivo%20Evaluation%20of%20Antibiotic%20Activity%20Against%20Mycobacterium%20abscessus%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Lerat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Romain%20Roth%20dit%22%2C%22lastName%22%3A%22Bettoni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Louis%22%2C%22lastName%22%3A%22Gaillard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chantal%22%2C%22lastName%22%3A%22Truffot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22Background.%20The%20prognosis%20of%20Mycobacterium%20abscessus%20infections%20is%20poor%20due%20to%20the%20lack%20of%20effective%20drug%20treatment.%20The%20objective%20of%20this%20study%20was%20to%20set%20up%20an%20animal%20model%20suitable%20to%20test%20antibiotic%20activity%20against%20M.%20abscessus.%5CnMethods.%20The%20following%20mouse%20strains%20were%20evaluated%3A%20Swiss%2C%20BALB%5C%2Fc%2C%20C57BL%5C%2F6%2C%20nude%2C%20beige%2C%20A%5C%2FJ%2C%20and%20GKO.%20Antibiotic%20activity%20was%20tested%20for%20clarithromycin%2C%20amikacin%2C%20cefoxitin%2C%20tigecycline%2C%20and%20bedaquiline%20%28TMC207%29.%20Finally%2C%20we%20evaluated%20the%203-drug%20combination%20clarithromycin%2C%20cefoxitin%2C%20and%20amikacin.%5CnResults.%20Nude%20and%20GKO%20mice%20fulfilled%20criteria%20for%20the%20model%20but%20only%20nude%20mice%20offered%20sufficient%20availability%20for%20large%20therapeutic%20experiments.%20Among%20the%203%20drugs%20usually%20combined%20for%20treatment%20of%20M.%20abscessus%20infection%2C%20cefoxitin%20was%20the%20most%20active%20because%20it%20improved%20survival%20and%20reduced%20bacillary%20loads%20in%20spleen%20whereas%20clarithromycin%20and%20amikacin%20prevented%20death%20but%20had%20little%20impact%20on%20bacillary%20loads.%20The%20triple-drug%20combination%20was%20not%20more%20active%20than%20cefoxitin%20alone.%20Tigecycline%20displayed%20bactericidal%20activity%20whereas%20bedaquiline%20was%20almost%20inactive.%5CnConclusions.%20Nude%20mice%20are%20an%20adequate%20model%20for%20in%20vivo%20chemotherapy%20studies.%20Among%20tested%20drugs%2C%20cefoxitin%20and%20tigecycline%20showed%20promising%20in%20vivo%20activity%20against%20M.%20abscessus.%20The%20best%20drug%20combination%20remains%20to%20be%20determined.%22%2C%22date%22%3A%2203%5C%2F15%5C%2F2014%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Finfdis%5C%2Fjit614%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjid.oxfordjournals.org%5C%2Fcontent%5C%2F209%5C%2F6%5C%2F905%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220022-1899%2C%201537-6613%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-04-27T17%3A07%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22NXSXGW9A%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Macheras%20et%20al.%22%2C%22parsedDate%22%3A%222014%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMacheras%2C%20E.%2C%20Konjek%2C%20J.%2C%20Roux%2C%20A.-L.%2C%20Thiberge%2C%20J.-M.%2C%20Bastian%2C%20S.%2C%20Le%26%23xE3%3Bo%2C%20S.%20C.%2C%20Palaci%2C%20M.%2C%20Sivadon-Tardy%2C%20V.%2C%20Gutierrez%2C%20C.%2C%20Richter%2C%20E.%2C%20R%26%23xFC%3Bsch-Gerdes%2C%20S.%2C%20Pfyffer%2C%20G.%20E.%2C%20Bodmer%2C%20T.%2C%20Jarlier%2C%20V.%2C%20Cambau%2C%20E.%2C%20Brisse%2C%20S.%2C%20Caro%2C%20V.%2C%20Rastogi%2C%20N.%2C%20Gaillard%2C%20J.-L.%20and%20Heym%2C%20B.%20%282014%29.%20%26lt%3Bb%26gt%3BMultilocus%20sequence%20typing%20scheme%20for%20the%20Mycobacterium%20abscessus%20complex%26lt%3B%5C%2Fb%26gt%3B.%20Research%20in%20Microbiology%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.resmic.2013.12.003%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.resmic.2013.12.003%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multilocus%20sequence%20typing%20scheme%20for%20the%20Mycobacterium%20abscessus%20complex%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edouard%22%2C%22lastName%22%3A%22Macheras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%22%2C%22lastName%22%3A%22Konjek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne-Laure%22%2C%22lastName%22%3A%22Roux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Michel%22%2C%22lastName%22%3A%22Thiberge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvaine%22%2C%22lastName%22%3A%22Bastian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvia%20Cardoso%22%2C%22lastName%22%3A%22Le%5Cu00e3o%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Moises%22%2C%22lastName%22%3A%22Palaci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9rie%22%2C%22lastName%22%3A%22Sivadon-Tardy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristina%22%2C%22lastName%22%3A%22Gutierrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elvira%22%2C%22lastName%22%3A%22Richter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabine%22%2C%22lastName%22%3A%22R%5Cu00fcsch-Gerdes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaby%20E.%22%2C%22lastName%22%3A%22Pfyffer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Bodmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvain%22%2C%22lastName%22%3A%22Brisse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Val%5Cu00e9rie%22%2C%22lastName%22%3A%22Caro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nalin%22%2C%22lastName%22%3A%22Rastogi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Louis%22%2C%22lastName%22%3A%22Gaillard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beate%22%2C%22lastName%22%3A%22Heym%22%7D%5D%2C%22abstractNote%22%3A%22We%20developed%20a%20multilocus%20sequence%20typing%20%28MLST%29%20scheme%20for%20Mycobacterium%20abscessus%20sensu%20lato%2C%20based%20on%20the%20partial%20sequencing%20of%20seven%20housekeeping%20genes%3A%20argH%2C%20cya%2C%20glpK%2C%20gnd%2C%20murC%2C%20pta%20and%20purH.%20This%20scheme%20was%20used%20to%20characterize%20a%20collection%20of%20227%20isolates%20recovered%20between%201994%20and%202010%20in%20France%2C%20Germany%2C%20Switzerland%20and%20Brazil.%20We%20identified%20100%20different%20sequence%20types%20%28STs%29%2C%20which%20were%20distributed%20into%20three%20groups%20on%20the%20tree%20obtained%20by%20concatenating%20the%20sequences%20of%20the%20seven%20housekeeping%20gene%20fragments%20%283576%20bp%29%3A%20the%20M.%20abscessus%20sensu%20stricto%20group%20%2844%20STs%29%2C%20the%20%5Cu201cM.%20massiliense%5Cu201d%20group%20%2831%20STs%29%20and%20the%20%5Cu201cM.%20bolletii%5Cu201d%20group%20%2825%20STs%29.%20SplitTree%20analysis%20showed%20a%20degree%20of%20intergroup%20lateral%20transfers.%20There%20was%20also%20evidence%20of%20lateral%20transfer%20events%20involving%20rpoB.%20The%20most%20prevalent%20STs%20in%20our%20collection%20were%20ST1%20%28CC5%3B%2020%20isolates%29%20and%20ST23%20%28CC3%3B%2031%20isolates%29.%20Both%20STs%20were%20found%20in%20Europe%20and%20Brazil%2C%20and%20the%20latter%20was%20implicated%20in%20a%20large%20post-surgical%20procedure%20outbreak%20in%20Brazil.%20Respiratory%20isolates%20from%20patients%20with%20cystic%20fibrosis%20belonged%20to%20a%20large%20variety%20of%20STs%3B%20however%2C%20ST2%20was%20predominant%20in%20this%20group%20of%20patients.%5CnOur%20MLST%20scheme%2C%20publicly%20available%20at%20www.pasteur.fr%5C%2Fmlst%2C%20offers%20investigators%20a%20valuable%20typing%20tool%20for%20M.%20abscessus%20sensu%20lato%20in%20future%20epidemiological%20studies%20throughout%20the%20world.%22%2C%22date%22%3A%222014%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.resmic.2013.12.003%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0923250813002234%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220923-2508%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222015-07-20T16%3A26%3A59Z%22%7D%7D%2C%7B%22key%22%3A%22XUBPKGGR%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Meyssonnier%20et%20al.%22%2C%22parsedDate%22%3A%222014-01-10%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMeyssonnier%2C%20V.%2C%20Bui%2C%20T.%20V.%2C%20Veziris%2C%20N.%2C%20Jarlier%2C%20V.%20and%20Robert%2C%20J.%20%282014%29.%20%26lt%3Bb%26gt%3BRifampicin%20mono-resistant%20tuberculosis%20in%20France%3A%20a%202005%26%23x2013%3B2010%20retrospective%20cohort%20analysis%26lt%3B%5C%2Fb%26gt%3B.%20BMC%20Infectious%20Diseases%20%26lt%3Bi%26gt%3B14%26lt%3B%5C%2Fi%26gt%3B%2C%2018%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2F1471-2334-14-18%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2F1471-2334-14-18%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Rifampicin%20mono-resistant%20tuberculosis%20in%20France%3A%20a%202005%5Cu20132010%20retrospective%20cohort%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanina%22%2C%22lastName%22%3A%22Meyssonnier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thuy%20Van%22%2C%22lastName%22%3A%22Bui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%5D%2C%22abstractNote%22%3A%22Rifampicin%20resistance%20is%20a%20risk%20factor%20for%20poor%20outcome%20in%20tuberculosis.%20Therefore%2C%20we%20sought%20to%20describe%20the%20characteristics%20and%20management%20of%20Rifampicin%20monoresistant%20%28RMR%29%20tuberculosis%20%28TB%29%20in%20France.%5CnPMID%3A%2024410906%22%2C%22date%22%3A%222014-01-10%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1186%5C%2F1471-2334-14-18%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.biomedcentral.com%5C%2F1471-2334%5C%2F14%5C%2F18%5C%2Fabstract%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221471-2334%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222014-03-02T08%3A37%3A11Z%22%7D%7D%2C%7B%22key%22%3A%224DH82WR9%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mordant%20et%20al.%22%2C%22parsedDate%22%3A%222014%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMordant%2C%20P.%2C%20Henry%2C%20B.%2C%20Morel%2C%20S.%2C%20Robert%2C%20J.%2C%20Veziris%2C%20N.%2C%20Le%20D%26%23xFB%3B%2C%20D.%2C%20Frechet-Jachym%2C%20M.%2C%20Similowski%2C%20T.%2C%20Caumes%2C%20%26%23xE9%3B.%2C%20Riquet%2C%20M.%20and%20Le%20Pimpec-Barthes%2C%20F.%20%282014%29.%20%26lt%3Bb%26gt%3BChirurgie%20et%20tuberculose%20multi%5C%2Fultrar%26%23xE9%3Bsistante%26%23x202F%3B%3A%20une%20revue%20de%20la%20litt%26%23xE9%3Brature%20r%26%23xE9%3Bhabilite%20une%20intervention%20adjuvante%20%26%23xE0%3B%20l%26%23x2019%3Bantibioth%26%23xE9%3Brapie%20chez%20des%20patients%20s%26%23xE9%3Blectionn%26%23xE9%3Bs%26lt%3B%5C%2Fb%26gt%3B.%20Revue%20des%20Maladies%20Respiratoires%20%26lt%3Bi%26gt%3B31%26lt%3B%5C%2Fi%26gt%3B%2C%20511%26%23x2013%3B524%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2014.01.014%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2014.01.014%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Chirurgie%20et%20tuberculose%20multi%5C%2Fultrar%5Cu00e9sistante%20%3A%20une%20revue%20de%20la%20litt%5Cu00e9rature%20r%5Cu00e9habilite%20une%20intervention%20adjuvante%20%5Cu00e0%20l%5Cu2019antibioth%5Cu00e9rapie%20chez%20des%20patients%20s%5Cu00e9lectionn%5Cu00e9s%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Mordant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Henry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Morel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Le%20D%5Cu00fb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Frechet-Jachym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22Similowski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22%5Cu00e9.%22%2C%22lastName%22%3A%22Caumes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Riquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Le%20Pimpec-Barthes%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2206%5C%2F2014%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.rmr.2014.01.014%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS0761842514001144%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%2207618425%22%2C%22language%22%3A%22fr%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-02-26T17%3A51%3A07Z%22%7D%7D%2C%7B%22key%22%3A%228XGU67HN%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mougari%20et%20al.%22%2C%22parsedDate%22%3A%222014-06-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMougari%2C%20F.%2C%20Raskine%2C%20L.%2C%20Ferroni%2C%20A.%2C%20Marcon%2C%20E.%2C%20Sermet-Gaudelus%2C%20I.%2C%20Veziris%2C%20N.%2C%20Heym%2C%20B.%2C%20Gaillard%2C%20J.-L.%2C%20Nassif%2C%20X.%20and%20Cambau%2C%20E.%20%282014%29.%20%26lt%3Bb%26gt%3BClonal%20Relationship%20and%20Differentiation%20among%20Mycobacterium%20abscessus%20Isolates%20as%20Determined%20Using%20the%20Semiautomated%20Repetitive%20Extragenic%20Palindromic%20Sequence%20PCR-Based%20DiversiLab%20System%26lt%3B%5C%2Fb%26gt%3B.%20J%20Clin%20Microbiol%20%26lt%3Bi%26gt%3B52%26lt%3B%5C%2Fi%26gt%3B%2C%201969%26%23x2013%3B1977%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.03600-13%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.03600-13%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Clonal%20Relationship%20and%20Differentiation%20among%20Mycobacterium%20abscessus%20Isolates%20as%20Determined%20Using%20the%20Semiautomated%20Repetitive%20Extragenic%20Palindromic%20Sequence%20PCR-Based%20DiversiLab%20System%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faiza%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Raskine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Agn%5Cu00e8s%22%2C%22lastName%22%3A%22Ferroni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Estelle%22%2C%22lastName%22%3A%22Marcon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Sermet-Gaudelus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beate%22%2C%22lastName%22%3A%22Heym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Louis%22%2C%22lastName%22%3A%22Gaillard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xavier%22%2C%22lastName%22%3A%22Nassif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%5D%2C%22abstractNote%22%3A%22Mycobacterium%20abscessus%20is%20a%20rapidly%20growing%20mycobacterium%20that%20causes%20respiratory%20tract%20infections%20in%20predisposed%20patients%2C%20such%20as%20those%20with%20cystic%20fibrosis%20and%20nosocomial%20skin%20and%20soft%20tissue%20infections.%20In%20order%20to%20investigate%20the%20clonal%20relationships%20between%20the%20strains%20causing%20epidemic%20episodes%2C%20we%20evaluated%20the%20discriminatory%20power%20of%20the%20semiautomated%20DiversiLab%20%28DL%29%20repetitive%20extragenic%20palindromic%20sequence%20PCR%20%28REP-PCR%29%20test%20for%20M.%20abscessus%20genotyping.%20Since%20M.%20abscessus%20was%20shown%20to%20be%20composed%20of%20subspecies%20%28M.%20abscessus%20subsp.%20massiliense%2C%20M.%20abscessus%20subsp.%20bolletii%2C%20and%20M.%20abscessus%20subsp.%20abscessus%29%2C%20we%20also%20evaluated%20the%20ability%20of%20this%20technique%20to%20differentiate%20subspecies.%20The%20technique%20was%20applied%20to%20two%20collections%20of%20clinical%20isolates%2C%20%28i%29%2083%20M.%20abscessus%20original%20isolates%20%2843%20M.%20abscessus%20subsp.%20abscessus%2C%2012%20M.%20abscessus%20subsp.%20bolletii%2C%20and%2028%20M.%20abscessus%20subsp.%20massiliense%29%20from%20infected%20patients%20and%20%28ii%29%2035%20repeated%20isolates%20obtained%20over%201%20year%20from%20four%20cystic%20fibrosis%20patients.%20The%20DL%20REP-PCR%20test%20was%20standardized%20for%20DNA%20extraction%2C%20DNA%20amplification%2C%20and%20electrophoresis%20pattern%20comparisons.%20Among%20the%20isolates%20from%20distinct%20patients%2C%2053%5C%2F83%20%2862%25%29%20isolates%20showed%20a%20specific%20pattern%2C%20and%2030%20were%20distributed%20in%2011%20clusters%20and%206%20patterns%2C%20with%202%20to%204%20isolates%20per%20pattern.%20The%20clusters%20and%20patterns%20did%20not%20fully%20correlate%20with%20multilocus%20sequence%20typing%20%28MLST%29%20analysis%20results.%20This%20revealed%20a%20high%20genomic%20diversity%20between%20patients%2C%20with%20a%20discriminatory%20power%20of%2098%25%20%28Simpson%26%23039%3Bs%20diversity%20index%29.%20However%2C%20since%20some%20isolates%20shared%20identical%20patterns%2C%20this%20raises%20the%20question%20of%20whether%20it%20is%20due%20to%20transmission%20between%20patients%20or%20a%20common%20reservoir.%20Multiple%20isolates%20from%20the%20same%20patient%20showed%20identical%20patterns%2C%20except%20for%20one%20patient%20infected%20by%20two%20strains.%20Between%20the%20M.%20abscessus%20subspecies%2C%20the%20indexes%20were%20%26lt%3B70%25%2C%20indicating%20that%20the%20DL%20REP-PCR%20test%20is%20not%20an%20accurate%20tool%20for%20identifying%20organisms%20to%20the%20subspecies%20level.%20REP-PCR%20appears%20to%20be%20a%20rapid%20genotyping%20method%20that%20is%20useful%20for%20investigating%20epidemics%20of%20M.%20abscessus%20infections.%22%2C%22date%22%3A%2206%5C%2F01%5C%2F2014%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2FJCM.03600-13%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjcm.asm.org%5C%2Fcontent%5C%2F52%5C%2F6%5C%2F1969%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220095-1137%2C%201098-660X%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-02-26T17%3A56%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22RFR9SHRP%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Renvoise%20and%20Bernard%22%2C%22parsedDate%22%3A%222014-11-24%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRenvoise%2C%20A.%20and%20Bernard%2C%20C.%20%282014%29.%20%26lt%3Bb%26gt%3BTraitement%20des%20infections%20a%26%23x300%3B%20Mycobacterium%20avium%20complex%26lt%3B%5C%2Fb%26gt%3B.%20J%20Antiinf%20%26lt%3Bi%26gt%3B16%26lt%3B%5C%2Fi%26gt%3B%2C%20199%26%23x2013%3B206%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.antinf.2014.10.003%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.antinf.2014.10.003%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Traitement%20des%20infections%20a%5Cu0300%20Mycobacterium%20avium%20complex%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A%22%2C%22lastName%22%3A%22Renvoise%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%22%2C%22lastName%22%3A%22Bernard%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2224%5C%2F11%5C%2F2014%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.antinf.2014.10.003%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.em-consulte.com%5C%2Farticle%5C%2F939859%5C%2Farticle%5C%2Ftraitement-des-infections-a-complex%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22language%22%3A%22fr%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-04-27T17%3A12%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22UXXSBNN5%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Renvoise%20et%20al.%22%2C%22parsedDate%22%3A%222014-07-10%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRenvoise%2C%20A.%2C%20Pang%2C%20S.%2C%20Bernard%2C%20C.%2C%20Brossier%2C%20F.%2C%20Veziris%2C%20N.%2C%20Capton%2C%20E.%2C%20Jarlier%2C%20V.%20and%20Sougakoff%2C%20W.%20%282014%29.%20%26lt%3Bb%26gt%3BFirst%20Whole-Genome%20Sequence%20of%20a%20Clinical%20Isolate%20of%20Multidrug-Resistant%20Mycobacterium%20bovis%20BCG%26lt%3B%5C%2Fb%26gt%3B.%20Genome%20Announcements%20%26lt%3Bi%26gt%3B2%26lt%3B%5C%2Fi%26gt%3B%2C%20e00611-14-e00611-14%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FgenomeA.00611-14%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FgenomeA.00611-14%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22First%20Whole-Genome%20Sequence%20of%20a%20Clinical%20Isolate%20of%20Multidrug-Resistant%20Mycobacterium%20bovis%20BCG%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Renvoise%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Pang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Capton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%22%2C%22lastName%22%3A%22Sougakoff%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222014-07-10%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2FgenomeA.00611-14%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fgenomea.asm.org%5C%2Fcgi%5C%2Fdoi%5C%2F10.1128%5C%2FgenomeA.00611-14%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222169-8287%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-02-26T17%3A49%3A15Z%22%7D%7D%2C%7B%22key%22%3A%22W9TXPI32%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Renvoise%20et%20al.%22%2C%22parsedDate%22%3A%222014-12-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRenvoise%2C%20A.%2C%20Bernard%2C%20C.%2C%20Veziris%2C%20N.%2C%20Galati%2C%20E.%2C%20Jarlier%2C%20V.%20and%20Robert%2C%20J.%20%282014%29.%20%26lt%3Bb%26gt%3BSignificant%20Difference%20in%20Drug%20Susceptibility%20Distribution%20between%20Mycobacterium%20avium%20and%20Mycobacterium%20intracellulare%26lt%3B%5C%2Fb%26gt%3B.%20Journal%20of%20Clinical%20Microbiology%20%26lt%3Bi%26gt%3B52%26lt%3B%5C%2Fi%26gt%3B%2C%204439%26%23x2013%3B4440%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.02127-14%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.02127-14%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Significant%20Difference%20in%20Drug%20Susceptibility%20Distribution%20between%20Mycobacterium%20avium%20and%20Mycobacterium%20intracellulare%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Renvoise%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Galati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Robert%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222014-12-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2FJCM.02127-14%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjcm.asm.org%5C%2Fcgi%5C%2Fdoi%5C%2F10.1128%5C%2FJCM.02127-14%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220095-1137%2C%201098-660X%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-03-26T17%3A50%3A45Z%22%7D%7D%2C%7B%22key%22%3A%22J2H5FEMJ%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ycart%20and%20Veziris%22%2C%22parsedDate%22%3A%222014-07-02%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BYcart%2C%20B.%20and%20Veziris%2C%20N.%20%282014%29.%20%26lt%3Bb%26gt%3BUnbiased%20Estimation%20of%20Mutation%20Rates%20under%20Fluctuating%20Final%20Counts%26lt%3B%5C%2Fb%26gt%3B.%20PLoS%20ONE%20%26lt%3Bi%26gt%3B9%26lt%3B%5C%2Fi%26gt%3B%2C%20e101434%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0101434%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0101434%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Unbiased%20Estimation%20of%20Mutation%20Rates%20under%20Fluctuating%20Final%20Counts%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bernard%22%2C%22lastName%22%3A%22Ycart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22Estimation%20methods%20for%20mutation%20rates%20%28or%20probabilities%29%20in%20Luria-Delbr%5Cu00fcck%20fluctuation%20analysis%20usually%20assume%20that%20the%20final%20number%20of%20cells%20remains%20constant%20from%20one%20culture%20to%20another.%20We%20show%20that%20this%20leads%20to%20systematically%20underestimate%20the%20mutation%20rate.%20Two%20levels%20of%20information%20on%20final%20numbers%20are%20considered%3A%20either%20the%20coefficient%20of%20variation%20has%20been%20independently%20estimated%2C%20or%20the%20final%20number%20of%20cells%20in%20each%20culture%20is%20known.%20In%20both%20cases%2C%20unbiased%20estimation%20methods%20are%20proposed.%20Their%20statistical%20properties%20are%20assessed%20both%20theoretically%20and%20through%20Monte-Carlo%20simulation.%20As%20an%20application%2C%20the%20data%20from%20two%20well%20known%20fluctuation%20analysis%20studies%20on%20Mycobacterium%20tuberculosis%20are%20reexamined.%22%2C%22date%22%3A%22July%202%2C%202014%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0101434%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fdx.doi.org%5C%2F10.1371%5C%2Fjournal.pone.0101434%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-02-26T17%3A51%3A44Z%22%7D%7D%5D%7D
Atallah, D., El Kassis, N., Araj, G., Nasr, M., Nasnas, R., Veziris, N. and Sarkis, D. (2014). Mycobacterial infection of breast prosthesis – a conservative treatment: a case report. BMC Infectious Diseases 14, 238, http://doi.org/10.1186/1471-2334-14-238.
Aubry, A., Sougakoff, W., Bodzongo, P., Delcroix, G., Armand, S., Millot, G., Jarlier, V., Courcol, R. and Lemaître, N. (2014). First Evaluation of Drug-Resistant Mycobacterium tuberculosis Clinical Isolates from Congo Revealed Misdetection of Fluoroquinolone Resistance by Line Probe Assay Due to a Double Substitution T80A-A90G in GyrA. PLoS ONE 9, e95083, http://doi.org/10.1371/journal.pone.0095083.
Bastos, M. L., Hussain, H., Weyer, K., Garcia-Garcia, Lourdes, Leimane, Vaira, Leung, Chi Chiu, Narita, Masahiro, Penã, J. M., Ponce-de-Leon, Alfredo, Seung, Kwonjune J., Shean, Karen, Sifuentes-Osornio, José, Walt, M. V. der, Werf, T. S. V. der, Yew, Wing Wai, Menzies, Dick, Ahuja, S., Ashkin, D., Avendaño, M., Banerjee, R., Bauer, M., Becerra, M., Benedetti, A., Burgos, M., Centis, R., Chan, E. D., Chiang, C. Y., Cobelens, F., Cox, H., D’Ambrosio, L., Lange, W. C. M. de, DeRiemer, K., Enarson, D., Falzon, D., Flanagan, K., Flood, J., Gandhi, N., Garcia-Garcia, L., Granich, R. M., Hollm-Delgado, M. G., Holtz, T. H., Hopewell, P., Iseman, M., Jarlsberg, L. G., Keshavjee, S., Kim, H. R., Koh, W. J., Lancaster, J., Lange, C., Leimane, V., Leung, C. C., Li, J., Menzies, D., Migliori, G. B., Mitnick, C. M., Narita, M., Nathanson, E., Odendaal, R., O’Riordan, P., Pai, M., Palmero, D., Park, S. K., Pasvol, G., Pena, J., Pérez-Guzmán, C., Ponce-de-Leon, A., Quelapio, M. I. D., Quy, H. T., Riekstina, V., Robert, J., Royce, S., Salim, M., Schaaf, H. S., Seung, K. J., Shah, L., Shean, K., Shim, T. S., Shin, S. S., Shiraishi, Y., Sifuentes-Osornio, J., Sotgiu, G., Strand, M. J., Sung, S. W., Tabarsi, P., Tupasi, T. E., Vargas, M. H., Altena, R. van, Walt, M. van der, Werf, T. S. van der, Viiklepp, P., Westenhouse, J., Yew, W. W. and Yim, J. J. (2014). Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis. Clin Infect Dis 59, 1364–1374, http://doi.org/10.1093/cid/ciu619.
Bernard, C., Brossier, F., Fréchet-Jachym, M., Morand, P. C., Coignard, S., Aslangul, E., Aubry, A., Jarlier, V., Sougakoff, W. and Veziris, N. (2014). Concomitant Multidrug-resistant Pulmonary Tuberculosis and Susceptible Tuberculous Meningitis. Emerging Infectious Diseases 20, 506–507, http://doi.org/10.3201/eid2003.131205.
Brossier, F., Sola, C., Millot, G., Jarlier, V., Veziris, N. and Sougakoff, W. (2014). Comparison of a Semiautomated Commercial Repetitive-Sequence-Based PCR Method with Spoligotyping, 24-Locus Mycobacterial Interspersed Repetitive-Unit–Variable-Number Tandem-Repeat Typing, and Restriction Fragment Length Polymorphism-Based Analysis of IS6110 for Mycobacterium tuberculosis Typing. J Clin Microbiol 52, 4082–4086, http://doi.org/10.1128/JCM.02226-14.
Cambau, E. and Drancourt, M. (2014). Steps towards the discovery of Mycobacterium tuberculosis by Robert Koch, 1882. Clin Microbiol Infect 20, 196–201, http://doi.org/10.1111/1469-0691.12555.
de Beer, J. L., Ködmön, C., van Ingen, J., Supply, P., van Soolingen, D. and The Global Network for the Molecular Surveillance of Tuberculosis 2010 (2014). Second worldwide proficiency study on variable number of tandem repeats typing of Mycobacterium tuberculosis complex. The International Journal of Tuberculosis and Lung Disease 18, 594–600, http://doi.org/10.5588/ijtld.13.0531.
De Beer, J. L., Kodmon, C., van der Werf, M. J., van Ingen, J., van Soolingen, D. and ECDC MDR-TB Molecular Surveillance Project Participants (2014). Molecular surveillance of multi- and extensively drug-resistant tuberculosis transmission in the European Union from 2003 to 2011. Euro Surveill 19.
de Masson, A., Maillart, E., Veziris, N., Meyssonnier, V., Papeix, C. and Caumes, E. (2014). Cavitary pulmonary disease in a patient treated with natalizumab. La Presse Médicale 43, 1009–1012, http://doi.org/10.1016/j.lpm.2013.12.012.
Delafont, V., Mougaris, F., Cambau, E., Joyeux, michel, Bouchon, D., Hechard, Y. and Moulin, L. (2014). First evidence of amoebae – mycobacteria association in drinking water network. Environ Sci Technol, http://doi.org/10.1021/es5036255.
Fangous, M.-S., Mougari, F., Gouriou, S., Calvez, E., Raskine, L., Cambau, E., Payan, C. and Héry-Arnaud, G. (2014). Classification Algorithm for Subspecies Identification within the Mycobacterium abscessus Species, Based on Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry. J Clin Microbiol 52, 3362–3369, http://doi.org/10.1128/JCM.00788-14.
Godreuil, S., Leban, N., Padilla, A., Hamel, R., Luplertlop, N., Chauffour, A., Vittecoq, M., Hoh, F., Thomas, F., Sougakoff, W., Lionne, C., Yssel, H. and Missé, D. (2014). Aedesin: Structure and Antimicrobial Activity against Multidrug Resistant Bacterial Strains Ed. Shih, C. PLoS ONE 9, e105441, http://doi.org/10.1371/journal.pone.0105441.
Lerat, I., Cambau, E., Bettoni, R. R. dit, Gaillard, J.-L., Jarlier, V., Truffot, C. and Veziris, N. (2014). In Vivo Evaluation of Antibiotic Activity Against Mycobacterium abscessus. J Infect Dis 209, 905–912, http://doi.org/10.1093/infdis/jit614.
Macheras, E., Konjek, J., Roux, A.-L., Thiberge, J.-M., Bastian, S., Leão, S. C., Palaci, M., Sivadon-Tardy, V., Gutierrez, C., Richter, E., Rüsch-Gerdes, S., Pfyffer, G. E., Bodmer, T., Jarlier, V., Cambau, E., Brisse, S., Caro, V., Rastogi, N., Gaillard, J.-L. and Heym, B. (2014). Multilocus sequence typing scheme for the Mycobacterium abscessus complex. Research in Microbiology, http://doi.org/10.1016/j.resmic.2013.12.003.
Meyssonnier, V., Bui, T. V., Veziris, N., Jarlier, V. and Robert, J. (2014). Rifampicin mono-resistant tuberculosis in France: a 2005–2010 retrospective cohort analysis. BMC Infectious Diseases 14, 18, http://doi.org/10.1186/1471-2334-14-18.
Mordant, P., Henry, B., Morel, S., Robert, J., Veziris, N., Le Dû, D., Frechet-Jachym, M., Similowski, T., Caumes, é., Riquet, M. and Le Pimpec-Barthes, F. (2014). Chirurgie et tuberculose multi/ultrarésistante : une revue de la littérature réhabilite une intervention adjuvante à l’antibiothérapie chez des patients sélectionnés. Revue des Maladies Respiratoires 31, 511–524, http://doi.org/10.1016/j.rmr.2014.01.014.
Mougari, F., Raskine, L., Ferroni, A., Marcon, E., Sermet-Gaudelus, I., Veziris, N., Heym, B., Gaillard, J.-L., Nassif, X. and Cambau, E. (2014). Clonal Relationship and Differentiation among Mycobacterium abscessus Isolates as Determined Using the Semiautomated Repetitive Extragenic Palindromic Sequence PCR-Based DiversiLab System. J Clin Microbiol 52, 1969–1977, http://doi.org/10.1128/JCM.03600-13.
Renvoise, A. and Bernard, C. (2014). Traitement des infections à Mycobacterium avium complex. J Antiinf 16, 199–206, http://doi.org/10.1016/j.antinf.2014.10.003.
Renvoise, A., Pang, S., Bernard, C., Brossier, F., Veziris, N., Capton, E., Jarlier, V. and Sougakoff, W. (2014). First Whole-Genome Sequence of a Clinical Isolate of Multidrug-Resistant Mycobacterium bovis BCG. Genome Announcements 2, e00611-14-e00611-14, http://doi.org/10.1128/genomeA.00611-14.
Renvoise, A., Bernard, C., Veziris, N., Galati, E., Jarlier, V. and Robert, J. (2014). Significant Difference in Drug Susceptibility Distribution between Mycobacterium avium and Mycobacterium intracellulare. Journal of Clinical Microbiology 52, 4439–4440, http://doi.org/10.1128/JCM.02127-14.
Ycart, B. and Veziris, N. (2014). Unbiased Estimation of Mutation Rates under Fluctuating Final Counts. PLoS ONE 9, e101434, http://doi.org/10.1371/journal.pone.0101434.

Publications du CNR en 2015

1368488 2015 1 heidelberg-university-faculty-of-medicine 50 creator asc year 1 227 https://cnrmyrma.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22QG8E5748%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Amarsy-Guerle%20et%20al.%22%2C%22parsedDate%22%3A%222015%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAmarsy-Guerle%2C%20R.%2C%20Mougari%2C%20F.%2C%20Jacquier%2C%20H.%2C%20Oliary%2C%20J.%2C%20Benmansour%2C%20H.%2C%20Riahi%2C%20J.%2C%20Ber%26%23xE7%3Bot%2C%20B.%2C%20Raskine%2C%20L.%20and%20Cambau%2C%20E.%20%282015%29.%20%26lt%3Bb%26gt%3BHigh%20medical%20impact%20of%20implementing%20the%20new%20polymeric%20bead-based%20BacT%5C%2FALERT%26%23xAE%3B%20FAPlus%20and%20FNPlus%20blood%20culture%20bottles%20in%20standard%20care%26lt%3B%5C%2Fb%26gt%3B.%20European%20Journal%20of%20Clinical%20Microbiology%20%26amp%3B%20Infectious%20Diseases%20%26lt%3Bi%26gt%3B34%26lt%3B%5C%2Fi%26gt%3B%2C%201031%26%23x2013%3B1037%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10096-015-2319-8%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10096-015-2319-8%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22High%20medical%20impact%20of%20implementing%20the%20new%20polymeric%20bead-based%20BacT%5C%2FALERT%5Cu00ae%20FAPlus%20and%20FNPlus%20blood%20culture%20bottles%20in%20standard%20care%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Amarsy-Guerle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Jacquier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Oliary%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Benmansour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Riahi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Ber%5Cu00e7ot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Raskine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Cambau%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%225%5C%2F2015%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1007%5C%2Fs10096-015-2319-8%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Flink.springer.com%5C%2F10.1007%5C%2Fs10096-015-2319-8%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220934-9723%2C%201435-4373%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-02-26T17%3A56%3A19Z%22%7D%7D%2C%7B%22key%22%3A%22K4IIZ9IX%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bernard%20et%20al.%22%2C%22parsedDate%22%3A%222015-03-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBernard%2C%20C.%2C%20Veziris%2C%20N.%2C%20Brossier%2C%20F.%2C%20Sougakoff%2C%20W.%2C%20Jarlier%2C%20V.%2C%20Robert%2C%20J.%20and%20Aubry%2C%20A.%20%282015%29.%20%26lt%3Bb%26gt%3BMolecular%20Diagnosis%20of%20Fluoroquinolone%20Resistance%20in%20Mycobacterium%20tuberculosis%26lt%3B%5C%2Fb%26gt%3B.%20Antimicrob%20Agents%20Chemother%20%26lt%3Bi%26gt%3B59%26lt%3B%5C%2Fi%26gt%3B%2C%201519%26%23x2013%3B1524%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.04058-14%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.04058-14%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Molecular%20Diagnosis%20of%20Fluoroquinolone%20Resistance%20in%20Mycobacterium%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%5D%2C%22abstractNote%22%3A%22As%20a%20consequence%20of%20the%20use%20of%20fluoroquinolones%20%28FQ%29%2C%20resistance%20to%20FQ%20has%20emerged%2C%20leading%20to%20cases%20of%20nearly%20untreatable%20and%20extensively%20drug-resistant%20tuberculosis.%20Mutations%20in%20DNA%20gyrase%20represent%20the%20main%20mechanism%20of%20FQ%20resistance.%20A%20full%20understanding%20of%20the%20pattern%20of%20mutations%20found%20in%20FQ-resistant%20%28FQr%29%20clinical%20isolates%2C%20and%20of%20their%20proportions%2C%20is%20crucial%20for%20improving%20molecular%20methods%20for%20the%20detection%20of%20FQ%20resistance%20in%20Mycobacterium%20tuberculosis.%20In%20this%20study%2C%20we%20reviewed%20the%20detection%20of%20FQ%20resistance%20in%20isolates%20addressed%20to%20the%20French%20National%20Reference%20Center%20for%20Mycobacteria%20from%202007%20to%202012%2C%20with%20the%20aim%20of%20evaluating%20the%20performance%20of%20PCR%20sequencing%20in%20a%20real-life%20context.%20gyrA%20and%20gyrB%20sequencing%2C%20performed%20prospectively%20on%20M.%20tuberculosis%20clinical%20isolates%2C%20was%20compared%20for%20FQ%20susceptibility%20to%202%20mg%5C%2Fliter%20ofloxacin%20by%20the%20reference%20proportion%20method.%20A%20total%20of%20605%20isolates%2C%20of%20which%2050%25%20were%20multidrug%20resistant%2C%20were%20analyzed.%20The%20increase%20in%20FQr%20strains%20among%20multidrug-resistant%20%28MDR%29%20strains%20during%20the%20time%20of%20the%20study%20was%20alarming%20%288%25%20to%2030%25%29.%20The%20majority%20%2878%25%29%20of%20the%20isolates%20with%20gyrA%20mutations%20were%20FQr%2C%20whereas%20only%2036%25%20of%20those%20with%20gyrB%20mutations%20were%20FQr.%20Only%2012%25%20of%20the%20FQr%20isolates%20had%20a%20single%20mutation%20in%20gyrB.%20Combined%20gyrA%20and%20gyrB%20sequencing%20led%20to%20%26gt%3B93%25%20sensitivity%20for%20detecting%20resistance.%20The%20analysis%20of%20the%20four%20false-positive%20and%20the%20five%20false-negative%20results%20of%20gyrA%20and%20gyrB%20sequencing%20illustrated%20the%20actual%20limitations%20of%20the%20reference%20proportion%20method.%20Our%20data%20emphasize%20the%20need%20for%20combined%20gyrA%20and%20gyrB%20sequencing%20in%20the%20investigation%20of%20FQ%20susceptibility%20in%20M.%20tuberculosis%20and%20challenge%20the%20validity%20of%20the%20current%20phenotype-based%20approach%20as%20the%20diagnostic%20gold%20standard%20for%20determining%20FQ%20resistance.%22%2C%22date%22%3A%222015-03-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2FAAC.04058-14%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Faac.asm.org%5C%2Fcontent%5C%2F59%5C%2F3%5C%2F1519%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220066-4804%2C%201098-6596%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-02-26T18%3A04%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22JHKFH9H7%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brossier%20et%20al.%22%2C%22parsedDate%22%3A%222015%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBrossier%2C%20F.%2C%20Sola%2C%20C.%2C%20Bernard%2C%20C.%2C%20Jarlier%2C%20V.%2C%20Veziris%2C%20N.%20and%20Sougakoff%2C%20W.%20%282015%29.%20%26lt%3Bb%26gt%3BCharacterization%20of%20a%20Clone%20of%20Mycobacterium%20tuberculosis%20Clinical%20Isolates%20with%20Mutations%20in%20KatG%20%28A110V%29%2C%20EthA%20%28Q269STOP%29%2C%20and%20the%20%26lt%3Bi%26gt%3BinhA%26lt%3B%5C%2Fi%26gt%3B%20Promoter%20%28%26%23x2212%3B15C%26%23x2192%3BT%29%26lt%3B%5C%2Fb%26gt%3B%20Ed.%20Land%2C%20G.%20A.%20Journal%20of%20Clinical%20Microbiology%20%26lt%3Bi%26gt%3B53%26lt%3B%5C%2Fi%26gt%3B%2C%203104%26%23x2013%3B3104%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.01537-15%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.01537-15%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Characterization%20of%20a%20Clone%20of%20Mycobacterium%20tuberculosis%20Clinical%20Isolates%20with%20Mutations%20in%20KatG%20%28A110V%29%2C%20EthA%20%28Q269STOP%29%2C%20and%20the%20%3Ci%3EinhA%3C%5C%2Fi%3E%20Promoter%20%28%5Cu221215C%5Cu2192T%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Sola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22G.%20A.%22%2C%22lastName%22%3A%22Land%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2209%5C%2F2015%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2FJCM.01537-15%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjcm.asm.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1128%5C%2FJCM.01537-15%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220095-1137%2C%201098-660X%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-02-26T18%3A04%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22ZP2XJUXK%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brossier%20et%20al.%22%2C%22parsedDate%22%3A%222015%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBrossier%2C%20F.%2C%20Sougakoff%2C%20W.%2C%20Bernard%2C%20C.%2C%20Petrou%2C%20M.%2C%20Adeyema%2C%20K.%2C%20Pham%2C%20A.%2C%20Amy%20de%20la%20Breteque%2C%20D.%2C%20Vallet%2C%20M.%2C%20Jarlier%2C%20V.%2C%20Sola%2C%20C.%20and%20Veziris%2C%20N.%20%282015%29.%20%26lt%3Bb%26gt%3BMolecular%20Analysis%20of%20the%20%26lt%3Bi%26gt%3BembCAB%26lt%3B%5C%2Fi%26gt%3B%20Locus%20and%20%26lt%3Bi%26gt%3BembR%26lt%3B%5C%2Fi%26gt%3B%20Gene%20Involved%20in%20Ethambutol%20Resistance%20in%20Clinical%20Isolates%20of%20Mycobacterium%20tuberculosis%20in%20France%26lt%3B%5C%2Fb%26gt%3B.%20Antimicrobial%20Agents%20and%20Chemotherapy%20%26lt%3Bi%26gt%3B59%26lt%3B%5C%2Fi%26gt%3B%2C%204800%26%23x2013%3B4808%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.00150-15%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.00150-15%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Molecular%20Analysis%20of%20the%20%3Ci%3EembCAB%3C%5C%2Fi%3E%20Locus%20and%20%3Ci%3EembR%3C%5C%2Fi%3E%20Gene%20Involved%20in%20Ethambutol%20Resistance%20in%20Clinical%20Isolates%20of%20Mycobacterium%20tuberculosis%20in%20France%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthieu%22%2C%22lastName%22%3A%22Petrou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karine%22%2C%22lastName%22%3A%22Adeyema%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Pham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diane%22%2C%22lastName%22%3A%22Amy%20de%20la%20Breteque%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marine%22%2C%22lastName%22%3A%22Vallet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Sola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2208%5C%2F2015%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2FAAC.00150-15%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Faac.asm.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1128%5C%2FAAC.00150-15%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220066-4804%2C%201098-6596%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-02-26T18%3A04%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22M8C4879E%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bui%20et%20al.%22%2C%22parsedDate%22%3A%222015%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBui%2C%20T.%20V.%2C%20L%26%23xE9%3Bvy-Bruhl%2C%20D.%2C%20Che%2C%20D.%2C%20Antoine%2C%20D.%2C%20Jarlier%2C%20V.%20and%20Robert%2C%20J.%20%282015%29.%20%26lt%3Bb%26gt%3BImpact%20of%20the%20BCG%20vaccination%20policy%20on%20tuberculous%20meningitis%20in%20children%20under%206%20years%20in%20metropolitan%20France%20between%202000%20and%202011%26lt%3B%5C%2Fb%26gt%3B.%20Euro%20Surveill%20%26lt%3Bi%26gt%3B20%26lt%3B%5C%2Fi%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Impact%20of%20the%20BCG%20vaccination%20policy%20on%20tuberculous%20meningitis%20in%20children%20under%206%20years%20in%20metropolitan%20France%20between%202000%20and%202011%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%20V.%22%2C%22lastName%22%3A%22Bui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22L%5Cu00e9vy-Bruhl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Che%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Antoine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Robert%22%7D%5D%2C%22abstractNote%22%3A%22In%20France%2C%20Bacillus%20Calmette%5Cu2013Gu%5Cu00e9rin%20%28BCG%29%20vaccination%20by%20multipuncture%20device%20was%20withdrawn%20in%202006.%20In%202007%2C%20universal%20mandatory%20BCG%20vaccination%20was%20replaced%20by%20vaccination%20of%20high-risk%20children.%20To%20evaluate%20the%20impact%20of%20these%20changes%20on%20tuberculous%20meningitis%20%28TBM%29%20epidemiology%2C%20data%20on%20culture-positive%20and%20culture-negative%20%28or%20unknown%20microbiological%20result%29%20TBM%20in%20%5Cu22645%20years%20olds%20were%20collected%20from%202000%5Cu20132011.%20Ten%20culture-positive%20and%2017%20culture-negative%20TBM%20cases%20were%20identified%2C%20with%20an%20annual%20incidence%20rate%20ranging%20from%200.16%20to%200.66%20cases%20per%2010%20million%20inhabitants.%20The%20average%20annual%20numbers%20of%20TBM%20cases%20were%202.7%20and%201.8%20from%202000%5Cu20132005%20and%202006%5Cu20132011%2C%20respectively.%20In%20Ile-de-France%20where%20all%20children%20are%20considered%20at%20risk%2C%20the%20overall%20incidence%20rates%20were%201.14%20and%200.29%20per%20million%20for%20the%20two%20periods.%20In%20other%20regions%20where%20only%20at-risk%20children%20are%20vaccinated%20since%202007%2C%20rates%20were%200.30%20and%200.47%2C%20respectively.%20None%20of%20these%20differences%20were%20significant.%20Annual%20incidence%20rates%20for%20each%20one%20year%20age%20group%20cohort%20were%20comparable%20before%20and%20after%20changes.%20Childhood%20TBM%20remains%20rare%20in%20France.%20No%20increase%20in%20incidence%20was%20observed%20after%20changes%20in%20BCG%20vaccination%20strategy.%20Ongoing%20surveillance%20should%20be%20maintained%2C%20as%20a%20slight%20increase%20in%20TBM%20in%20the%20coming%20years%20remains%20possible%2C%20in%20the%20context%20of%20suboptimal%20vaccination%20coverage%20of%20high-risk%20children.%22%2C%22date%22%3A%222015%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221560-7917%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-04-27T19%3A39%3A59Z%22%7D%7D%2C%7B%22key%22%3A%22H9WA64GZ%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cambau%20et%20al.%22%2C%22parsedDate%22%3A%222015-03-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCambau%2C%20E.%2C%20Viveiros%2C%20M.%2C%20Machado%2C%20D.%2C%20Raskine%2C%20L.%2C%20Ritter%2C%20C.%2C%20Tortoli%2C%20E.%2C%20Matthys%2C%20V.%2C%20Hoffner%2C%20S.%2C%20Richter%2C%20E.%2C%20Perez%20Del%20Molino%2C%20M.%20L.%2C%20Cirillo%2C%20D.%20M.%2C%20van%20Soolingen%2C%20D.%20and%20Bottger%2C%20E.%20C.%20%282015%29.%20%26lt%3Bb%26gt%3BRevisiting%20susceptibility%20testing%20in%20MDR-TB%20by%20a%20standardized%20quantitative%20phenotypic%20assessment%20in%20a%20European%20multicentre%20study%26lt%3B%5C%2Fb%26gt%3B.%20Journal%20of%20Antimicrobial%20Chemotherapy%20%26lt%3Bi%26gt%3B70%26lt%3B%5C%2Fi%26gt%3B%2C%20686%26%23x2013%3B696%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdku438%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdku438%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Revisiting%20susceptibility%20testing%20in%20MDR-TB%20by%20a%20standardized%20quantitative%20phenotypic%20assessment%20in%20a%20European%20multicentre%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Viveiros%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Raskine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Ritter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Tortoli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Matthys%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Hoffner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Richter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20L.%22%2C%22lastName%22%3A%22Perez%20Del%20Molino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%20M.%22%2C%22lastName%22%3A%22Cirillo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22van%20Soolingen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20C.%22%2C%22lastName%22%3A%22Bottger%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222015-03-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fjac%5C%2Fdku438%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.jac.oxfordjournals.org%5C%2Fcgi%5C%2Fdoi%5C%2F10.1093%5C%2Fjac%5C%2Fdku438%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220305-7453%2C%201460-2091%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-02-26T17%3A56%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22DBT6PGEE%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Catho%20et%20al.%22%2C%22parsedDate%22%3A%222015%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCatho%2C%20G.%2C%20Couraud%2C%20S.%2C%20Grard%2C%20S.%2C%20Bouaziz%2C%20A.%2C%20S%26%23xE9%3Bn%26%23xE9%3Bchal%2C%20A.%2C%20Valour%2C%20F.%2C%20Perpoint%2C%20T.%2C%20Braun%2C%20E.%2C%20Biron%2C%20F.%2C%20Ferry%2C%20T.%2C%20Chidiac%2C%20C.%2C%20Freymond%2C%20N.%2C%20Perrot%2C%20E.%2C%20Souquet%2C%20P.-J.%2C%20Maury%2C%20J.-M.%2C%20Tronc%2C%20F.%2C%20Veziris%2C%20N.%2C%20Lina%2C%20G.%2C%20Dumitrescu%2C%20O.%20and%20Ader%2C%20F.%20%282015%29.%20%26lt%3Bb%26gt%3BManagement%20of%20emerging%20multidrug-resistant%20tuberculosis%20in%20a%20low-prevalence%20setting%26lt%3B%5C%2Fb%26gt%3B.%20Clinical%20Microbiology%20and%20Infection%20%26lt%3Bi%26gt%3B21%26lt%3B%5C%2Fi%26gt%3B%2C%20472.e7-472.e10%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2014.12.022%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2014.12.022%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Management%20of%20emerging%20multidrug-resistant%20tuberculosis%20in%20a%20low-prevalence%20setting%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Catho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Couraud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Grard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Bouaziz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22S%5Cu00e9n%5Cu00e9chal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Valour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22Perpoint%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Braun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Biron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22Ferry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Chidiac%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Freymond%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Perrot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.-J.%22%2C%22lastName%22%3A%22Souquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.-M.%22%2C%22lastName%22%3A%22Maury%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Tronc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Lina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%22%2C%22lastName%22%3A%22Dumitrescu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Ader%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2205%5C%2F2015%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cmi.2014.12.022%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS1198743X15001767%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221198743X%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-02-26T17%3A51%3A07Z%22%7D%7D%2C%7B%22key%22%3A%227FHR7W58%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Coolen%20et%20al.%22%2C%22parsedDate%22%3A%222015%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCoolen%2C%20N.%2C%20Morand%2C%20P.%2C%20Martin%2C%20C.%2C%20Hubert%2C%20D.%2C%20Kanaan%2C%20R.%2C%20Chapron%2C%20J.%2C%20Honor%26%23xE9%3B%2C%20I.%2C%20Dusser%2C%20D.%2C%20Audureau%2C%20E.%2C%20Veziris%2C%20N.%20and%20Burgel%2C%20P.-R.%20%282015%29.%20%26lt%3Bb%26gt%3BReduced%20risk%20of%20nontuberculous%20mycobacteria%20in%20cystic%20fibrosis%20adults%20receiving%20long-term%20azithromycin%26lt%3B%5C%2Fb%26gt%3B.%20Journal%20of%20Cystic%20Fibrosis%20%26lt%3Bi%26gt%3B14%26lt%3B%5C%2Fi%26gt%3B%2C%20594%26%23x2013%3B599%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jcf.2015.02.006%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jcf.2015.02.006%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Reduced%20risk%20of%20nontuberculous%20mycobacteria%20in%20cystic%20fibrosis%20adults%20receiving%20long-term%20azithromycin%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Coolen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Morand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cl%5Cu00e9mence%22%2C%22lastName%22%3A%22Martin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominique%22%2C%22lastName%22%3A%22Hubert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reem%22%2C%22lastName%22%3A%22Kanaan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeanne%22%2C%22lastName%22%3A%22Chapron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Honor%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Dusser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Etienne%22%2C%22lastName%22%3A%22Audureau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre-R%5Cu00e9gis%22%2C%22lastName%22%3A%22Burgel%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2209%5C%2F2015%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jcf.2015.02.006%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS1569199315000466%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%2215691993%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-03-26T17%3A56%3A16Z%22%7D%7D%2C%7B%22key%22%3A%22FFFWDEIV%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Grard%20et%20al.%22%2C%22parsedDate%22%3A%222015%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGrard%2C%20S.%2C%20Catho%2C%20G.%2C%20Valour%2C%20F.%2C%20Bouaziz%2C%20A.%2C%20Perpoint%2C%20T.%2C%20Braun%2C%20E.%2C%20Biron%2C%20F.%2C%20Miailhes%2C%20P.%2C%20Ferry%2C%20T.%2C%20Chidiac%2C%20C.%2C%20Souquet%2C%20P.-J.%2C%20Couraud%2C%20S.%2C%20Lina%2C%20G.%2C%20Goutelle%2C%20S.%2C%20Veziris%2C%20N.%2C%20Dumitrescu%2C%20O.%20and%20Ader%2C%20F.%20%282015%29.%20%26lt%3Bb%26gt%3BLinezolid%20in%20the%20Starter%20Combination%20for%20Multidrug-Resistant%20Tuberculosis%3A%20Time%20to%20Move%20on%20to%20Group%20Four%3F%26lt%3B%5C%2Fb%26gt%3B%20Open%20Forum%20Infectious%20Diseases%20%26lt%3Bi%26gt%3B2%26lt%3B%5C%2Fi%26gt%3B%2C%20ofv175%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fofid%5C%2Fofv175%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fofid%5C%2Fofv175%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Linezolid%20in%20the%20Starter%20Combination%20for%20Multidrug-Resistant%20Tuberculosis%3A%20Time%20to%20Move%20on%20to%20Group%20Four%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Soazic%22%2C%22lastName%22%3A%22Grard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gaud%22%2C%22lastName%22%3A%22Catho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florent%22%2C%22lastName%22%3A%22Valour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anissa%22%2C%22lastName%22%3A%22Bouaziz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Perpoint%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Evelyne%22%2C%22lastName%22%3A%22Braun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7ois%22%2C%22lastName%22%3A%22Biron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Miailhes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tristan%22%2C%22lastName%22%3A%22Ferry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Chidiac%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre-Jean%22%2C%22lastName%22%3A%22Souquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%5Cu00e9bastien%22%2C%22lastName%22%3A%22Couraud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G%5Cu00e9rard%22%2C%22lastName%22%3A%22Lina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvain%22%2C%22lastName%22%3A%22Goutelle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oana%22%2C%22lastName%22%3A%22Dumitrescu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Ader%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2212%5C%2F2015%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fofid%5C%2Fofv175%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fofid.oxfordjournals.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1093%5C%2Fofid%5C%2Fofv175%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222328-8957%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-02-26T17%3A51%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22FKAFPDF7%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guglielmetti%20and%20Robert%22%2C%22parsedDate%22%3A%222015-06-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGuglielmetti%2C%20L.%20and%20Robert%2C%20J.%20%282015%29.%20%26lt%3Bb%26gt%3BB%26%23xE9%3Bdaquiline%26%23xA0%3B%3A%20de%20l%26%23x2019%3Bin%20vitro%20aux%20essais%20cliniques%20d%26%23x2019%3Bun%20nouvel%20antituberculeux%26lt%3B%5C%2Fb%26gt%3B.%20Journal%20des%20Anti-infectieux%20%26lt%3Bi%26gt%3B17%26lt%3B%5C%2Fi%26gt%3B%2C%2060%26%23x2013%3B66%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.antinf.2014.12.003%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.antinf.2014.12.003%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22B%5Cu00e9daquiline%5Cu00a0%3A%20de%20l%5Cu2019in%20vitro%20aux%20essais%20cliniques%20d%5Cu2019un%20nouvel%20antituberculeux%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Robert%22%7D%5D%2C%22abstractNote%22%3A%22La%20tuberculose%20est%20une%20cause%20majeure%20de%20morbidit%5Cu00e9%20et%20mortalit%5Cu00e9%20dans%20le%20monde.%20Le%20contr%5Cu00f4le%20de%20la%20tuberculose%20est%20grev%5Cu00e9%20par%20la%20r%5Cu00e9sistance%20aux%20antituberculeux%2C%20et%20plus%20particuli%5Cu00e8rement%20celle%20%5Cu00e0%20la%20rifampicine%20et%20l%5Cu2019isoniazide.%20La%20b%5Cu00e9daquiline%20est%20la%20premi%5Cu00e8re%20mol%5Cu00e9cule%20d%5Cu2019une%20nouvelle%20classe%20d%5Cu2019antituberculeux%2C%20les%20diarylquinolines%2C%20dont%20le%20m%5Cu00e9canisme%20d%5Cu2019action%20est%20l%5Cu2019inhibition%20de%20l%5Cu2019ATP-synthase%20mycobact%5Cu00e9rienne.%20Dans%20cette%20revue%2C%20nous%20pr%5Cu00e9sentons%20les%20donn%5Cu00e9es%20actuelles%20sur%20la%20b%5Cu00e9daquiline%20dont%20les%20%5Cu00e9tudes%20r%5Cu00e9alis%5Cu00e9es%20avant%20son%20approbation%20par%20les%20agences%20du%20m%5Cu00e9dicament%20aux%20%5Cu00c9tats-Unis%20et%20en%20Europe.%20Apr%5Cu00e8s%20les%20%5Cu00e9tudes%20in%20vitro%20et%20in%20vivo%20dans%20le%20mod%5Cu00e8le%20animal%2C%20nous%20pr%5Cu00e9senterons%20les%20r%5Cu00e9sultats%20obtenus%20en%20clinique%20chez%20l%5Cu2019homme.%20La%20b%5Cu00e9daquiline%20a%20une%20activit%5Cu00e9%20tr%5Cu00e8s%20prometteuse%20in%20vitro%20et%20dans%20les%20mod%5Cu00e8les%20animaux%20contre%20Mycobacterium%20tuberculosis%20mais%20aussi%20contre%20d%5Cu2019autres%20mycobact%5Cu00e9ries%20n%5Cu2019appartenant%20pas%20au%20complexe%20tuberculosis.%20Ces%20r%5Cu00e9sultats%20ont%20%5Cu00e9t%5Cu00e9%20confirm%5Cu00e9s%20dans%20les%20premiers%20essais%20cliniques%20r%5Cu00e9alis%5Cu00e9s%20chez%20des%20patients%20atteints%20par%20tuberculose%20%5Cu00e0%20bacilles%20multir%5Cu00e9sistants%20et%20ultrar%5Cu00e9sistants.%20Toutefois%2C%20dans%20un%20de%20ces%20essais%2C%20il%20a%20%5Cu00e9t%5Cu00e9%20mis%20en%20%5Cu00e9vidence%20une%20surmortalit%5Cu00e9%20dans%20le%20groupe%20des%20patients%20trait%5Cu00e9s%20par%20b%5Cu00e9daquiline.%20Cet%20%5Cu00e9v%5Cu00e9nement%20majeur%20tr%5Cu00e8s%20pr%5Cu00e9occupant%20n%5Cu2019a%20pas%20pu%20%5Cu00eatre%20expliqu%5Cu00e9%20%5Cu00e0%20ce%20jour%2C%20malgr%5Cu00e9%20une%20analyse%20approfondie%20des%20causes%20des%20d%5Cu00e9c%5Cu00e8s.%20La%20b%5Cu00e9daquiline%20est%20le%20premier%20m%5Cu00e9dicament%20avec%20un%20nouveau%20m%5Cu00e9canisme%20d%5Cu2019action%20%5Cu00e0%20%5Cu00eatre%20approuv%5Cu00e9%20pour%20le%20traitement%20de%20la%20tuberculose%20apr%5Cu00e8s%20plus%20de%2040ans.%20De%20futures%20%5Cu00e9tudes%20devront%20permettre%20de%20mieux%20%5Cu00e9valuer%20sa%20place%20dans%20de%20nouvelles%20associations%20qui%20pourraient%20permettre%20soit%20de%20raccourcir%20la%20dur%5Cu00e9e%20du%20traitement%20soit%20une%20meilleure%20efficacit%5Cu00e9%20des%20traitement%20des%20tuberculoses%20%5Cu00e0%20bacilles%20multir%5Cu00e9sistants.%5CnTuberculosis%20is%20a%20major%20cause%20of%20morbidity%20and%20mortality%20worldwide.%20Global%20tuberculosis%20control%20is%20jeopardized%20by%20drug%20resistance%2C%20and%20especially%20multidrug-resistance%20defined%20by%20resistance%20to%20rifampicin%20and%20isoniazid.%20Bedaquiline%20is%20the%20first%20compound%20of%20a%20new%20class%20of%20anti-tuberculosis%20drugs%2C%20the%20diarylquinolines%2C%20which%20act%20by%20inhibiting%20the%20mycobacterial%20ATP%20synthase.%20In%20the%20present%20review%2C%20we%20will%20expose%20the%20current%20knowledge%20regarding%20bedaquiline%20including%20the%20results%20of%20the%20studies%2C%20which%20have%20been%20completed%20prior%20to%20its%20approval%20by%20the%20United%20States%20and%20European%20drug%20agencies.%20After%20in%20vitro%20studies%20and%20in%20vivo%20research%20conducted%20in%20animal%20models%2C%20we%20will%20particularly%20detail%20the%20findings%20of%20clinical%20trials.%20Bedaquiline%20has%20shown%20promising%20activity%20in%20vitro%20and%20in%20the%20animal%20model%20against%20Mycobacterium%20tuberculosis%20isolates%20but%20also%20against%20non-tuberculous%20mycobacteria.%20These%20results%20have%20been%20confirmed%20in%20the%20first%20clinical%20trials%20including%20multidrug-resistant%20and%20extensive%20drug-resistant%20tuberculosis%20patients.%20One%20of%20these%20trials%20reported%20an%20increase%20in%20mortality%20in%20the%20bedaquiline-treated%20arm%2C%20which%20has%20to%20date%20not%20been%20explained%20despite%20thorough%20investigation%20of%20the%20causes%20of%20death.%20Bedaquiline%20is%20the%20first%20drug%20with%20a%20new%20mechanism%20of%20action%20to%20be%20approved%20for%20tuberculosis%20treatment%20after%20more%20than%2040%5Cu00a0years.%20Future%20studies%20will%20better%20define%20its%20role%20inside%20new%20drug%20regimens%20with%20the%20potential%20to%20shorten%20treatment%20or%20achieve%20better%20outcome%20in%20multidrug-resistant%20tuberculosis.%22%2C%22date%22%3A%22June%201%2C%202015%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.antinf.2014.12.003%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS2210654514000908%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222210-6545%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-08-02T16%3A25%3A53Z%22%7D%7D%2C%7B%22key%22%3A%22D5NBDMRS%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guglielmetti%20et%20al.%22%2C%22parsedDate%22%3A%222015%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGuglielmetti%2C%20L.%2C%20Mougari%2C%20F.%2C%20Lopes%2C%20A.%2C%20Raskine%2C%20L.%20and%20Cambau%2C%20E.%20%282015%29.%20%26lt%3Bb%26gt%3BHuman%20infections%20due%20to%20nontuberculous%20mycobacteria%3A%20the%20infectious%20diseases%20and%20clinical%20microbiology%20specialists%26%23x2019%3B%20point%20of%20view%26lt%3B%5C%2Fb%26gt%3B.%20Future%20Microbiology%20%26lt%3Bi%26gt%3B10%26lt%3B%5C%2Fi%26gt%3B%2C%201467%26%23x2013%3B1483%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2217%5C%2Ffmb.15.64%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2217%5C%2Ffmb.15.64%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Human%20infections%20due%20to%20nontuberculous%20mycobacteria%3A%20the%20infectious%20diseases%20and%20clinical%20microbiology%20specialists%5Cu2019%20point%20of%20view%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faiza%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amanda%22%2C%22lastName%22%3A%22Lopes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Raskine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2209%5C%2F2015%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.2217%5C%2Ffmb.15.64%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.futuremedicine.com%5C%2Fdoi%5C%2F10.2217%5C%2Ffmb.15.64%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221746-0913%2C%201746-0921%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-03-26T17%3A49%3A02Z%22%7D%7D%2C%7B%22key%22%3A%229FTWPRVV%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guglielmetti%20et%20al.%22%2C%22parsedDate%22%3A%222015-01-15%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGuglielmetti%2C%20L.%2C%20D%26%23xFB%3B%2C%20D.%20L.%2C%20Jachym%2C%20M.%2C%20Henry%2C%20B.%2C%20Martin%2C%20D.%2C%20Caumes%2C%20Eric%2C%20Veziris%2C%20Nicolas%2C%20M%26%23xE9%3Btivier%2C%20N.%2C%20Robert%2C%20J.%2C%20Andrejak%2C%20C.%2C%20Bernard%2C%20C.%2C%20Brossier%2C%20F.%2C%20Chadelat%2C%20K.%2C%20Dautzenberg%2C%20B.%2C%20Jarlier%2C%20V.%2C%20Raskine%2C%20L.%2C%20Rivoire%2C%20B.%2C%20Veziris%2C%20N.%2C%20Appere%2C%20C.%2C%20Assouline%2C%20P.%2C%20Borie%2C%20R.%2C%20Boukari%2C%20L.%2C%20Caseris%2C%20M.%2C%20Caumes%2C%20E.%2C%20Douadi%2C%20Y.%2C%20Dumoulin%2C%20J.%2C%20Duval%2C%20C.%2C%20Faucher%2C%20J.%20F.%2C%20Gallien%2C%20S.%2C%20Godet%2C%20C.%2C%20Grusse%2C%20J.%20L.%2C%20Lopes%2C%20A.%2C%20Meynard%2C%20J.%20L.%2C%20Naccache%2C%20J.%20M.%2C%20Philippe%2C%20B.%2C%20Richaud%2C%20C.%20and%20Saad%2C%20H.%20%282015%29.%20%26lt%3Bb%26gt%3BCompassionate%20Use%20of%20Bedaquiline%20for%20the%20Treatment%20of%20Multidrug-Resistant%20and%20Extensively%20Drug-Resistant%20Tuberculosis%3A%20Interim%20Analysis%20of%20a%20French%20Cohort%26lt%3B%5C%2Fb%26gt%3B.%20Clin%20Infect%20Dis%20%26lt%3Bi%26gt%3B60%26lt%3B%5C%2Fi%26gt%3B%2C%20188%26%23x2013%3B194%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciu786%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciu786%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Compassionate%20Use%20of%20Bedaquiline%20for%20the%20Treatment%20of%20Multidrug-Resistant%20and%20Extensively%20Drug-Resistant%20Tuberculosis%3A%20Interim%20Analysis%20of%20a%20French%20Cohort%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Damien%20Le%22%2C%22lastName%22%3A%22D%5Cu00fb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathilde%22%2C%22lastName%22%3A%22Jachym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beno%5Cu00eet%22%2C%22lastName%22%3A%22Henry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diane%22%2C%22lastName%22%3A%22Martin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Caumes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22M%5Cu00e9tivier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Andrejak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Chadelat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Dautzenberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Raskine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Rivoire%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Appere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Assouline%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Borie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Boukari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Caseris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Caumes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Y.%22%2C%22lastName%22%3A%22Douadi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Dumoulin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Duval%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20F.%22%2C%22lastName%22%3A%22Faucher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Gallien%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Godet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20Le%22%2C%22lastName%22%3A%22Grusse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Lopes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20L.%22%2C%22lastName%22%3A%22Meynard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20M.%22%2C%22lastName%22%3A%22Naccache%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Philippe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Richaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Saad%22%7D%5D%2C%22abstractNote%22%3A%22Background.%20Bedaquiline%20is%20a%20new%20antibiotic%20that%20was%20approved%20for%20the%20treatment%20of%20multidrug-resistant%20%28MDR%29%20tuberculosis.%20We%20aimed%20to%20evaluate%20the%20short-term%20microbiological%20efficacy%20and%20the%20tolerability%20profile%20of%20bedaquiline.%5CnMethods.%20We%20performed%20a%20retrospective%20cohort%20study%20among%20patients%20with%20MDR%20tuberculosis%20receiving%20bedaquiline%20for%20compassionate%20use%20between%20January%202010%20and%20July%202013%20and%20evaluated%20at%206%20months%20of%20bedaquiline%20treatment.%5CnResults.%20A%20total%20of%2035%20patients%20with%20MDR%20tuberculosis%20were%20included%20in%20the%20study.%20Nineteen%20%2854%25%29%20had%20extensively%20drug-resistant%20%28XDR%29%20tuberculosis%2C%20and%2014%20%2840%25%29%20had%20isolates%20resistant%20to%20fluoroquinolones%20%28Fqs%29%20or%20second-line%20injectables.%20Bedaquiline%20was%20associated%20with%20a%20median%20of%204%20%28range%2C%202%5Cu20135%29%20other%20drugs%2C%20including%20linezolid%20in%2033%20%2894%25%29%20cases.%20At%206%20months%20of%20bedaquiline%20treatment%2C%20culture%20conversion%20was%20achieved%20in%2028%20of%2029%20%2897%25%29%20cases%20with%20culture-positive%20pulmonary%20tuberculosis%20at%20bedaquiline%20initiation.%20Median%20time%20to%20culture%20conversion%20was%2085%20days%20%28range%2C%208%5Cu2013235%20days%29.%20Variables%20independently%20associated%20with%20culture%20conversion%20were%20treatment%20with%20a%20Fq%20%28P%20%3D%20.01%29%2C%20absence%20of%20lung%20cavities%20%28P%20%26lt%3B%20.001%29%2C%20and%20absence%20of%20hepatitis%20C%20virus%20infection%20%28P%20%3D%20.001%29.%20A%20total%20of%207%20patients%20%2820%25%29%20experienced%20a%20%5Cu226560-ms%20increase%20in%20QT%20interval%2C%20leading%20to%20bedaquiline%20discontinuation%20in%202%20%286%25%29%20cases.%20Severe%20liver%20enzyme%20elevation%20occurred%20in%202%20patients%20%286%25%29.%20During%20the%20study%20period%2C%201%20death%20%283%25%29%20occurred%20and%20was%20reported%20as%20unrelated%20to%20tuberculosis%20or%20antituberculosis%20treatment.%5CnConclusions.%20The%20use%20of%20bedaquiline%20combined%20with%20other%20active%20drugs%20has%20the%20potential%20to%20achieve%20high%20culture%20conversion%20rates%20in%20complicated%20MDR%20and%20XDR%20tuberculosis%20cases%2C%20with%20a%20reassuring%20safety%20profile%20at%206%20months%20of%20treatment.%22%2C%22date%22%3A%222015-01-15%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciu786%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fcid.oxfordjournals.org%5C%2Fcontent%5C%2F60%5C%2F2%5C%2F188%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221058-4838%2C%201537-6591%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-03-26T17%3A55%3A16Z%22%7D%7D%2C%7B%22key%22%3A%22VN5MQSXI%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Herv%5Cu00e9%20et%20al.%22%2C%22parsedDate%22%3A%222015%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHerv%26%23xE9%3B%2C%20C.%2C%20Bergot%2C%20E.%2C%20Veziris%2C%20N.%20and%20Blanc%2C%20F.-X.%20%282015%29.%20%26lt%3Bb%26gt%3BLa%20tuberculose%20en%202015%26%23x202F%3B%3A%20du%20diagnostic%20%26%23xE0%3B%20la%20d%26%23xE9%3Btection%20des%20formes%20r%26%23xE9%3Bsistantes%26lt%3B%5C%2Fb%26gt%3B.%20Revue%20des%20Maladies%20Respiratoires%20%26lt%3Bi%26gt%3B32%26lt%3B%5C%2Fi%26gt%3B%2C%20784%26%23x2013%3B790%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2015.06.008%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2015.06.008%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22La%20tuberculose%20en%202015%20%3A%20du%20diagnostic%20%5Cu00e0%20la%20d%5Cu00e9tection%20des%20formes%20r%5Cu00e9sistantes%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Herv%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Bergot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.-X.%22%2C%22lastName%22%3A%22Blanc%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2210%5C%2F2015%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.rmr.2015.06.008%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS0761842515002636%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%2207618425%22%2C%22language%22%3A%22fr%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-03-26T17%3A55%3A47Z%22%7D%7D%2C%7B%22key%22%3A%227VS7VHZC%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Isaakidis%20et%20al.%22%2C%22parsedDate%22%3A%222015-08-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BIsaakidis%2C%20P.%2C%20Casas%2C%20E.%20C.%2C%20Das%2C%20M.%2C%20Tseretopoulou%2C%20X.%2C%20Ntzani%2C%20E.%20E.%20and%20Ford%2C%20N.%20%282015%29.%20%26lt%3Bb%26gt%3BTreatment%20outcomes%20for%20HIV%20and%20MDR-TB%20co-infected%20adults%20and%20children%3A%20systematic%20review%20and%20meta-analysis%26lt%3B%5C%2Fb%26gt%3B.%20The%20International%20Journal%20of%20Tuberculosis%20and%20Lung%20Disease%20%26lt%3Bi%26gt%3B19%26lt%3B%5C%2Fi%26gt%3B%2C%20969%26%23x2013%3B978%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.15.0123%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.15.0123%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Treatment%20outcomes%20for%20HIV%20and%20MDR-TB%20co-infected%20adults%20and%20children%3A%20systematic%20review%20and%20meta-analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Isaakidis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20C.%22%2C%22lastName%22%3A%22Casas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Das%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22X.%22%2C%22lastName%22%3A%22Tseretopoulou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20E.%22%2C%22lastName%22%3A%22Ntzani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Ford%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20incidence%20of%20multidrug-resistant%20tuberculosis%20%28MDR-TB%29%20is%20increasing%20in%20high%20human%20immunodeficiency%20virus%20%28HIV%29%20prevalence%20settings%2C%20with%20high%20associated%20mortality.%20Treatment%20outcomes%20in%20HIV-co-infected%20adults%20and%20children%20are%20poorly%20documented.OBJECTIVE%3A%20To%20systematically%20assess%20treatment%20outcomes%20among%20HIV%5Cu2013MDR-TB%20co-infected%20patients.METHODS%3A%20We%20searched%20two%20databases%20and%20the%20proceedings%20of%20an%20annual%20international%20conference%20up%20to%20November%202014%20for%20studies%20reporting%20on%20major%20clinical%20outcomes%20among%20HIV%5Cu2013MDR-TB-co-infected%20adults%20and%20children%2C%20and%20pooled%20the%20results%20using%20random-effects%20meta-analysis.RESULTS%3A%20Of%204812%20abstracts%20and%20articles%20screened%2C%2030%20studies%20providing%20data%20on%202578%20adults%20and%20147%20children%20were%20included.%20Overall%20pooled%20treatment%20success%20was%2056.9%25%20%2895%25%20confidence%20interval%20%5BCI%5D%2046.2%5Cu201367.6%29%2C%2049.9%25%20%2895%25CI%2038.5%5Cu201361.2%29%20among%20adults%20and%2083.4%25%20%2895%25CI%2074.7%5Cu201392%29%20among%20children.%20Mortality%20was%2038%25%20in%20adults%20%2895%25CI%2028%5Cu201348.1%29%20and%2011.4%25%20%2895%25CI%205.8%5Cu201317.1%29%20in%20children.%20Loss%20to%20follow-up%20was%20higher%20among%20adults%20%2816.1%25%2C%2095%25CI%209%5Cu201323.2%29%20than%20among%20children%20%283.9%25%2C%2095%25CI%200.9%5Cu20136.9%29.%20Adverse%20events%20were%20experienced%20by%20the%20majority%20of%20patients%3B%20however%2C%20this%20was%20inconsistently%20documented.%20The%20use%20of%20fluoroquinolones%2C%20aminoglycosides%20and%20Group%20IV%20drugs%20appeared%20to%20be%20associated%20with%20treatment%20success.CONCLUSION%3A%20The%20proportion%20of%20HIV%5Cu2013MDR-TB-co-infected%20patients%20achieving%20treatment%20success%20was%20similar%20to%20success%20rates%20reported%20among%20MDR-TB%20patients%20in%20general%2C%20regardless%20of%20HIV%20status%3B%20however%2C%20mortality%20was%20higher%2C%20particularly%20among%20adults%2C%20highlighting%20the%20need%20for%20early%20diagnosis%20and%20more%20effective%20treatment%20regimens.%22%2C%22date%22%3A%222015-08-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.5588%5C%2Fijtld.15.0123%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-01-08T18%3A11%3A15Z%22%7D%7D%2C%7B%22key%22%3A%22DTZ7F3ZB%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jaubert%20et%20al.%22%2C%22parsedDate%22%3A%222015%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BJaubert%2C%20J.%2C%20Mougari%2C%20F.%2C%20Picot%2C%20S.%2C%20Boukerrou%2C%20M.%2C%20Barau%2C%20G.%2C%20Ali%20Ahmed%2C%20S.-A.%2C%20Raskine%2C%20L.%2C%20Camuset%2C%20G.%2C%20Michault%2C%20A.%2C%20Simac%2C%20C.%20and%20Cambau%2C%20E.%20%282015%29.%20%26lt%3Bb%26gt%3BA%20case%20of%20postoperative%20breast%20infection%20by%20Mycobacterium%20fortuitum%20associated%20with%20the%20hospital%20water%20supply%26lt%3B%5C%2Fb%26gt%3B.%20American%20Journal%20of%20Infection%20Control%20%26lt%3Bi%26gt%3B43%26lt%3B%5C%2Fi%26gt%3B%2C%20406%26%23x2013%3B408%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ajic.2014.12.023%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ajic.2014.12.023%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20case%20of%20postoperative%20breast%20infection%20by%20Mycobacterium%20fortuitum%20associated%20with%20the%20hospital%20water%20supply%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julien%22%2C%22lastName%22%3A%22Jaubert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faiza%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandrine%22%2C%22lastName%22%3A%22Picot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Malik%22%2C%22lastName%22%3A%22Boukerrou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georges%22%2C%22lastName%22%3A%22Barau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sitty-Amina%22%2C%22lastName%22%3A%22Ali%20Ahmed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Raskine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guillaume%22%2C%22lastName%22%3A%22Camuset%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alain%22%2C%22lastName%22%3A%22Michault%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Simac%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2204%5C%2F2015%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ajic.2014.12.023%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS0196655314014308%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%2201966553%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-02-26T17%3A56%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22VA8JMHTG%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kibleur%20and%20Veziris%22%2C%22parsedDate%22%3A%222015-03-23%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKibleur%2C%20Y.%20and%20Veziris%2C%20N.%20%282015%29.%20%26lt%3Bb%26gt%3BFrench%20Nationwide%20Cohort%20Temporary%20Utilization%20Authorization%20Survey%20of%20GranuPAS%26%23xAE%3B%20in%20MDR-TB%20Patients%26lt%3B%5C%2Fb%26gt%3B.%20Chemotherapy%20%26lt%3Bi%26gt%3B60%26lt%3B%5C%2Fi%26gt%3B%2C%20174%26%23x2013%3B179%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1159%5C%2F000371869%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1159%5C%2F000371869%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22French%20Nationwide%20Cohort%20Temporary%20Utilization%20Authorization%20Survey%20of%20GranuPAS%5Cu00ae%20in%20MDR-TB%20Patients%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yves%22%2C%22lastName%22%3A%22Kibleur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222015-3-23%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1159%5C%2F000371869%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.karger.com%5C%2F%3Fdoi%3D10.1159%5C%2F000371869%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220009-3157%2C%201421-9794%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-03-26T17%3A54%3A51Z%22%7D%7D%2C%7B%22key%22%3A%22SVWG3WRG%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Reibel%20et%20al.%22%2C%22parsedDate%22%3A%222015%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BReibel%2C%20F.%2C%20Cambau%2C%20E.%20and%20Aubry%2C%20A.%20%282015%29.%20%26lt%3Bb%26gt%3BHistoire%20et%20actualit%26%23xE9%3B%20du%20traitement%20de%20la%20l%26%23xE8%3Bpre%26lt%3B%5C%2Fb%26gt%3B.%20Journal%20des%20Anti-Infectieux%20%26lt%3Bi%26gt%3B17%26lt%3B%5C%2Fi%26gt%3B%2C%2091%26%23x2013%3B98%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.antinf.2015.01.004%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.antinf.2015.01.004%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Histoire%20et%20actualit%5Cu00e9%20du%20traitement%20de%20la%20l%5Cu00e8pre%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Reibel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%5D%2C%22abstractNote%22%3A%22Histoire%20et%20actualit%5Cu00e9%20du%20traitement%20de%20la%20l%5Cu00e8pre%22%2C%22date%22%3A%222015%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.antinf.2015.01.004%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.em-consulte.com%5C%2Farticle%5C%2F1008047%5C%2Fhistoire-et-actualite-du-traitement-de-la-lepre%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-01T16%3A22%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22EIHIVTCZ%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Reibel%20et%20al.%22%2C%22parsedDate%22%3A%222015-09%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BReibel%2C%20F.%2C%20Cambau%2C%20E.%20and%20Aubry%2C%20A.%20%282015%29.%20%26lt%3Bb%26gt%3BUpdate%20on%20the%20epidemiology%2C%20diagnosis%2C%20and%20treatment%20of%20leprosy%26lt%3B%5C%2Fb%26gt%3B.%20M%26%23xE9%3Bdecine%20et%20Maladies%20Infectieuses%20%26lt%3Bi%26gt%3B45%26lt%3B%5C%2Fi%26gt%3B%2C%20383%26%23x2013%3B393%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.medmal.2015.09.002%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.medmal.2015.09.002%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Update%20on%20the%20epidemiology%2C%20diagnosis%2C%20and%20treatment%20of%20leprosy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Reibel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Aubry%22%7D%5D%2C%22abstractNote%22%3A%22Leprosy%20is%20an%20infectious%20disease%20that%20has%20now%20been%20reported%20for%20more%20than%202000%20years.%20The%20leprosy%20elimination%20goal%20set%20by%20the%20World%20Health%20Organization%20%28WHO%29%2C%20i.e.%20a%20global%20prevalence%20rate%20%26lt%3B%201%20patient%20per%2010%2C000%20population%2C%20was%20achieved%20in%20the%20year%202000%2C%20but%20more%20than%20200%2C000%20new%20case%20patients%20are%20still%20reported%20each%20year%2C%20particularly%20in%20India%2C%20Brazil%2C%20and%20Indonesia.%20Leprosy%20is%20a%20specific%20infection%3A%20%28i%29%20it%20is%20a%20chronic%20infection%20primarily%20affecting%20the%20skin%20and%20peripheral%20nerves%2C%20%28ii%29%20Mycobacterium%20leprae%20is%20one%20of%20the%20last%20bacterial%20species%20of%20medical%20interest%20that%20cannot%20be%20cultured%20in%20vitro%20%28mainly%20because%20of%20its%20reductive%20genome%20evolution%29%2C%20and%20%28iii%29%20transmission%20and%20pathophysiological%20data%20is%20still%20limited.%20The%20various%20presentations%20of%20the%20disease%20%28Ridley-Jopling%20and%20WHO%20classifications%29%20are%20correlated%20with%20the%20patient%26%23039%3Bs%20immune%20response%2C%20bacillary%20load%2C%20and%20by%20the%20delay%20before%20diagnosis.%20Multidrug%20therapy%20%28dapsone%2C%20rifampicin%2C%20with%20or%20without%20clofazimine%29%20has%20been%20recommended%20since%201982%20as%20the%20standard%20treatment%20of%20leprosy%3B%206%20months%20for%20patients%20presenting%20with%20paucibacillary%20leprosy%20and%2012%20months%20for%20patients%20presenting%20with%20multibacillary%20leprosy.%20The%20worldwide%20use%20of%20leprosy%20drugs%20started%20in%20the%201980s%20and%20their%20free%20access%20since%201995%20contributed%20to%20the%20drastic%20decline%20in%20the%20number%20of%20new%20case%20patients.%20Resistant%20strains%20are%20however%20emerging%20despite%20the%20use%20of%20multidrug%20therapy%3B%20identifying%20and%20monitoring%20resistance%20is%20still%20necessary.%22%2C%22date%22%3A%22septembre%202015%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.medmal.2015.09.002%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0399077X1500181X%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220399-077X%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-08-02T16%3A28%3A14Z%22%7D%7D%2C%7B%22key%22%3A%22U4GH9AVW%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Reibel%20et%20al.%22%2C%22parsedDate%22%3A%222015-10-06%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BReibel%2C%20F.%2C%20Chauffour%2C%20A.%2C%20Brossier%2C%20F.%2C%20Jarlier%2C%20V.%2C%20Cambau%2C%20E.%20and%20Aubry%2C%20A.%20%282015%29.%20%26lt%3Bb%26gt%3BNew%20Insights%20into%20the%20Geographic%20Distribution%20of%20Mycobacterium%20leprae%20SNP%20Genotypes%20Determined%20for%20Isolates%20from%20Leprosy%20Cases%20Diagnosed%20in%20Metropolitan%20France%20and%20French%20Territories%26lt%3B%5C%2Fb%26gt%3B%20Ed.%20Johnson%2C%20C.%20PLOS%20Neglected%20Tropical%20Diseases%20%26lt%3Bi%26gt%3B9%26lt%3B%5C%2Fi%26gt%3B%2C%20e0004141%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pntd.0004141%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pntd.0004141%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22New%20Insights%20into%20the%20Geographic%20Distribution%20of%20Mycobacterium%20leprae%20SNP%20Genotypes%20Determined%20for%20Isolates%20from%20Leprosy%20Cases%20Diagnosed%20in%20Metropolitan%20France%20and%20French%20Territories%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Reibel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Johnson%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222015-10-6%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pntd.0004141%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fdx.plos.org%5C%2F10.1371%5C%2Fjournal.pntd.0004141%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221935-2735%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-03-26T17%3A54%3A10Z%22%7D%7D%2C%7B%22key%22%3A%229W9IFB5M%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Renvois%5Cu00e9%20et%20al.%22%2C%22parsedDate%22%3A%222015%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRenvois%26%23xE9%3B%2C%20A.%2C%20Brossier%2C%20F.%2C%20Galati%2C%20E.%2C%20Veziris%2C%20N.%2C%20Sougakoff%2C%20W.%2C%20Aubry%2C%20A.%2C%20Robert%2C%20J.%2C%20Cambau%2C%20E.%2C%20Jarlier%2C%20V.%20and%20Bernard%2C%20C.%20%282015%29.%20%26lt%3Bb%26gt%3BAssessing%20Primary%20and%20Secondary%20Resistance%20to%20Clarithromycin%20and%20Amikacin%20in%20Infections%20Due%20to%20Mycobacterium%20avium%20Complex%26lt%3B%5C%2Fb%26gt%3B.%20Antimicrobial%20Agents%20and%20Chemotherapy%20%26lt%3Bi%26gt%3B59%26lt%3B%5C%2Fi%26gt%3B%2C%207153%26%23x2013%3B7155%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.01027-15%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.01027-15%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Assessing%20Primary%20and%20Secondary%20Resistance%20to%20Clarithromycin%20and%20Amikacin%20in%20Infections%20Due%20to%20Mycobacterium%20avium%20Complex%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Renvois%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eve%22%2C%22lastName%22%3A%22Galati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Bernard%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2211%5C%2F2015%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2FAAC.01027-15%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Faac.asm.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1128%5C%2FAAC.01027-15%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220066-4804%2C%201098-6596%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-03-26T17%3A47%3A49Z%22%7D%7D%2C%7B%22key%22%3A%22ARQU57G3%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Robert%20and%20CNR-MyRMA%22%2C%22parsedDate%22%3A%222015-03-24%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRobert%2C%20J.%20and%20CNR-MyRMA%20%282015%29.%20%26lt%3Bb%26gt%3BR%26%23xE9%3Bsistance%20aux%20antituberculeux%20en%20France%20en%202013%26lt%3B%5C%2Fb%26gt%3B.%20Bulletin%20Epid%26%23xE9%3Bmiologique%20Hebdomadaire%20%26lt%3Bi%26gt%3B9%26%23x2013%3B10%26lt%3B%5C%2Fi%26gt%3B%2C%20172%26%23x2013%3B174%2C%20URL%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fwww.invs.sante.fr%5C%2Fbeh%5C%2F2015%5C%2F9-10%5C%2Fpdf%5C%2F2015_9-10_4.pdf%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fwww.invs.sante.fr%5C%2Fbeh%5C%2F2015%5C%2F9-10%5C%2Fpdf%5C%2F2015_9-10_4.pdf%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22R%5Cu00e9sistance%20aux%20antituberculeux%20en%20France%20en%202013%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22%22%2C%22lastName%22%3A%22CNR-MyRMA%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2224%20mar%202015%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.invs.sante.fr%5C%2Fbeh%5C%2F2015%5C%2F9-10%5C%2Fpdf%5C%2F2015_9-10_4.pdf%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-04-25T16%3A19%3A55Z%22%7D%7D%2C%7B%22key%22%3A%22SCP4EEUH%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Roux%20et%20al.%22%2C%22parsedDate%22%3A%222015%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRoux%2C%20A.-L.%2C%20Catherinot%2C%20E.%2C%20Soismier%2C%20N.%2C%20Heym%2C%20B.%2C%20Bellis%2C%20G.%2C%20Lemonnier%2C%20L.%2C%20Chiron%2C%20R.%2C%20Fauroux%2C%20B.%2C%20Le%20Bourgeois%2C%20M.%2C%20Munck%2C%20A.%2C%20Pin%2C%20I.%2C%20Sermet%2C%20I.%2C%20Gutierrez%2C%20C.%2C%20Veziris%2C%20N.%2C%20Jarlier%2C%20V.%2C%20Cambau%2C%20E.%2C%20Herrmann%2C%20J.-L.%2C%20Guillemot%2C%20D.%20and%20Gaillard%2C%20J.-L.%20%282015%29.%20%26lt%3Bb%26gt%3BComparing%20Mycobacterium%20massiliense%20and%20Mycobacterium%20abscessus%20lung%20infections%20in%20cystic%20fibrosis%20patients%26lt%3B%5C%2Fb%26gt%3B.%20Journal%20of%20Cystic%20Fibrosis%20%26lt%3Bi%26gt%3B14%26lt%3B%5C%2Fi%26gt%3B%2C%2063%26%23x2013%3B69%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jcf.2014.07.004%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jcf.2014.07.004%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Comparing%20Mycobacterium%20massiliense%20and%20Mycobacterium%20abscessus%20lung%20infections%20in%20cystic%20fibrosis%20patients%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne-Laure%22%2C%22lastName%22%3A%22Roux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilie%22%2C%22lastName%22%3A%22Catherinot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Soismier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beate%22%2C%22lastName%22%3A%22Heym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gil%22%2C%22lastName%22%3A%22Bellis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lydie%22%2C%22lastName%22%3A%22Lemonnier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rapha%5Cu00ebl%22%2C%22lastName%22%3A%22Chiron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brigitte%22%2C%22lastName%22%3A%22Fauroux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muriel%22%2C%22lastName%22%3A%22Le%20Bourgeois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Munck%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Pin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Sermet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cristina%22%2C%22lastName%22%3A%22Gutierrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Louis%22%2C%22lastName%22%3A%22Herrmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Didier%22%2C%22lastName%22%3A%22Guillemot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Louis%22%2C%22lastName%22%3A%22Gaillard%22%7D%5D%2C%22abstractNote%22%3A%22Background%5CnMycobacterium%20massiliense%20is%20closely%20related%20to%20Mycobacterium%20abscessus%20and%20is%20also%20a%20frequent%20cause%20of%20mycobacterial%20lung%20disease%20in%20patients%20with%20cystic%20fibrosis%20%28CF%29.%20There%20has%20been%20no%20previous%20investigation%20of%20possible%20differences%20between%20M.%20massiliense%20and%20M.%20abscessus%20infections%20in%20the%20setting%20of%20CF.%5CnMethods%5CnWe%20studied%20a%20prospective%20cohort%20of%2016%20M.%20massiliense%20and%2027%20M.%20abscessus%20lung%20infection%20cases%20with%20CF%2C%20with%20a%20mean%20follow-up%20of%206%5Cu2005years.%5CnResults%5CnM.%20massiliense%20cases%20were%20younger%20than%20M.%20abscessus%20cases%20%28mean%20age%3A%2012.8%20vs%2017.1%5Cu2005years%3B%20p%5Cu2005%3D%5Cu20050.02%29%20at%20the%20time%20of%20the%20first%20mycobacterial%20isolation%20and%20also%20had%20lower%20body%20mass%20index%20values%20%28mean%3A%2016.4%20vs%2019.3%5Cu2005kg%5C%2Fm2%2C%20p%5Cu2005%3D%5Cu20050.002%29.%20All%20M.%20massiliense%20cases%2C%20except%20one%2C%20had%20negative%20BMI%20Z-score%20values%20at%20the%20time%20of%20the%20first%20mycobacterial%20isolation%20%2811%5C%2F12%20vs%2016%5C%2F23%20M.%20abscessus%20cases%2C%20p%5Cu2005%3D%5Cu20050.04%29.%20Clarithromycin-based%20combination%20therapies%20led%20to%20mycobacterial%20eradication%20in%20100%25%20of%20M.%20massiliense%20cases%20but%20only%20in%2027%25%20of%20M.%20abscessus%20cases%20%28p%5Cu2005%3D%5Cu20050.009%29.%5CnConclusion%5CnOur%20data%20show%20a%20particular%20link%20between%20M.%20massiliense%20and%20malnutrition%20specifically%20in%20CF%20patients.%20Unlike%20M.%20abscessus%2C%20the%20bacteriological%20response%20of%20M.%20massiliense%20to%20combination%20antibiotic%20therapies%20containing%20clarithromycin%20was%20excellent.%20Distinguishing%20between%20M.%20massiliense%20and%20M.%20abscessus%20has%20major%20clinical%20implications%20for%20CF%20patients.%22%2C%22date%22%3A%222015%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jcf.2014.07.004%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.cysticfibrosisjournal.com%5C%2Farticle%5C%2FS1569199314001659%5C%2Fabstract%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221569-1993%22%2C%22language%22%3A%22English%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-09-08T15%3A58%3A39Z%22%7D%7D%5D%7D
Amarsy-Guerle, R., Mougari, F., Jacquier, H., Oliary, J., Benmansour, H., Riahi, J., Berçot, B., Raskine, L. and Cambau, E. (2015). High medical impact of implementing the new polymeric bead-based BacT/ALERT® FAPlus and FNPlus blood culture bottles in standard care. European Journal of Clinical Microbiology & Infectious Diseases 34, 1031–1037, http://doi.org/10.1007/s10096-015-2319-8.
Bernard, C., Veziris, N., Brossier, F., Sougakoff, W., Jarlier, V., Robert, J. and Aubry, A. (2015). Molecular Diagnosis of Fluoroquinolone Resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 59, 1519–1524, http://doi.org/10.1128/AAC.04058-14.
Brossier, F., Sola, C., Bernard, C., Jarlier, V., Veziris, N. and Sougakoff, W. (2015). Characterization of a Clone of Mycobacterium tuberculosis Clinical Isolates with Mutations in KatG (A110V), EthA (Q269STOP), and the inhA Promoter (−15C→T) Ed. Land, G. A. Journal of Clinical Microbiology 53, 3104–3104, http://doi.org/10.1128/JCM.01537-15.
Brossier, F., Sougakoff, W., Bernard, C., Petrou, M., Adeyema, K., Pham, A., Amy de la Breteque, D., Vallet, M., Jarlier, V., Sola, C. and Veziris, N. (2015). Molecular Analysis of the embCAB Locus and embR Gene Involved in Ethambutol Resistance in Clinical Isolates of Mycobacterium tuberculosis in France. Antimicrobial Agents and Chemotherapy 59, 4800–4808, http://doi.org/10.1128/AAC.00150-15.
Bui, T. V., Lévy-Bruhl, D., Che, D., Antoine, D., Jarlier, V. and Robert, J. (2015). Impact of the BCG vaccination policy on tuberculous meningitis in children under 6 years in metropolitan France between 2000 and 2011. Euro Surveill 20.
Cambau, E., Viveiros, M., Machado, D., Raskine, L., Ritter, C., Tortoli, E., Matthys, V., Hoffner, S., Richter, E., Perez Del Molino, M. L., Cirillo, D. M., van Soolingen, D. and Bottger, E. C. (2015). Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study. Journal of Antimicrobial Chemotherapy 70, 686–696, http://doi.org/10.1093/jac/dku438.
Catho, G., Couraud, S., Grard, S., Bouaziz, A., Sénéchal, A., Valour, F., Perpoint, T., Braun, E., Biron, F., Ferry, T., Chidiac, C., Freymond, N., Perrot, E., Souquet, P.-J., Maury, J.-M., Tronc, F., Veziris, N., Lina, G., Dumitrescu, O. and Ader, F. (2015). Management of emerging multidrug-resistant tuberculosis in a low-prevalence setting. Clinical Microbiology and Infection 21, 472.e7-472.e10, http://doi.org/10.1016/j.cmi.2014.12.022.
Coolen, N., Morand, P., Martin, C., Hubert, D., Kanaan, R., Chapron, J., Honoré, I., Dusser, D., Audureau, E., Veziris, N. and Burgel, P.-R. (2015). Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin. Journal of Cystic Fibrosis 14, 594–599, http://doi.org/10.1016/j.jcf.2015.02.006.
Grard, S., Catho, G., Valour, F., Bouaziz, A., Perpoint, T., Braun, E., Biron, F., Miailhes, P., Ferry, T., Chidiac, C., Souquet, P.-J., Couraud, S., Lina, G., Goutelle, S., Veziris, N., Dumitrescu, O. and Ader, F. (2015). Linezolid in the Starter Combination for Multidrug-Resistant Tuberculosis: Time to Move on to Group Four? Open Forum Infectious Diseases 2, ofv175, http://doi.org/10.1093/ofid/ofv175.
Guglielmetti, L. and Robert, J. (2015). Bédaquiline : de l’in vitro aux essais cliniques d’un nouvel antituberculeux. Journal des Anti-infectieux 17, 60–66, http://doi.org/10.1016/j.antinf.2014.12.003.
Guglielmetti, L., Mougari, F., Lopes, A., Raskine, L. and Cambau, E. (2015). Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists’ point of view. Future Microbiology 10, 1467–1483, http://doi.org/10.2217/fmb.15.64.
Guglielmetti, L., Dû, D. L., Jachym, M., Henry, B., Martin, D., Caumes, Eric, Veziris, Nicolas, Métivier, N., Robert, J., Andrejak, C., Bernard, C., Brossier, F., Chadelat, K., Dautzenberg, B., Jarlier, V., Raskine, L., Rivoire, B., Veziris, N., Appere, C., Assouline, P., Borie, R., Boukari, L., Caseris, M., Caumes, E., Douadi, Y., Dumoulin, J., Duval, C., Faucher, J. F., Gallien, S., Godet, C., Grusse, J. L., Lopes, A., Meynard, J. L., Naccache, J. M., Philippe, B., Richaud, C. and Saad, H. (2015). Compassionate Use of Bedaquiline for the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Interim Analysis of a French Cohort. Clin Infect Dis 60, 188–194, http://doi.org/10.1093/cid/ciu786.
Hervé, C., Bergot, E., Veziris, N. and Blanc, F.-X. (2015). La tuberculose en 2015 : du diagnostic à la détection des formes résistantes. Revue des Maladies Respiratoires 32, 784–790, http://doi.org/10.1016/j.rmr.2015.06.008.
Isaakidis, P., Casas, E. C., Das, M., Tseretopoulou, X., Ntzani, E. E. and Ford, N. (2015). Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis. The International Journal of Tuberculosis and Lung Disease 19, 969–978, http://doi.org/10.5588/ijtld.15.0123.
Jaubert, J., Mougari, F., Picot, S., Boukerrou, M., Barau, G., Ali Ahmed, S.-A., Raskine, L., Camuset, G., Michault, A., Simac, C. and Cambau, E. (2015). A case of postoperative breast infection by Mycobacterium fortuitum associated with the hospital water supply. American Journal of Infection Control 43, 406–408, http://doi.org/10.1016/j.ajic.2014.12.023.
Kibleur, Y. and Veziris, N. (2015). French Nationwide Cohort Temporary Utilization Authorization Survey of GranuPAS® in MDR-TB Patients. Chemotherapy 60, 174–179, http://doi.org/10.1159/000371869.
Reibel, F., Cambau, E. and Aubry, A. (2015). Histoire et actualité du traitement de la lèpre. Journal des Anti-Infectieux 17, 91–98, http://doi.org/10.1016/j.antinf.2015.01.004.
Reibel, F., Cambau, E. and Aubry, A. (2015). Update on the epidemiology, diagnosis, and treatment of leprosy. Médecine et Maladies Infectieuses 45, 383–393, http://doi.org/10.1016/j.medmal.2015.09.002.
Reibel, F., Chauffour, A., Brossier, F., Jarlier, V., Cambau, E. and Aubry, A. (2015). New Insights into the Geographic Distribution of Mycobacterium leprae SNP Genotypes Determined for Isolates from Leprosy Cases Diagnosed in Metropolitan France and French Territories Ed. Johnson, C. PLOS Neglected Tropical Diseases 9, e0004141, http://doi.org/10.1371/journal.pntd.0004141.
Renvoisé, A., Brossier, F., Galati, E., Veziris, N., Sougakoff, W., Aubry, A., Robert, J., Cambau, E., Jarlier, V. and Bernard, C. (2015). Assessing Primary and Secondary Resistance to Clarithromycin and Amikacin in Infections Due to Mycobacterium avium Complex. Antimicrobial Agents and Chemotherapy 59, 7153–7155, http://doi.org/10.1128/AAC.01027-15.
Robert, J. and CNR-MyRMA (2015). Résistance aux antituberculeux en France en 2013. Bulletin Epidémiologique Hebdomadaire 9–10, 172–174, URL: http://www.invs.sante.fr/beh/2015/9-10/pdf/2015_9-10_4.pdf.
Roux, A.-L., Catherinot, E., Soismier, N., Heym, B., Bellis, G., Lemonnier, L., Chiron, R., Fauroux, B., Le Bourgeois, M., Munck, A., Pin, I., Sermet, I., Gutierrez, C., Veziris, N., Jarlier, V., Cambau, E., Herrmann, J.-L., Guillemot, D. and Gaillard, J.-L. (2015). Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients. Journal of Cystic Fibrosis 14, 63–69, http://doi.org/10.1016/j.jcf.2014.07.004.

Publications du CNR en 2016

1368488 2016 1 heidelberg-university-faculty-of-medicine 50 creator asc year 1 225 https://cnrmyrma.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22XMPDSNWQ%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bernard%20et%20al.%22%2C%22parsedDate%22%3A%222016-07-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBernard%2C%20J.%2C%20Armand-Lef%26%23xE8%3Bvre%2C%20L.%2C%20Luce%2C%20E.%2C%20Mniai%2C%20A.%20E.%2C%20Chau%2C%20F.%2C%20Casalino%2C%20E.%2C%20Andremont%2C%20A.%20and%20Rupp%26%23xE9%3B%2C%20E.%20%282016%29.%20%26lt%3Bb%26gt%3BImpact%20of%20a%20short%20exposure%20to%20levofloxacin%20on%20faecal%20densities%20and%20relative%20abundance%20of%20total%20and%20quinolone-resistant%20Enterobacteriaceae%26lt%3B%5C%2Fb%26gt%3B.%20Clinical%20Microbiology%20and%20Infection%20%26lt%3Bi%26gt%3B22%26lt%3B%5C%2Fi%26gt%3B%2C%20646.e1-646.e4%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2016.04.015%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2016.04.015%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Impact%20of%20a%20short%20exposure%20to%20levofloxacin%20on%20faecal%20densities%20and%20relative%20abundance%20of%20total%20and%20quinolone-resistant%20Enterobacteriaceae%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Armand-Lef%5Cu00e8vre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Luce%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20El%22%2C%22lastName%22%3A%22Mniai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Chau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Casalino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Andremont%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Rupp%5Cu00e9%22%7D%5D%2C%22abstractNote%22%3A%22Emergence%20of%20resistant%20Enterobacteriaceae%20in%20the%20intestinal%20microbiota%20during%20antibiotic%5Cntreatment%20is%20well%20documented%20but%20its%20early%20dynamic%20is%20not.%20Here%2C%20we%20compared%20the%20densities%5Cnof%20total%20Enterobacteriaceae%20and%20relative%20abundance%20%28RA%29%20of%20quinolone-resistant%20Enterobacteriaceae%5Cn%28QRE%29%20in%20the%20first%20stool%20passed%20by%20patients%20who%20had%20a%20short%20exposure%20to%20levofloxacin%5Cn%28levofloxacin%2C%20n%3D12%29%20or%20not%20%28control%2C%20n%3D8%29.%20Mean%20densities%20%28SD%29%20%28log%20CFU%5C%2Fg%20stool%29%5Cnof%20total%20Enterobacteriaceae%20were%20lower%20in%20the%20levofloxacin%20group%20than%20in%20the%20control%5Cngroup%5Cu20143.4%20%281.6%29%20versus%206.7%20%281.7%29%2C%20respectively%2C%20p%20%26lt%3B0.001.%22%2C%22date%22%3A%222016%5C%2F07%5C%2F01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cmi.2016.04.015%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.clinicalmicrobiologyandinfection.com%5C%2Farticle%5C%2FS1198-743X%2816%2930091-X%5C%2Fabstract%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221198-743X%22%2C%22language%22%3A%22English%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-03-02T22%3A40%3A30Z%22%7D%7D%2C%7B%22key%22%3A%22W4SXQV97%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bernard%20et%20al.%22%2C%22parsedDate%22%3A%222016-09-07%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBernard%2C%20C.%2C%20Aubry%2C%20A.%2C%20Chauffour%2C%20A.%2C%20Brossier%2C%20F.%2C%20Robert%2C%20J.%20and%20Veziris%2C%20N.%20%282016%29.%20%26lt%3Bb%26gt%3BIn%20vivo%20Mycobacterium%20tuberculosis%20fluoroquinolone%20resistance%20emergence%3A%20a%20complex%20phenomenon%20poorly%20detected%20by%20current%20diagnostic%20tests%26lt%3B%5C%2Fb%26gt%3B.%20J%20Antimicrob%20Chemother%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkw344%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkw344%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22In%20vivo%20Mycobacterium%20tuberculosis%20fluoroquinolone%20resistance%20emergence%3A%20a%20complex%20phenomenon%20poorly%20detected%20by%20current%20diagnostic%20tests%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20Heteroresistance%2C%20described%20both%20in%20terms%20of%20various%20point%20mutations%20resulting%20in%20different%20levels%20of%20resistance%20and%20in%20terms%20of%20a%20mixture%20of%20mutant%20and%20WT%20bacilli%2C%20is%20identified%20in%20up%20to%20one-third%20of%20fluoroquinolone%20%28FQ%29-resistant%20Mycobacterium%20tuberculosis%20isolates.%20Heteroresistance%20is%20a%20challenge%20for%20current%20phenotypic%20and%20genotypic%20susceptibility%20testing%20%28DST%29%20regimes.%20We%20aimed%20to%20compare%20the%20performances%20of%20different%20phenotypic%20and%20genotypic%20DST%20in%20the%20context%20of%20FQ%20heteroresistance%20by%20mimicking%2C%20in%20a%20murine%20model%2C%20the%20course%20of%20selection%20of%20FQ%20resistance%20during%20treatment.%5CnMETHODS%3A%20The%20capacity%20of%20different%20phenotypic%20DST%20%5BLowenstein-Jensen%20%28LJ%29%20medium%20containing%20either%202%20mg%5C%2FL%20ofloxacin%20or%200.5%2C%201%20or%202%20mg%5C%2FL%20moxifloxacin%5D%20and%20genotypic%20DST%20%28gyrA%5C%2FB%20Sanger%20sequencing%29%20to%20detect%20FQ%20resistance%20was%20analysed.%5CnRESULTS%3A%20Ninety-seven%20percent%20of%20mice%20harboured%20a%20heterogeneous%20population.%20The%20proportion%20of%20mice%20in%20which%20FQ%20resistance%20was%20detected%20varied%20according%20to%20the%20medium%20used%20%2897%25%20for%200.5%20mg%5C%2FL%20moxifloxacin%2C%2080%25%20for%202%20mg%5C%2FL%20ofloxacin%2C%2047%25%20for%201%20mg%5C%2FL%20moxifloxacin%20and%2025%25%20for%202%20mg%5C%2FL%20moxifloxacin%29.%20Compared%20with%20phenotypic%20DST%2C%20genotypic%20DST%20had%20a%20low%20sensitivity%20for%20detection%20of%20resistance%20%2833%25%29.%5CnCONCLUSIONS%3A%20Our%20study%20shows%20the%20in%20vivo%20complexity%20of%20FQ%20resistance%20emergence%20and%20the%20poor%20sensitivity%20of%20Sanger%20DNA%20sequencing%20for%20detection%20of%20heteroresistance.%20Our%20data%20support%20the%20use%20of%200.5%20mg%5C%2FL%20moxifloxacin%20in%20LJ%20for%20detection%20of%20FQ%20resistance%2C%20but%20not%20the%20recent%20increase%20in%20the%20ofloxacin%20critical%20concentration%20from%202%20to%204%20mg%5C%2FL%20given%20in%20the%20WHO%20recommendations.%22%2C%22date%22%3A%22Sep%207%2C%202016%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fjac%5C%2Fdkw344%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221460-2091%22%2C%22language%22%3A%22ENG%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-01-08T18%3A02%3A04Z%22%7D%7D%2C%7B%22key%22%3A%2282KFKIR3%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brossier%20and%20Aubry%22%2C%22parsedDate%22%3A%222016%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBrossier%2C%20F.%20and%20Aubry%2C%20A.%20%282016%29.%20%26lt%3Bb%26gt%3BRe%26%23x301%3Bsistance%20de%20Mycobacterium%20tuberculosis%20aux%20antituberculeux%26lt%3B%5C%2Fb%26gt%3B.%20Feuillets%20Bio%20%26lt%3Bi%26gt%3B328%26lt%3B%5C%2Fi%26gt%3B%2C%2017%26%23x2013%3B25%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1684%5C%2Fabc.2016.1132%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1684%5C%2Fabc.2016.1132%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Re%5Cu0301sistance%20de%20Mycobacterium%20tuberculosis%20aux%20antituberculeux%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A%22%2C%22lastName%22%3A%22Aubry%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222016%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1684%5C%2Fabc.2016.1132%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-08-02T16%3A23%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22IKHZHS3H%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brossier%20et%20al.%22%2C%22parsedDate%22%3A%222016-06%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBrossier%2C%20F.%2C%20Guindo%2C%20D.%2C%20Pham%2C%20A.%2C%20Reibel%2C%20F.%2C%20Sougakoff%2C%20W.%2C%20Veziris%2C%20N.%20and%20Aubry%2C%20A.%20%282016%29.%20%26lt%3Bb%26gt%3BPerformance%20of%20the%20New%20Version%20%28v2.0%29%20of%20the%20GenoType%20MTBDRsl%20Test%20for%20Detection%20of%20Resistance%20to%20Second-Line%20Drugs%20in%20Multidrug-Resistant%20Mycobacterium%20tuberculosis%20Complex%20Strains%26lt%3B%5C%2Fb%26gt%3B.%20J%20Clin%20Microbiol%20%26lt%3Bi%26gt%3B54%26lt%3B%5C%2Fi%26gt%3B%2C%201573%26%23x2013%3B1580%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.00051-16%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.00051-16%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Performance%20of%20the%20New%20Version%20%28v2.0%29%20of%20the%20GenoType%20MTBDRsl%20Test%20for%20Detection%20of%20Resistance%20to%20Second-Line%20Drugs%20in%20Multidrug-Resistant%20Mycobacterium%20tuberculosis%20Complex%20Strains%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Guindo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Pham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Reibel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%5D%2C%22abstractNote%22%3A%22Detecting%20resistance%20to%20fluoroquinolones%20%28FQ%29%20and%20second-line%20injectable%20drugs%20%28amikacin%20%5BAMK%5D%2C%20kanamycin%20%5BKAN%5D%2C%20and%20capreomycin%20%5BCAP%5D%29%20is%20crucial%20given%20the%20worldwide%20increase%20in%20the%20incidence%20of%20extensively%20drug-resistant%20tuberculosis%20%28XDR-TB%29.%20A%20new%20version%20of%20the%20GenoType%20MTBDRsl%20test%20%28v2.0%29%20has%20been%20developed%20to%20improve%20the%20detection%20of%20resistance%20to%20FQ%20%28involving%20gyrA%20and%20gyrB%20mutations%29%20and%20to%20second-line%20injectable%20drugs%20%28involving%20rrs%20and%20eis%20promoter%20mutations%29%20in%20Mycobacterium%20tuberculosis%20A%20collection%20of%20127%20multidrug-resistant%20%28MDR%29%20M.%20tuberculosis%20complex%20strains%20was%20tested%20using%20the%20first%20%28v1%29%20and%20second%20%28v2.0%29%20versions%20of%20the%20MTBDRsl%20test%2C%20as%20well%20as%20DNA%20sequencing.%20The%20specificities%20in%20resistance%20detection%20of%20v1%20and%20v2.0%20were%20similar%20throughout%2C%20whereas%20the%20levels%20of%20sensitivity%20of%20v2.0%20were%20superior%20for%20FQ%20%2894.8%25%20versus%2089.6%25%29%20and%20KAN%20%2890.5%25%20versus%2059.5%25%29%20but%20similar%20for%20AMK%20%2891.3%25%29%20and%20CAP%20%2883.0%25%29.%20The%20sensitivity%20and%20specificity%20of%20v2.0%20were%20superior%20to%20those%20of%20v1%20for%20the%20detection%20of%20pre-XDR%20strains%20%2883.3%25%20versus%2075.0%25%20and%2088.6%25%20versus%2067.1%25%2C%20respectively%29%2C%20whereas%20the%20sensitivity%20of%20v2.0%20was%20superior%20to%20that%20of%20v1%20only%20for%20the%20detection%20of%20XDR%20strains%20%2883.0%25%20versus%2049.1%25%29.%20In%20conclusion%2C%20MTBDRsl%20v2.0%20is%20superior%20to%20MTBDRsl%20v1%20and%20efficiently%20detects%20the%20most%20common%20mutations%20involved%20in%20resistance%20to%20FQ%20and%20aminoglycosides%5C%2FCAP.%20However%2C%20due%20to%20mutations%20not%20recognized%20by%20v2.0%20or%20to%20the%20presence%20of%20resistance%20mechanisms%20not%20yet%20characterized%20%28particularly%20mechanisms%20related%20to%20monoresistance%20to%20aminoglycosides%20or%20CAP%29%2C%20the%20results%20for%20wild-type%20strains%20obtained%20with%20MTBDRsl%20v2.0%20should%20be%20confirmed%20by%20further%20DNA%20sequencing%20and%20phenotypic%20drug%20susceptibility%20testing.%22%2C%22date%22%3A%22Jun%202016%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2FJCM.00051-16%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221098-660X%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-07-17T13%3A51%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22QH92KQPE%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brossier%20et%20al.%22%2C%22parsedDate%22%3A%222016-12-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBrossier%2C%20F.%2C%20Cambau%2C%20E.%2C%20Tessier%2C%20E.%2C%20Jarlier%2C%20V.%20and%20Sougakoff%2C%20W.%20%282016%29.%20%26lt%3Bb%26gt%3BThe%20in%26%23xA0%3Bvitro%20mechanisms%20of%20isoniazid%20and%20ethionamide%20resistance%20poorly%20reflect%20those%20in%26%23xA0%3Bvivo%20in%20Mycobacterium%20tuberculosis%26lt%3B%5C%2Fb%26gt%3B.%20Tuberculosis%20%26lt%3Bi%26gt%3B101%26lt%3B%5C%2Fi%26gt%3B%2C%20144%26%23x2013%3B145%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.tube.2016.09.028%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.tube.2016.09.028%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20in%5Cu00a0vitro%20mechanisms%20of%20isoniazid%20and%20ethionamide%20resistance%20poorly%20reflect%20those%20in%5Cu00a0vivo%20in%20Mycobacterium%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilie%22%2C%22lastName%22%3A%22Tessier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22December%201%2C%202016%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.tube.2016.09.028%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1472979216303766%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221472-9792%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-08-02T16%3A12%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22MXPTFNZS%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brossier%20et%20al.%22%2C%22parsedDate%22%3A%222016-09-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBrossier%2C%20F.%2C%20Boudinet%2C%20M.%2C%20Jarlier%2C%20V.%2C%20Petrella%2C%20S.%20and%20Sougakoff%2C%20W.%20%282016%29.%20%26lt%3Bb%26gt%3BComparative%20study%20of%20enzymatic%20activities%20of%20new%20KatG%20mutants%20from%20low-%20and%20high-level%20isoniazid-resistant%20clinical%20isolates%20of%20Mycobacterium%20tuberculosis%26lt%3B%5C%2Fb%26gt%3B.%20Tuberculosis%20%26lt%3Bi%26gt%3B100%26lt%3B%5C%2Fi%26gt%3B%2C%2015%26%23x2013%3B24%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.tube.2016.06.002%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.tube.2016.06.002%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Comparative%20study%20of%20enzymatic%20activities%20of%20new%20KatG%20mutants%20from%20low-%20and%20high-level%20isoniazid-resistant%20clinical%20isolates%20of%20Mycobacterium%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marl%5Cu00e8ne%22%2C%22lastName%22%3A%22Boudinet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phanie%22%2C%22lastName%22%3A%22Petrella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%5D%2C%22abstractNote%22%3A%22Resistance%20to%20isoniazid%20%28INH-R%29%20in%20Mycobacterium%20tuberculosis%20is%20mainly%20due%20to%20mutations%20at%20position%20315%20%28S315T%29%20of%20the%20catalase-peroxidase%20KatG.%20We%20identified%2016%20mutations%20%28including%2013%20biochemically%20uncharacterized%20mutations%29%20in%20KatG%20from%20INH-R%20clinical%20isolates%20of%20M.%5Cu00a0tuberculosis%20showing%20mutations%20other%20than%20S315T.%20The%20KatG%20enzymatic%20activities%20%28catalase%2C%20peroxidase%2C%20free%20radical%20production%20and%20isonicotinoyl-NAD%20formation%29%20of%20wild-type%20KatG%20and%20the%2016%20mutants%20were%20determined%20and%20correlated%20to%20their%20spatial%20location%20in%20a%20KatG%20model%20structure.%20Of%20all%20mutations%20studied%2C%20H270R%2C%20which%20conferred%20a%20high%20level%20of%20INH-R%20and%20results%20in%20the%20disruption%20of%20a%20coordination%20bond%20with%20the%20heme%2C%20caused%20complete%20loss%20of%20all%20enzymatic%20KatG%20activities.%20The%20mutants%20generally%20associated%20with%20a%20very%20high%20level%20of%20INH-R%20were%20all%20characterized%20by%20a%20drastic%20reduction%20in%20catalase%20activity%20and%20a%20marked%20decrease%20in%20INH%20activation%20activities.%20One%20mutant%2C%20A162E%2C%20displayed%20a%20behavior%20similar%20to%20S315T%2C%20i.e.%20a%20moderate%20decrease%20in%20catalase%20activity%20and%20a%20drastic%20decrease%20in%20the%20formation%20of%20the%20radical%20form%20of%20INH.%20Finally%2C%20the%20mutants%20associated%20with%20a%20low%20level%20of%20INH-R%20showed%20a%20moderate%20reduction%20in%20the%20four%20catalytic%20activities%2C%20likely%20stemming%20from%20an%20overall%20alteration%20of%20the%20folding%20and%5C%2For%20stability%20of%20the%20KatG%20protein.%22%2C%22date%22%3A%22September%201%2C%202016%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.tube.2016.06.002%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1472979216300403%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221472-9792%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-08-02T16%3A09%3A47Z%22%7D%7D%2C%7B%22key%22%3A%223Z54DDAJ%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chauffour%20et%20al.%22%2C%22parsedDate%22%3A%222016-10-18%22%2C%22numChildren%22%3A6%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BChauffour%2C%20A.%2C%20Robert%2C%20J.%2C%20Veziris%2C%20N.%2C%20Aubry%2C%20A.%20and%20Jarlier%2C%20V.%20%282016%29.%20%26lt%3Bb%26gt%3BSterilizing%20Activity%20of%20Fully%20Oral%20Intermittent%20Regimens%20against%20Mycobacterium%20ulcerans%20Infection%20in%20Mice%26lt%3B%5C%2Fb%26gt%3B.%20PLOS%20Neglected%20Tropical%20Diseases%20%26lt%3Bi%26gt%3B10%26lt%3B%5C%2Fi%26gt%3B%2C%20e0005066%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pntd.0005066%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pntd.0005066%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Sterilizing%20Activity%20of%20Fully%20Oral%20Intermittent%20Regimens%20against%20Mycobacterium%20ulcerans%20Infection%20in%20Mice%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%5D%2C%22abstractNote%22%3A%22Author%20Summary%20Buruli%20ulcer%2C%20caused%20by%20Mycobacterium%20ulcerans%2C%20is%20the%20third%20most%20frequent%20disease%20due%20to%20a%20bacteria%20of%20the%20mycobacteria%20family%2C%20after%20tuberculosis%20and%20leprosy.%20The%20disease%20consists%20of%20a%20cutaneous%20infection%20leading%20to%20skin%20ulcerations%20that%20can%20cause%20severe%20and%20debilitating%20scars.%20It%20occurs%20mostly%20in%20Africa%20where%20access%20to%20healthcare%20is%20still%20difficult.%20Until%20recently%2C%20surgery%20was%20the%20only%20way%20to%20treat%20Buruli%20ulcer.%20Recently%2C%20a%20medical%20treatment%20based%20on%20two%20antibiotics%20%28rifampin%20and%20streptomycin%29%20was%20found%20to%20be%20active%20in%20an%20experimental%20infection%20model%20and%20was%20recommended%20by%20WHO%20in%202004%20for%20humans.%20A%20drawback%20of%20this%20new%20medical%20approach%20is%20a%20long%20and%20daily%20administration%20%282%20months%29%20of%20streptomycin%2C%20an%20aminoglycoside%2C%20which%20requires%20daily%20injections%20and%20can%20have%20secondary%20effects.%20In%20our%20research%2C%20we%20sought%20to%20find%20a%20fully%20oral%20and%20intermittent%20treatment%20to%20facilitate%20the%20management%20of%20the%20patients%20on%20the%20field.%20The%20antibiotics%20combinations%20we%20studied%20were%20efficient%20in%20our%20model%20and%20would%20need%20now%20to%20be%20tested%20on%20the%20field.%22%2C%22date%22%3A%2218%20oct.%202016%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pntd.0005066%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjournals.plos.org%5C%2Fplosntds%5C%2Farticle%3Fid%3D10.1371%5C%2Fjournal.pntd.0005066%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221935-2735%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-11T23%3A51%3A36Z%22%7D%7D%2C%7B%22key%22%3A%22W88HJZMM%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chazel%20et%20al.%22%2C%22parsedDate%22%3A%222016%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BChazel%2C%20M.%2C%20Marchandin%2C%20H.%2C%20Keck%2C%20N.%2C%20Terru%2C%20D.%2C%20Carri%26%23xE8%3Bre%2C%20C.%2C%20Ponsoda%2C%20M.%2C%20Jacomo%2C%20V.%2C%20Panteix%2C%20G.%2C%20Bouzinbi%2C%20N.%2C%20Ba%26%23xF1%3Buls%2C%20A.-L.%2C%20Choisy%2C%20M.%2C%20Solassol%2C%20J.%2C%20Aubry%2C%20A.%20and%20Godreuil%2C%20S.%20%282016%29.%20%26lt%3Bb%26gt%3BEvaluation%20of%20the%20SLOMYCO%20Sensititre%26%23xAE%3B%20panel%20for%20testing%20the%20antimicrobial%20susceptibility%20of%20Mycobacterium%20marinum%20isolates%26lt%3B%5C%2Fb%26gt%3B.%20Annals%20of%20Clinical%20Microbiology%20and%20Antimicrobials%20%26lt%3Bi%26gt%3B15%26lt%3B%5C%2Fi%26gt%3B%2C%2030%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12941-016-0145-1%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12941-016-0145-1%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Evaluation%20of%20the%20SLOMYCO%20Sensititre%5Cu00ae%20panel%20for%20testing%20the%20antimicrobial%20susceptibility%20of%20Mycobacterium%20marinum%20isolates%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marion%22%2C%22lastName%22%3A%22Chazel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H%5Cu00e9l%5Cu00e8ne%22%2C%22lastName%22%3A%22Marchandin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Keck%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominique%22%2C%22lastName%22%3A%22Terru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Carri%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Ponsoda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V%5Cu00e9ronique%22%2C%22lastName%22%3A%22Jacomo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Panteix%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Bouzinbi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne-Laure%22%2C%22lastName%22%3A%22Ba%5Cu00f1uls%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Choisy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Solassol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvain%22%2C%22lastName%22%3A%22Godreuil%22%7D%5D%2C%22abstractNote%22%3A%22The%20agar%20dilution%20method%20is%20currently%20considered%20as%20the%20reference%20method%20for%20Mycobacterium%20marinum%20drug%20susceptibility%20testing%20%28DST%29.%20As%20it%20is%20time-consuming%2C%20alternative%20methods%2C%20such%20as%20the%20E-test%2C%20were%20evaluated%20for%20M.%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20marinum%20DST%2C%20but%20without%20success.%20The%20SLOMYCO%20Sensititre%5Cu00ae%20panel%2C%20recently%20commercialized%20by%20TREK%20Diagnostic%20Systems%20%28Cleveland%2C%20OH%29%2C%20can%20be%20used%20for%20DST%20in%20slow-growing%20mycobacteria%20and%20for%20antimicrobial%20agents%20recommended%20by%20the%20Clinical%20and%20Laboratory%20Standards%20Institute%20%28CLSI%29%20for%20M.%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20marinum%20DST.%20The%20main%20goal%20of%20this%20work%20was%20to%20evaluate%20the%20SLOMYCO%20Sensititre%5Cu00ae%20panel%20method%20for%20DST%20in%20M.%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20marinum%20isolates%20from%20human%20patients%20and%20fish%20relative%20to%20the%20reference%20agar%20dilution%20method.%22%2C%22date%22%3A%222016%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12941-016-0145-1%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fdx.doi.org%5C%2F10.1186%5C%2Fs12941-016-0145-1%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221476-0711%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-09-18T14%3A29%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22JTUN4R8I%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Crabol%20et%20al.%22%2C%22parsedDate%22%3A%222016-03-23%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCrabol%2C%20Y.%2C%20Catherinot%2C%20E.%2C%20Veziris%2C%20N.%2C%20Jullien%2C%20V.%20and%20Lortholary%2C%20O.%20%282016%29.%20%26lt%3Bb%26gt%3BRifabutin%3A%20where%20do%20we%20stand%20in%202016%3F%26lt%3B%5C%2Fb%26gt%3B%20J%20Antimicrob%20Chemother%20dkw024%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkw024%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkw024%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Rifabutin%3A%20where%20do%20we%20stand%20in%202016%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yoann%22%2C%22lastName%22%3A%22Crabol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emilie%22%2C%22lastName%22%3A%22Catherinot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jullien%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Lortholary%22%7D%5D%2C%22abstractNote%22%3A%22Rifabutin%20is%20a%20spiro-piperidyl-rifamycin%20structurally%20closely%20related%20to%20rifampicin%20that%20shares%20many%20of%20its%20properties.%20We%20attempted%20to%20address%20the%20reasons%20why%20this%20drug%2C%20which%20was%20recently%20recognized%20as%20a%20WHO%20Essential%20Medicine%2C%20still%20had%20a%20far%20narrower%20range%20of%20indications%20than%20rifampicin%2C%2024%20years%20after%20its%20launch.%20In%20this%20comprehensive%20review%20of%20the%20classic%20and%20more%20recent%20rifabutin%20experimental%20and%20clinical%20studies%2C%20the%20current%20state%20of%20knowledge%20about%20rifabutin%20is%20depicted%2C%20relying%20on%20specific%20pharmacokinetics%2C%20pharmacodynamics%2C%20antimicrobial%20properties%2C%20resistance%20data%20and%20side%20effects%20compared%20with%20rifampicin.%20There%20are%20consistent%20in%20vitro%20data%20and%20clinical%20studies%20showing%20that%20rifabutin%20has%20at%20least%20equivalent%20activity%5C%2Fefficacy%20and%20acceptable%20tolerance%20compared%20with%20rifampicin%20in%20TB%20and%20non-tuberculous%20mycobacterial%20diseases.%20Clinical%20studies%20have%20emphasized%20the%20clinical%20benefits%20of%20low%20rifabutin%20liver%20induction%20in%20patients%20with%20AIDS%20under%20PIs%2C%20in%20solid%20organ%20transplant%20patients%20under%20immunosuppressive%20drugs%20or%20in%20patients%20presenting%20intolerable%20side%20effects%20related%20to%20rifampicin.%20The%20contribution%20of%20rifabutin%20for%20rifampicin-resistant%2C%20but%20rifabutin-susceptible%2C%20Mycobacterium%20tuberculosis%20isolates%20according%20to%20the%20present%20breakpoints%20has%20been%20challenged%20and%20is%20now%20controversial.%20Compared%20with%20rifampicin%2C%20rifabutin%26%23039%3Bs%20lower%20AUC%20is%20balanced%20by%20higher%20intracellular%20penetration%20and%20lower%20MIC%20for%20most%20pathogens.%20Clinical%20studies%20are%20lacking%20in%20non-mycobacterial%20infections.%22%2C%22date%22%3A%222016-03-23%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fjac%5C%2Fdkw024%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjac.oxfordjournals.org%5C%2Fcontent%5C%2Fearly%5C%2F2016%5C%2F03%5C%2F22%5C%2Fjac.dkw024%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220305-7453%2C%201460-2091%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-01-08T18%3A02%3A19Z%22%7D%7D%2C%7B%22key%22%3A%229EJDIMF5%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fox%20et%20al.%22%2C%22parsedDate%22%3A%222016-03-29%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BFox%2C%20G.%20J.%2C%20Benedetti%2C%20A.%2C%20Mitnick%2C%20C.%20D.%2C%20Pai%2C%20M.%2C%20Menzies%2C%20D.%20and%20Mdr-Tb%2C%20T.%20C.%20G.%20for%20M.-A.%20of%20I.%20P.%20D.%20in%20%282016%29.%20%26lt%3Bb%26gt%3BPropensity%20Score-Based%20Approaches%20to%20Confounding%20by%20Indication%20in%20Individual%20Patient%20Data%20Meta-Analysis%3A%20Non-Standardized%20Treatment%20for%20Multidrug%20Resistant%20Tuberculosis%26lt%3B%5C%2Fb%26gt%3B.%20PLOS%20ONE%20%26lt%3Bi%26gt%3B11%26lt%3B%5C%2Fi%26gt%3B%2C%20e0151724%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0151724%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0151724%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Propensity%20Score-Based%20Approaches%20to%20Confounding%20by%20Indication%20in%20Individual%20Patient%20Data%20Meta-Analysis%3A%20Non-Standardized%20Treatment%20for%20Multidrug%20Resistant%20Tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20J.%22%2C%22lastName%22%3A%22Fox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%22%2C%22lastName%22%3A%22Benedetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carole%20D.%22%2C%22lastName%22%3A%22Mitnick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Madhukar%22%2C%22lastName%22%3A%22Pai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dick%22%2C%22lastName%22%3A%22Menzies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22The%20Collaborative%20Group%20for%20Meta-Analysis%20of%20Individual%20Patient%20Data%20in%22%2C%22lastName%22%3A%22Mdr-Tb%22%7D%5D%2C%22abstractNote%22%3A%22Background%20In%20the%20absence%20of%20randomized%20clinical%20trials%2C%20meta-analysis%20of%20individual%20patient%20data%20%28IPD%29%20from%20observational%20studies%20may%20provide%20the%20most%20accurate%20effect%20estimates%20for%20an%20intervention.%20However%2C%20confounding%20by%20indication%20remains%20an%20important%20concern%20that%20can%20be%20addressed%20by%20incorporating%20individual%20patient%20covariates%20in%20different%20ways.%20We%20compared%20different%20analytic%20approaches%20to%20account%20for%20confounding%20in%20IPD%20from%20patients%20treated%20for%20multi-drug%20resistant%20tuberculosis%20%28MDR-TB%29.%20%20%20Methods%20Two%20antibiotic%20classes%20were%20evaluated%2C%20fluoroquinolones%5Cu2014considered%20the%20cornerstone%20of%20effective%20MDR-TB%20treatment%5Cu2014and%20macrolides%2C%20which%20are%20known%20to%20be%20safe%2C%20yet%20are%20ineffective%20in%20vitro.%20The%20primary%20outcome%20was%20treatment%20success%20against%20treatment%20failure%2C%20relapse%20or%20death.%20Effect%20estimates%20were%20obtained%20using%20multivariable%20and%20propensity-score%20based%20approaches.%20%20%20Results%20Fluoroquinolone%20antibiotics%20were%20used%20in%2028%20included%20studies%2C%20within%20which%206%2C612%20patients%20received%20a%20fluoroquinolone%20and%20723%20patients%20did%20not.%20Macrolides%20were%20used%20in%2015%20included%20studies%2C%20within%20which%20459%20patients%20received%20this%20class%20of%20antibiotics%20and%203%2C670%20did%20not.%20Both%20standard%20multivariable%20regression%20and%20propensity%20score-based%20methods%20resulted%20in%20similar%20effect%20estimates%20for%20early%20and%20late%20generation%20fluoroquinolones%2C%20while%20macrolide%20antibiotics%20use%20was%20associated%20with%20reduced%20treatment%20success.%20%20%20Conclusions%20In%20this%20individual%20patient%20data%20meta-analysis%2C%20standard%20multivariable%20and%20propensity-score%20based%20methods%20of%20adjusting%20for%20individual%20patient%20covariates%20for%20observational%20studies%20yielded%20produced%20similar%20effect%20estimates.%20Even%20when%20adjustment%20is%20made%20for%20potential%20confounding%2C%20interpretation%20of%20adjusted%20estimates%20must%20still%20consider%20the%20potential%20for%20residual%20bias.%22%2C%22date%22%3A%2229%20mars%202016%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0151724%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjournals.plos.org%5C%2Fplosone%5C%2Farticle%3Fid%3D10.1371%5C%2Fjournal.pone.0151724%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221932-6203%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-01-08T18%3A09%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22JCCDZBI4%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fox%20et%20al.%22%2C%22parsedDate%22%3A%222016-04-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BFox%2C%20G.%20J.%2C%20Mitnick%2C%20C.%20D.%2C%20Benedetti%2C%20A.%2C%20Chan%2C%20E.%20D.%2C%20Becerra%2C%20M.%2C%20Chiang%2C%20C.-Y.%2C%20Keshavjee%2C%20S.%2C%20Koh%2C%20W.-J.%2C%20Shiraishi%2C%20Y.%2C%20Viiklepp%2C%20P.%2C%20Yim%2C%20J.-J.%2C%20Pasvol%2C%20G.%2C%20Robert%2C%20J.%2C%20Shim%2C%20T.%20S.%2C%20Shin%2C%20S.%20S.%2C%20Menzies%2C%20Dick%2C%20Mdr-Tb%2C%20%20for%20the%20C.%20G.%20for%20M.-A.%20of%20I.%20P.%20D.%20in%2C%20Ahuja%2C%20S.%2C%20Ashkin%2C%20D.%2C%20Avenda%26%23xF1%3Bo%2C%20M.%2C%20Banerjee%2C%20R.%2C%20Bauer%2C%20M.%2C%20Burgos%2C%20M.%2C%20Centis%2C%20R.%2C%20Cobelens%2C%20F.%2C%20Cox%2C%20H.%2C%20D%26%23x2019%3BAmbrosio%2C%20L.%2C%20Lange%2C%20W.%20C.%20M.%20de%2C%20DeRiemer%2C%20K.%2C%20Enarson%2C%20D.%2C%20Falzon%2C%20D.%2C%20Flanagan%2C%20K.%2C%20Flood%2C%20J.%2C%20Gandhi%2C%20N.%2C%20Garcia-Garcia%2C%20L.%2C%20Granich%2C%20R.%20M.%2C%20Hollm-Delgado%2C%20M.%20G.%2C%20Holtz%2C%20T.%20H.%2C%20Hopewell%2C%20P.%2C%20Iseman%2C%20M.%2C%20Jarlsberg%2C%20L.%20G.%2C%20Kim%2C%20H.%20R.%2C%20Lancaster%2C%20J.%2C%20Lange%2C%20C.%2C%20Leimane%2C%20V.%2C%20Leung%2C%20C.%20C.%2C%20Li%2C%20J.%2C%20Menzies%2C%20D.%2C%20Migliori%2C%20G.%20B.%2C%20Narita%2C%20M.%2C%20Nathanson%2C%20E.%2C%20Odendaal%2C%20R.%2C%20O%26%23x2019%3BRiordan%2C%20P.%2C%20Pai%2C%20M.%2C%20Palmero%2C%20D.%2C%20Park%2C%20S.%20K.%2C%20Pena%2C%20J.%2C%20P%26%23xE9%3Brez-Guzm%26%23xE1%3Bn%2C%20C.%2C%20Ponce-de-Leon%2C%20A.%2C%20Quelapio%2C%20M.%20I.%20D.%2C%20Quy%2C%20H.%20T.%2C%20Riekstina%2C%20V.%2C%20Royce%2C%20S.%2C%20Salim%2C%20M.%2C%20Schaaf%2C%20H.%20S.%2C%20Seung%2C%20K.%20J.%2C%20Shah%2C%20L.%2C%20Shean%2C%20K.%2C%20Sifuentes-Osornio%2C%20J.%2C%20Sotgiu%2C%20G.%2C%20Strand%2C%20M.%20J.%2C%20Sung%2C%20S.%20W.%2C%20Tabarsi%2C%20P.%2C%20Tupasi%2C%20T.%20E.%2C%20Vargas%2C%20M.%20H.%2C%20Altena%2C%20R.%20van%2C%20Walt%2C%20M.%20van%20der%2C%20Werf%2C%20T.%20S.%20van%20der%2C%20Westenhouse%2C%20J.%20and%20Yew%2C%20W.%20W.%20%282016%29.%20%26lt%3Bb%26gt%3BSurgery%20as%20an%20Adjunctive%20Treatment%20for%20Multidrug-Resistant%20Tuberculosis%3A%20An%20Individual%20Patient%20Data%20Metaanalysis%26lt%3B%5C%2Fb%26gt%3B.%20Clin%20Infect%20Dis%20%26lt%3Bi%26gt%3B62%26lt%3B%5C%2Fi%26gt%3B%2C%20887%26%23x2013%3B895%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciw002%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciw002%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Surgery%20as%20an%20Adjunctive%20Treatment%20for%20Multidrug-Resistant%20Tuberculosis%3A%20An%20Individual%20Patient%20Data%20Metaanalysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20J.%22%2C%22lastName%22%3A%22Fox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carole%20D.%22%2C%22lastName%22%3A%22Mitnick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%22%2C%22lastName%22%3A%22Benedetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%20D.%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mercedes%22%2C%22lastName%22%3A%22Becerra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chen-Yuan%22%2C%22lastName%22%3A%22Chiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salmaan%22%2C%22lastName%22%3A%22Keshavjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Won-Jung%22%2C%22lastName%22%3A%22Koh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuji%22%2C%22lastName%22%3A%22Shiraishi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Piret%22%2C%22lastName%22%3A%22Viiklepp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jae-Joon%22%2C%22lastName%22%3A%22Yim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffrey%22%2C%22lastName%22%3A%22Pasvol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jerome%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tae%20Sun%22%2C%22lastName%22%3A%22Shim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sonya%20S.%22%2C%22lastName%22%3A%22Shin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dick%22%2C%22lastName%22%3A%22Menzies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22for%20the%20Collaborative%20Group%20for%20Meta-Analysis%20of%20Individual%20Patient%20Data%20in%22%2C%22lastName%22%3A%22Mdr-Tb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Ahuja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Ashkin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Avenda%5Cu00f1o%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Banerjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Bauer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Burgos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Centis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Cobelens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22D%27Ambrosio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%20C.%20M.%20de%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22DeRiemer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Enarson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Falzon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Flanagan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Flood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Gandhi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Garcia-Garcia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20M.%22%2C%22lastName%22%3A%22Granich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20G.%22%2C%22lastName%22%3A%22Hollm-Delgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%20H.%22%2C%22lastName%22%3A%22Holtz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Hopewell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Iseman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20G.%22%2C%22lastName%22%3A%22Jarlsberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%20R.%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Lancaster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Leimane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20C.%22%2C%22lastName%22%3A%22Leung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Menzies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20B.%22%2C%22lastName%22%3A%22Migliori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Narita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Nathanson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Odendaal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22O%27Riordan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Pai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Palmero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20K.%22%2C%22lastName%22%3A%22Park%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Pena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22P%5Cu00e9rez-Guzm%5Cu00e1n%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Ponce-de-Leon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20I.%20D.%22%2C%22lastName%22%3A%22Quelapio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%20T.%22%2C%22lastName%22%3A%22Quy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Riekstina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Royce%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Salim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%20S.%22%2C%22lastName%22%3A%22Schaaf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20J.%22%2C%22lastName%22%3A%22Seung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Shean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Sifuentes-Osornio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Sotgiu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20J.%22%2C%22lastName%22%3A%22Strand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20W.%22%2C%22lastName%22%3A%22Sung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Tabarsi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%20E.%22%2C%22lastName%22%3A%22Tupasi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20H.%22%2C%22lastName%22%3A%22Vargas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20van%22%2C%22lastName%22%3A%22Altena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20van%20der%22%2C%22lastName%22%3A%22Walt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%20S.%20van%20der%22%2C%22lastName%22%3A%22Werf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Westenhouse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%20W.%22%2C%22lastName%22%3A%22Yew%22%7D%5D%2C%22abstractNote%22%3A%22Background.%20Medical%20treatment%20for%20multidrug-resistant%20%28MDR%29-tuberculosis%20is%20complex%2C%20toxic%2C%20and%20associated%20with%20poor%20outcomes.%20Surgical%20lung%20resection%20may%20be%20used%20as%20an%20adjunct%20to%20medical%20therapy%2C%20with%20the%20intent%20of%20reducing%20bacterial%20burden%20and%20improving%20cure%20rates.%20We%20conducted%20an%20individual%20patient%20data%20metaanalysis%20to%20evaluate%20the%20effectiveness%20of%20surgery%20as%20adjunctive%20therapy%20for%20MDR-tuberculosis.%5CnMethods.%20Individual%20patient%20data%2C%20was%20obtained%20from%20the%20authors%20of%2026%20cohort%20studies%2C%20identified%20from%203%20systematic%20reviews%20of%20MDR-tuberculosis%20treatment.%20Data%20included%20the%20clinical%20characteristics%20and%20medical%20and%20surgical%20therapy%20of%20each%20patient.%20Primary%20analyses%20compared%20treatment%20success%20%28cure%20and%20completion%29%20to%20a%20combined%20outcome%20of%20failure%2C%20relapse%2C%20or%20death.%20The%20effects%20of%20all%20forms%20of%20resection%20surgery%2C%20pneumonectomy%2C%20and%20partial%20lung%20resection%20were%20evaluated.%5CnResults.%20A%20total%20of%204238%20patients%20from%2018%20surgical%20studies%20and%202193%20patients%20from%208%20nonsurgical%20studies%20were%20included.%20Pulmonary%20resection%20surgery%20was%20performed%20on%20478%20patients.%20Partial%20lung%20resection%20surgery%20was%20associated%20with%20improved%20treatment%20success%20%28adjusted%20odds%20ratio%20%5BaOR%5D%2C%203.0%3B%2095%25%20confidence%20interval%20%5BCI%5D%2C%201.5%5Cu20135.9%3B%20I2R%2C%2011.8%25%29%2C%20but%20pneumonectomy%20was%20not%20%28aOR%2C%201.1%3B%2095%25%20CI%2C%20.6%5Cu20132.3%3B%20I2R%2C%2013.2%25%29.%20Treatment%20success%20was%20more%20likely%20when%20surgery%20was%20performed%20after%20culture%20conversion%20than%20before%20conversion%20%28aOR%2C%202.6%3B%2095%25%20CI%2C%200.9%5Cu20137.1%3B%20I2R%2C%200.2%25%29.%5CnConclusions.%20Partial%20lung%20resection%2C%20but%20not%20pneumonectomy%2C%20was%20associated%20with%20improved%20treatment%20success%20among%20patients%20with%20MDR-tuberculosis.%20Although%20improved%20outcomes%20may%20reflect%20patient%20selection%2C%20partial%20lung%20resection%20surgery%20after%20culture%20conversion%20may%20improve%20treatment%20outcomes%20in%20patients%20who%20receive%20optimal%20medical%20therapy.%22%2C%22date%22%3A%2204%5C%2F01%5C%2F2016%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciw002%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fcid.oxfordjournals.org%5C%2Fcontent%5C%2F62%5C%2F7%5C%2F887%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221058-4838%2C%201537-6591%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-03-27T17%3A31%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22KXN8PMNV%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guglielmetti%20et%20al.%22%2C%22parsedDate%22%3A%222016-08-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGuglielmetti%2C%20L.%2C%20D%26%23xFB%3B%2C%20D.%20L.%2C%20Veziris%2C%20N.%2C%20Caumes%2C%20E.%2C%20Marigot-Outtandy%2C%20D.%2C%20Yazdanpanah%2C%20Y.%2C%20Robert%2C%20J.%20and%20Fr%26%23xE9%3Bchet-Jachym%2C%20M.%20%282016%29.%20%26lt%3Bb%26gt%3BIs%20bedaquiline%20as%20effective%20as%20fluoroquinolones%20in%20the%20treatment%20of%20multidrug-resistant%20tuberculosis%3F%26lt%3B%5C%2Fb%26gt%3B%20European%20Respiratory%20Journal%20%26lt%3Bi%26gt%3B48%26lt%3B%5C%2Fi%26gt%3B%2C%20582%26%23x2013%3B585%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.00411-2016%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.00411-2016%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Is%20bedaquiline%20as%20effective%20as%20fluoroquinolones%20in%20the%20treatment%20of%20multidrug-resistant%20tuberculosis%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Damien%20Le%22%2C%22lastName%22%3A%22D%5Cu00fb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Caumes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhiba%22%2C%22lastName%22%3A%22Marigot-Outtandy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yazdan%22%2C%22lastName%22%3A%22Yazdanpanah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathilde%22%2C%22lastName%22%3A%22Fr%5Cu00e9chet-Jachym%22%7D%5D%2C%22abstractNote%22%3A%22Extract%5CnBedaquiline%20%28Bdq%29%20is%20approved%20for%20the%20treatment%20of%20multidrug-resistant%20%28MDR%29%20tuberculosis%20%28TB%29.%20In%20a%20phase%20IIb%20trial%2C%20Bdq%20allowed%20a%20significant%20reduction%20in%20time%20to%20culture%20conversion%20and%20improved%20outcome%20in%20MDR-TB%20patients%20%5B1%2C%202%5D.%20Preliminary%20reports%20of%20Bdq%20compassionate%20use%20have%20shown%20promising%20results%20%5B3%5Cu20135%5D.%20However%2C%20in%20an%20early%20bactericidal%20activity%20%28EBA%29%20study%2C%20the%20association%20of%20moxifloxacin%20%28Mfx%29%20with%20PA-824%20and%20pyrazinamide%20showed%20better%20activity%20than%20Bdq-based%20associations%20%5B6%5D.%20In%20addition%2C%20resistance%20to%20fluoroquinolones%20%28Fq%29%20has%20been%20associated%20with%20poorer%20outcome%20in%20MDR-TB%20before%20Bdq%20use%20%5B7%5D.%20These%20data%20reinforce%20the%20pivotal%20role%20of%20Fq.%20Comparing%20Bdq%20to%20Fq%20in%20interventional%20studies%20is%20challenging.%20Indeed%2C%20the%20paucity%20of%20drugs%20available%20for%20MDR-TB%20treatment%2C%20and%20the%20need%20for%20combination%20therapy%2C%20often%20impose%20the%20need%20to%20use%20all%20available%20drugs.%5CnBedaquiline%20and%20fluoroquinolone%20treatments%20give%20similar%20culture%20conversion%20rates%20at%206%20months%20in%20MDR-TB%20patients%20http%3A%5C%2F%5C%2Fow.ly%5C%2FoqVY300mJCy%22%2C%22date%22%3A%222016%5C%2F08%5C%2F01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1183%5C%2F13993003.00411-2016%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Ferj.ersjournals.com%5C%2Fcontent%5C%2F48%5C%2F2%5C%2F582%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220903-1936%2C%201399-3003%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-09-18T14%3A31%3A05Z%22%7D%7D%2C%7B%22key%22%3A%22B97IEKH8%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Henry%20et%20al.%22%2C%22parsedDate%22%3A%222016%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHenry%2C%20B.%2C%20Revest%2C%20M.%2C%20Dournon%2C%20N.%2C%20Epelboin%2C%20L.%2C%20Mellon%2C%20G.%2C%20Bellaud%2C%20G.%2C%20Mordant%2C%20P.%2C%20Le%20D%26%23xFB%3B%2C%20D.%2C%20V%26%23xE9%3Bziris%2C%20N.%2C%20Bernard%2C%20C.%2C%20Morel%2C%20S.%2C%20Jaur%26%23xE9%3Bguiberry%2C%20S.%2C%20Michelet%2C%20C.%2C%20Bricaire%2C%20F.%2C%20Tattevin%2C%20P.%20and%20Caumes%2C%20%26%23xC9%3B.%20%282016%29.%20%26lt%3Bb%26gt%3BPreliminary%20Favorable%20Outcome%20for%20Medically%20and%20Surgically%20Managed%20Extensively%20Drug-Resistant%20Tuberculosis%2C%20France%2C%202009%26%23x2013%3B2014%26lt%3B%5C%2Fb%26gt%3B.%20Emerging%20Infectious%20Diseases%20%26lt%3Bi%26gt%3B22%26lt%3B%5C%2Fi%26gt%3B%2C%20518%26%23x2013%3B521%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3201%5C%2Feid2203.151130%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3201%5C%2Feid2203.151130%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Preliminary%20Favorable%20Outcome%20for%20Medically%20and%20Surgically%20Managed%20Extensively%20Drug-Resistant%20Tuberculosis%2C%20France%2C%202009%5Cu20132014%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beno%5Cu00eet%22%2C%22lastName%22%3A%22Henry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthieu%22%2C%22lastName%22%3A%22Revest%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Dournon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lo%5Cu00efc%22%2C%22lastName%22%3A%22Epelboin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guillaume%22%2C%22lastName%22%3A%22Mellon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guillaume%22%2C%22lastName%22%3A%22Bellaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre%22%2C%22lastName%22%3A%22Mordant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Damien%22%2C%22lastName%22%3A%22Le%20D%5Cu00fb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22V%5Cu00e9ziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%5Cu00e9bastien%22%2C%22lastName%22%3A%22Morel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phane%22%2C%22lastName%22%3A%22Jaur%5Cu00e9guiberry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Michelet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7ois%22%2C%22lastName%22%3A%22Bricaire%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre%22%2C%22lastName%22%3A%22Tattevin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22%5Cu00c9ric%22%2C%22lastName%22%3A%22Caumes%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2203%5C%2F2016%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.3201%5C%2Feid2203.151130%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwwwnc.cdc.gov%5C%2Feid%5C%2Farticle%5C%2F22%5C%2F3%5C%2F15-1130_article.htm%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221080-6040%2C%201080-6059%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-09-18T14%3A30%3A08Z%22%7D%7D%2C%7B%22key%22%3A%22GZ4KD98U%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lach%5Cu00e2tre%20et%20al.%22%2C%22parsedDate%22%3A%222016-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLach%26%23xE2%3Btre%2C%20M.%2C%20Rioux%2C%20C.%2C%20D%26%23xFB%3B%2C%20D.%20L.%2C%20Fr%26%23xE9%3Bchet-Jachym%2C%20M.%2C%20Veziris%2C%20N.%2C%20Bouvet%2C%20E.%20and%20Yazdanpanah%2C%20Y.%20%282016%29.%20%26lt%3Bb%26gt%3BBedaquiline%20plus%20delamanid%20for%20XDR%20tuberculosis%26lt%3B%5C%2Fb%26gt%3B.%20Lancet%20Infect%20Dis%20%26lt%3Bi%26gt%3B16%26lt%3B%5C%2Fi%26gt%3B%2C%20294%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1473-3099%2816%2900047-5%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1473-3099%2816%2900047-5%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Bedaquiline%20plus%20delamanid%20for%20XDR%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Lach%5Cu00e2tre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Rioux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Damien%20Le%22%2C%22lastName%22%3A%22D%5Cu00fb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathilde%22%2C%22lastName%22%3A%22Fr%5Cu00e9chet-Jachym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisabeth%22%2C%22lastName%22%3A%22Bouvet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yazdan%22%2C%22lastName%22%3A%22Yazdanpanah%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Mar%202016%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2FS1473-3099%2816%2900047-5%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221474-4457%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-04-06T12%3A56%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22BBGVJEMN%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lafeuille%20et%20al.%22%2C%22parsedDate%22%3A%222016%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLafeuille%2C%20E.%2C%20Veziris%2C%20N.%2C%20Sougakoff%2C%20W.%2C%20Roure%2C%20F.%2C%20Le%20D%26%23xFB%3B%2C%20D.%2C%20Dournon%2C%20N.%2C%20Caumes%2C%20E.%2C%20Jarlier%2C%20V.%2C%20Aubry%2C%20A.%2C%20Robert%2C%20J.%20and%20Bernard%2C%20C.%20%282016%29.%20%26lt%3Bb%26gt%3BXDR-tuberculosis%20in%20France%3A%20Community%20transmission%20due%20to%20non-compliance%20with%20isolation%20precautions%26lt%3B%5C%2Fb%26gt%3B.%20M%26%23xE9%3Bdecine%20et%20Maladies%20Infectieuses%20%26lt%3Bi%26gt%3B46%26lt%3B%5C%2Fi%26gt%3B%2C%2052%26%23x2013%3B55%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.medmal.2015.12.008%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.medmal.2015.12.008%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22XDR-tuberculosis%20in%20France%3A%20Community%20transmission%20due%20to%20non-compliance%20with%20isolation%20precautions%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Lafeuille%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Roure%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Le%20D%5Cu00fb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Dournon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Caumes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Bernard%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2202%5C%2F2016%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.medmal.2015.12.008%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Flinkinghub.elsevier.com%5C%2Fretrieve%5C%2Fpii%5C%2FS0399077X15003091%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220399077X%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-03-26T17%3A53%3A43Z%22%7D%7D%2C%7B%22key%22%3A%226E5QJBC3%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lange%20et%20al.%22%2C%22parsedDate%22%3A%222016-09-29%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLange%2C%20C.%2C%20Duarte%2C%20R.%2C%20Fr%26%23xE9%3Bchet-Jachym%2C%20M.%2C%20Guenther%2C%20G.%2C%20Guglielmetti%2C%20L.%2C%20Olaru%2C%20I.%20D.%2C%20Oliveira%2C%20O.%2C%20Rumetshofer%2C%20R.%2C%20Veziris%2C%20N.%20and%20van%20Leth%2C%20F.%20%282016%29.%20%26lt%3Bb%26gt%3BLimited%20Benefit%20of%20the%20New%20Shorter%20Multidrug-Resistant%20Tuberculosis%20Regimen%20in%20Europe%26lt%3B%5C%2Fb%26gt%3B.%20Am%20J%20Respir%20Crit%20Care%20Med%20%26lt%3Bi%26gt%3B194%26lt%3B%5C%2Fi%26gt%3B%2C%201029%26%23x2013%3B1031%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1164%5C%2Frccm.201606-1097LE%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1164%5C%2Frccm.201606-1097LE%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Limited%20Benefit%20of%20the%20New%20Shorter%20Multidrug-Resistant%20Tuberculosis%20Regimen%20in%20Europe%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raquel%22%2C%22lastName%22%3A%22Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathilde%22%2C%22lastName%22%3A%22Fr%5Cu00e9chet-Jachym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gunar%22%2C%22lastName%22%3A%22Guenther%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ioana%20D.%22%2C%22lastName%22%3A%22Olaru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olena%22%2C%22lastName%22%3A%22Oliveira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rudolf%22%2C%22lastName%22%3A%22Rumetshofer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%22%2C%22lastName%22%3A%22van%20Leth%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22septembre%2029%2C%202016%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1164%5C%2Frccm.201606-1097LE%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.atsjournals.org%5C%2Fdoi%5C%2Fabs%5C%2F10.1164%5C%2Frccm.201606-1097LE%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221073-449X%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-01-08T18%3A05%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22THGEPMJ5%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lortholary%20et%20al.%22%2C%22parsedDate%22%3A%222016%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLortholary%2C%20O.%2C%20Roussillon%2C%20C.%2C%20Boucherie%2C%20C.%2C%20Padoin%2C%20C.%2C%20Chaix%2C%20M.-L.%2C%20Breton%2C%20G.%2C%20Rami%2C%20A.%2C%20Veziris%2C%20N.%2C%20Patey%2C%20O.%2C%20Caumes%2C%20E.%2C%20May%2C%20T.%2C%20Molina%2C%20J.-M.%2C%20Robert%2C%20J.%2C%20Tod%2C%20M.%2C%20Fagard%2C%20C.%20and%20Ch%26%23xEA%3Bne%2C%20G.%20%282016%29.%20%26lt%3Bb%26gt%3BTenofovir%20DF%5C%2Femtricitabine%20and%20efavirenz%20combination%20therapy%20for%20HIV%20infection%20in%20patients%20treated%20for%20tuberculosis%3A%20the%20ANRS%20129%20BKVIR%20trial%26lt%3B%5C%2Fb%26gt%3B.%20Journal%20of%20Antimicrobial%20Chemotherapy%20%26lt%3Bi%26gt%3B71%26lt%3B%5C%2Fi%26gt%3B%2C%20783%26%23x2013%3B793%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkv384%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkv384%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Tenofovir%20DF%5C%2Femtricitabine%20and%20efavirenz%20combination%20therapy%20for%20HIV%20infection%20in%20patients%20treated%20for%20tuberculosis%3A%20the%20ANRS%20129%20BKVIR%20trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Lortholary%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%22%2C%22lastName%22%3A%22Roussillon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9line%22%2C%22lastName%22%3A%22Boucherie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Padoin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Laure%22%2C%22lastName%22%3A%22Chaix%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guillaume%22%2C%22lastName%22%3A%22Breton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Agathe%22%2C%22lastName%22%3A%22Rami%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Patey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Caumes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thierry%22%2C%22lastName%22%3A%22May%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Michel%22%2C%22lastName%22%3A%22Molina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9rome%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michel%22%2C%22lastName%22%3A%22Tod%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Fagard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Genevi%5Cu00e8ve%22%2C%22lastName%22%3A%22Ch%5Cu00eane%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2203%5C%2F2016%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fjac%5C%2Fdkv384%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.jac.oxfordjournals.org%5C%2Flookup%5C%2Fdoi%5C%2F10.1093%5C%2Fjac%5C%2Fdkv384%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220305-7453%2C%201460-2091%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-02-26T17%3A51%3A07Z%22%7D%7D%2C%7B%22key%22%3A%2296NQCXTI%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mieras%20et%20al.%22%2C%22parsedDate%22%3A%222016-06-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMieras%2C%20L.%2C%20Anthony%2C%20R.%2C%20van%20Brakel%2C%20W.%2C%20Bratschi%2C%20M.%20W.%2C%20van%20den%20Broek%2C%20J.%2C%20Cambau%2C%20E.%2C%20Cavaliero%2C%20A.%2C%20Kasang%2C%20C.%2C%20Perera%2C%20G.%2C%20Reichman%2C%20L.%2C%20Richardus%2C%20J.%20H.%2C%20Saunderson%2C%20P.%2C%20Steinmann%2C%20P.%20and%20Yew%2C%20W.%20W.%20%282016%29.%20%26lt%3Bb%26gt%3BNegligible%20risk%20of%20inducing%20resistance%20in%20Mycobacterium%20tuberculosis%20with%20single-dose%20rifampicin%20as%20post-exposure%20prophylaxis%20for%20leprosy%26lt%3B%5C%2Fb%26gt%3B.%20Infectious%20Diseases%20of%20Poverty%20%26lt%3Bi%26gt%3B5%26lt%3B%5C%2Fi%26gt%3B%2C%2046%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs40249-016-0140-y%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs40249-016-0140-y%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Negligible%20risk%20of%20inducing%20resistance%20in%20Mycobacterium%20tuberculosis%20with%20single-dose%20rifampicin%20as%20post-exposure%20prophylaxis%20for%20leprosy%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liesbeth%22%2C%22lastName%22%3A%22Mieras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Anthony%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wim%22%2C%22lastName%22%3A%22van%20Brakel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20W.%22%2C%22lastName%22%3A%22Bratschi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacques%22%2C%22lastName%22%3A%22van%20den%20Broek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arielle%22%2C%22lastName%22%3A%22Cavaliero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christa%22%2C%22lastName%22%3A%22Kasang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geethal%22%2C%22lastName%22%3A%22Perera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lee%22%2C%22lastName%22%3A%22Reichman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan%20Hendrik%22%2C%22lastName%22%3A%22Richardus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Saunderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Steinmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wing%20Wai%22%2C%22lastName%22%3A%22Yew%22%7D%5D%2C%22abstractNote%22%3A%22Post-exposure%20prophylaxis%20%28PEP%29%20for%20leprosy%20is%20administered%20as%20one%20single%20dose%20of%20rifampicin%20%28SDR%29%20to%20the%20contacts%20of%20newly%20diagnosed%20leprosy%20patients.%20SDR%20reduces%20the%20risk%20of%20developing%20leprosy%20among%20contacts%20by%20around%2060%5Cu00a0%25%20in%20the%20first%202%5Cu20133%20years%20after%20receiving%20SDR.%20In%20countries%20where%20SDR%20is%20currently%20being%20implemented%20under%20routine%20programme%20conditions%20in%20defined%20areas%2C%20questions%20were%20raised%20by%20health%20authorities%20and%20professional%20bodies%20about%20the%20possible%20risk%20of%20inducing%20rifampicin%20resistance%20among%20the%20M.%20tuberculosis%20strains%20circulating%20in%20these%20areas.%20This%20issue%20has%20not%20been%20addressed%20in%20scientific%20literature%20to%20date.%20To%20produce%20an%20authoritative%20consensus%20statement%20about%20the%20risk%20that%20SDR%20would%20induce%20rifampicin-resistant%20tuberculosis%2C%20a%20meeting%20was%20convened%20with%20tuberculosis%20%28TB%29%20and%20leprosy%20experts.%20The%20experts%20carefully%20reviewed%20and%20discussed%20the%20available%20evidence%20regarding%20the%20mechanisms%20and%20risk%20factors%20for%20the%20development%20of%20%28multi%29%20drug-resistance%20in%20M.%20tuberculosis%20with%20a%20view%20to%20the%20special%20situation%20of%20the%20use%20of%20SDR%20as%20PEP%20for%20leprosy.%20They%20concluded%20that%20SDR%20given%20to%20contacts%20of%20leprosy%20patients%2C%20in%20the%20absence%20of%20symptoms%20of%20active%20TB%2C%20poses%20a%20negligible%20risk%20of%20generating%20resistance%20in%20M.%20tuberculosis%20in%20individuals%20and%20at%20the%20population%20level.%20Thus%2C%20the%20benefits%20of%20SDR%20prophylaxis%20in%20reducing%20the%20risk%20of%20developing%20leprosy%20in%20contacts%20of%20new%20leprosy%20patients%20far%20outweigh%20the%20risks%20of%20generating%20drug%20resistance%20in%20M.%20tuberculosis.%22%2C%22date%22%3A%22June%208%2C%202016%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1186%5C%2Fs40249-016-0140-y%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs40249-016-0140-y%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222049-9957%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-08-02T16%3A18%3A45Z%22%7D%7D%2C%7B%22key%22%3A%2277H4JAIT%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mougari%20et%20al.%22%2C%22parsedDate%22%3A%222016-08-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMougari%2C%20F.%2C%20Amarsy%2C%20R.%2C%20Veziris%2C%20N.%2C%20Bastian%2C%20S.%2C%20Brossier%2C%20F.%2C%20Ber%26%23xE7%3Bot%2C%20B.%2C%20Raskine%2C%20L.%20and%20Cambau%2C%20E.%20%282016%29.%20%26lt%3Bb%26gt%3BStandardized%20interpretation%20of%20antibiotic%20susceptibility%20testing%20and%20resistance%20genotyping%20for%20Mycobacterium%20abscessus%20with%20regard%20to%20subspecies%20and%20erm41%20sequevar%26lt%3B%5C%2Fb%26gt%3B.%20J%20Antimicrob%20Chemother%20%26lt%3Bi%26gt%3B71%26lt%3B%5C%2Fi%26gt%3B%2C%202208%26%23x2013%3B2212%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkw130%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkw130%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Standardized%20interpretation%20of%20antibiotic%20susceptibility%20testing%20and%20resistance%20genotyping%20for%20Mycobacterium%20abscessus%20with%20regard%20to%20subspecies%20and%20erm41%20sequevar%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faiza%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rishma%22%2C%22lastName%22%3A%22Amarsy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvaine%22%2C%22lastName%22%3A%22Bastian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%5Cu00e9atrice%22%2C%22lastName%22%3A%22Ber%5Cu00e7ot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Raskine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%5D%2C%22abstractNote%22%3A%22Objectives%20The%20objective%20of%20this%20study%20was%20to%20provide%20standardized%20antibiotic%20susceptibility%20testing%20%28AST%29%20for%20Mycobacterium%20abscessus%20with%20regard%20to%20subspecies.%5CnMethods%20One%20hundred%20and%20sixty-five%20clinical%20isolates%20were%20tested%20for%20susceptibility%20to%2015%20antibiotics%20using%20a%20commercial%20microdilution%20method%2C%20at%20two%20reading%20times%3A%20%28i%29%20early%20reading%20time%20%28ERT%29%2C%20when%20the%20growth%20control%20was%20first%20positive%3B%20and%20%28ii%29%20late%20reading%20time%20%28LRT%29%2C%20of%2014%20days%2C%20for%20detecting%20inducible%20resistance.%20In%20addition%2C%20genes%20or%20mutations%20involved%20in%20resistance%20were%20studied%20%5Berm%2841%29%2C%20rrl%20and%20rrs%5D.%5CnResults%20Three%20patterns%20were%20observed%20for%20clarithromycin%3A%20%28i%29%20MIC%20%26gt%3B16%20mg%5C%2FL%20at%20ERT%20%28median%205%20days%29%20for%2015%20isolates%20%5B10%20subsp.%20abscessus%20erm%2841%29%20sequevar%20T28%2C%203%20subsp.%20bolletii%20and%202%20subsp.%20massiliense%5D%20among%20which%209%20harboured%20an%20a2058g%5C%2Fc%20rrl%20mutation%3B%20%28ii%29%20MIC%20%5Cu226416%20mg%5C%2FL%20at%20ERT%2C%20but%20%26gt%3B16%20mg%5C%2FL%20at%20LRT%2C%20for%20106%20isolates%20%5B84%20abscessus%20erm%2841%29%20T28%20and%2022%20bolletii%5D%20showing%20intrinsic%20inducible%20resistance%3B%20and%20%28iii%29%20MIC%20%5Cu22644%20mg%5C%2FL%20at%20ERT%20and%20LRT%20for%2044%20isolates%20%5B18%20abscessus%20erm%2841%29%20C28%20and%2026%20massiliense%5D.%20Amikacin%20MIC%20was%20%26gt%3B64%20mg%5C%2FL%20for%20eight%20isolates%20%5Bfive%20abscessus%20erm%2841%29%20T28%2C%20two%20massiliense%20and%20one%20bolletii%5D%20among%20which%20seven%20harboured%20the%20a1408g%20rrs%20mutation%2C%20but%20%5Cu226464%20mg%5C%2FL%20for%20the%20remaining%20isolates%20without%20mutation.%20For%20the%20other%20antibiotics%2C%20only%20one%20WT%20pattern%20was%20observed%2C%20with%20cefoxitin%2C%20tigecycline%20and%20linezolid%20showing%20MIC%20values%20compatible%20with%20susceptibility.%5CnConclusions%20Standard%20AST%20can%20predict%20clarithromycin%20and%20amikacin%20resistance%20using%20interpretation%20rules%20with%20regard%20to%20subspecies.%20For%20other%20antibiotics%2C%20since%20only%20one%20pattern%20is%20observed%2C%20there%20is%20no%20need%20for%20systematic%20phenotypic%20or%20genotypic%20testing.%22%2C%22date%22%3A%2208%5C%2F01%5C%2F2016%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fjac%5C%2Fdkw130%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjac.oxfordjournals.org%5C%2Fcontent%5C%2F71%5C%2F8%5C%2F2208%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220305-7453%2C%201460-2091%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-09-18T14%3A30%3A28Z%22%7D%7D%2C%7B%22key%22%3A%22RZ6CP2V6%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mougari%20et%20al.%22%2C%22parsedDate%22%3A%222016-12-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMougari%2C%20F.%2C%20Guglielmetti%2C%20L.%2C%20Raskine%2C%20L.%2C%20Sermet-Gaudelus%2C%20I.%2C%20Veziris%2C%20N.%20and%20Cambau%2C%20E.%20%282016%29.%20%26lt%3Bb%26gt%3BInfections%20caused%20by%20Mycobacterium%20abscessus%3A%20epidemiology%2C%20diagnostic%20tools%20and%20treatment%26lt%3B%5C%2Fb%26gt%3B.%20Expert%20Review%20of%20Anti-infective%20Therapy%20%26lt%3Bi%26gt%3B14%26lt%3B%5C%2Fi%26gt%3B%2C%201139%26%23x2013%3B1154%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F14787210.2016.1238304%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F14787210.2016.1238304%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Infections%20caused%20by%20Mycobacterium%20abscessus%3A%20epidemiology%2C%20diagnostic%20tools%20and%20treatment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faiza%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Raskine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Sermet-Gaudelus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%5D%2C%22abstractNote%22%3A%22Introduction%3A%20Mycobacterium%20abscessus%20is%20an%20emerging%20mycobacteria%20that%20is%20responsible%20for%20lung%20diseases%20and%20healthcare-associated%20extrapulmonary%20infections.%20Recent%20findings%20support%20its%20taxonomic%20status%20as%20a%20single%20species%20comprising%203%20subspecies%20designated%20abscessus%2C%20bolletii%20and%20massiliense.%20We%20performed%20a%20review%20of%20English-language%20publications%20investigating%20all%20three%20of%20these%20subspecies.Areas%20covered%3A%20Worldwide%2C%20human%20infections%20are%20often%20attributable%20to%20environmental%20contamination%2C%20although%20the%20isolation%20of%20M.%20abscessus%20in%20this%20reservoir%20is%20very%20rare.%20Basic%20research%20has%20demonstrated%20an%20association%20between%20virulence%20and%20cell%20wall%20components%20and%20cording%2C%20and%20genome%20analysis%20has%20identified%20gene%20transfer%20from%20other%20bacteria.%20The%20bacteriological%20diagnosis%20of%20M.%20abscessus%20is%20based%20on%20innovative%20tools%20combining%20molecular%20biology%20and%20mass%20spectrometry.%20Genotypic%20and%20phenotypic%20susceptibility%20testing%20are%20required%20to%20predict%20the%20success%20of%20macrolide%20%28clarithromycin%20or%20azithromycin%29-based%20therapeutic%20regimens.%20Genotyping%20methods%20are%20helpful%20to%20assess%20relapse%20and%20cross-transmission%20and%20to%20search%20for%20a%20common%20source.%20Treatment%20is%20not%20standardised%2C%20and%20outcomes%20are%20often%20unsatisfactory.Expert%20commentary%3A%20M.%20abscessus%20is%20still%20an%20open%20field%20in%20terms%20of%20clinical%20and%20bacteriological%20research.%20Further%20knowledge%20of%20its%20ecology%20and%20transmission%20routes%2C%20as%20well%20as%20host-pathogen%20interactions%2C%20is%20required.%20Because%20the%20number%20of%20human%20cases%20is%20increasing%2C%20it%20is%20also%20necessary%20to%20identify%20more%20active%20treatments%20and%20perform%20clinical%20trials%20to%20assess%20standard%20effective%20regimens.%22%2C%22date%22%3A%22December%201%2C%202016%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1080%5C%2F14787210.2016.1238304%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fdx.doi.org%5C%2F10.1080%5C%2F14787210.2016.1238304%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221478-7210%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-08-02T14%3A39%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22NFC657MC%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pantel%20et%20al.%22%2C%22parsedDate%22%3A%222016-09-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPantel%2C%20A.%2C%20Petrella%2C%20S.%2C%20Veziris%2C%20N.%2C%20Matrat%2C%20S.%2C%20Bouige%2C%20A.%2C%20Ferrand%2C%20H.%2C%20Sougakoff%2C%20W.%2C%20Mayer%2C%20C.%20and%20Aubry%2C%20A.%20%282016%29.%20%26lt%3Bb%26gt%3BDescription%20of%20compensatory%20gyrA%20mutations%20restoring%20fluoroquinolone%20susceptibility%20in%20Mycobacterium%20tuberculosis%26lt%3B%5C%2Fb%26gt%3B.%20J%20Antimicrob%20Chemother%20%26lt%3Bi%26gt%3B71%26lt%3B%5C%2Fi%26gt%3B%2C%202428%26%23x2013%3B2431%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkw169%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkw169%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Description%20of%20compensatory%20gyrA%20mutations%20restoring%20fluoroquinolone%20susceptibility%20in%20Mycobacterium%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alix%22%2C%22lastName%22%3A%22Pantel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phanie%22%2C%22lastName%22%3A%22Petrella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phanie%22%2C%22lastName%22%3A%22Matrat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Bouige%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H%5Cu00e9l%5Cu00e8ne%22%2C%22lastName%22%3A%22Ferrand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudine%22%2C%22lastName%22%3A%22Mayer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%5D%2C%22abstractNote%22%3A%22Objectives%20Resistance%20to%20fluoroquinolones%20%28FQs%29%20in%20Mycobacterium%20tuberculosis%20%28Mtb%29%20is%20mainly%20due%20to%20mutations%20in%20DNA%20gyrase%20%28GyrA2B2%29%2C%20with%20the%20most%20common%20substitutions%20located%20at%20positions%2090%20and%2094%20in%20GyrA.%20Two%20clinical%20MDR%20Mtb%20%28MDR-TB%29%20strains%20harbouring%20an%20A90E%20or%20D94N%20substitution%20in%20GyrA%20were%20found%20to%20be%20surprisingly%20susceptible%20to%20FQs%20%28ofloxacin%20MIC%20%5Cu22642%20mg%5C%2FL%29.%20We%20studied%20the%20impact%20of%20the%20additional%20GyrA%20substitutions%20found%20in%20these%20strains%20%28T80A%20and%20T80A%20%2B%20A90G%2C%20respectively%29%20on%20FQ%20susceptibility.%5CnMethods%20Mutants%20of%20interest%20were%20generated%20by%20site-specific%20mutagenesis%20of%20GyrA%20alleles.%20WT%20and%20mutant%20TB%20DNA%20gyrase%20subunits%20were%20overexpressed%20in%20Escherichia%20coli%20and%20purified%2C%20and%20the%20in%20vitro%20susceptibility%20to%20FQs%20of%20their%20DNA%20supercoiling%20reaction%20was%20studied.%5CnResults%20IC50s%20of%20mutant%20gyrase%20complexes%20bearing%20GyrA%20D94N%20and%20A90E%20were%203-%20to%2036-fold%20higher%20than%20WT%20IC50s%2C%20whereas%20IC50s%20of%20gyrase%20bearing%20T80A%20%2B%20A90G%20%2B%20D94N%20and%20T80A%20%2B%20A90E%20were%20close%20to%20the%20WT%20IC50s.%5CnConclusions%20We%20demonstrated%20that%20substitutions%20T80A%20and%20A90G%20restore%20FQ%20susceptibility%20when%20associated%20with%20a%20substitution%20implicated%20in%20high-level%20FQ%20resistance.%20Line%20probe%20assay%20misclassification%20of%20MDR-TB%20strains%20as%20pre-XDR%20or%20XDR%20can%20be%20corrected%20by%20sequence%20analysis%20of%20gyrA.%22%2C%22date%22%3A%2209%5C%2F01%5C%2F2016%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fjac%5C%2Fdkw169%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fjac.oxfordjournals.org%5C%2Fcontent%5C%2F71%5C%2F9%5C%2F2428%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220305-7453%2C%201460-2091%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222016-09-18T14%3A30%3A40Z%22%7D%7D%2C%7B%22key%22%3A%22A9ZUD9JN%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Parize%20et%20al.%22%2C%22parsedDate%22%3A%222016%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BParize%2C%20P.%2C%20Hamelin%2C%20A.%2C%20Veziris%2C%20N.%2C%20Morand%2C%20P.%20C.%2C%20Guillemain%2C%20R.%2C%20Lortholary%2C%20O.%20and%20Dupin%2C%20N.%20%282016%29.%20%26lt%3Bb%26gt%3BInduction%20therapy%20with%20linezolid%5C%2Fclarithromycin%20combination%20for%20Mycobacterium%20chelonae%20skin%20infections%20in%20immunocompromised%20hosts%26lt%3B%5C%2Fb%26gt%3B.%20Journal%20of%20the%20European%20Academy%20of%20Dermatology%20and%20Venereology%20%26lt%3Bi%26gt%3B30%26lt%3B%5C%2Fi%26gt%3B%2C%20101%26%23x2013%3B105%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fjdv.12965%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fjdv.12965%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Induction%20therapy%20with%20linezolid%5C%2Fclarithromycin%20combination%20for%20Mycobacterium%20chelonae%20skin%20infections%20in%20immunocompromised%20hosts%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Parize%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Hamelin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.C.%22%2C%22lastName%22%3A%22Morand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Guillemain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%22%2C%22lastName%22%3A%22Lortholary%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Dupin%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2201%5C%2F2016%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1111%5C%2Fjdv.12965%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fdoi.wiley.com%5C%2F10.1111%5C%2Fjdv.12965%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%2209269959%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-12T09%3A23%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22JYLD7TLG%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Raharolahy%20et%20al.%22%2C%22parsedDate%22%3A%222016-08-07%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRaharolahy%2C%20O.%2C%20Ramarozatovo%2C%20L.%20S.%2C%20Ranaivo%2C%20I.%20M.%2C%20Sendrasoa%2C%20F.%20A.%2C%20Andrianarison%2C%20M.%2C%20Andrianarivelo%2C%20M.%20R.%2C%20Cambau%2C%20E.%20and%20Rabenja%2C%20F.%20R.%20%282016%29.%20%26lt%3Bb%26gt%3BA%20Case%20of%20Fluoroquinolone-Resistant%20Leprosy%20Discovered%20after%209%20Years%20of%20Misdiagnosis%26lt%3B%5C%2Fb%26gt%3B.%20Case%20Reports%20in%20Infectious%20Diseases%20%26lt%3Bi%26gt%3B2016%26lt%3B%5C%2Fi%26gt%3B%2C%204632369%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1155%5C%2F2016%5C%2F4632369%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1155%5C%2F2016%5C%2F4632369%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20Case%20of%20Fluoroquinolone-Resistant%20Leprosy%20Discovered%20after%209%20Years%20of%20Misdiagnosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Onivola%22%2C%22lastName%22%3A%22Raharolahy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lala%20S.%22%2C%22lastName%22%3A%22Ramarozatovo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irina%20M.%22%2C%22lastName%22%3A%22Ranaivo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fandresena%20A.%22%2C%22lastName%22%3A%22Sendrasoa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Malalaniaina%22%2C%22lastName%22%3A%22Andrianarison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mala%20Rakoto%22%2C%22lastName%22%3A%22Andrianarivelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fahafahantsoa%20Rapelanoro%22%2C%22lastName%22%3A%22Rabenja%22%7D%5D%2C%22abstractNote%22%3A%22We%20report%20a%20case%20of%20misdiagnosed%20leprosy%20in%20a%2021-year-old%20Malagasy%20male%2C%20who%2C%20improperly%20treated%2C%20developed%20secondary%20mycobacterial%20resistance%20to%20fluoroquinolone.%20The%20patient%20contracted%20the%20infection%209%20years%20prior%20to%20the%20current%20consultation%2C%20displaying%20on%20the%20right%20thigh%20a%20single%20papulonodular%20lesion%2C%20which%20progressively%20spread%20to%20the%20lower%20leg%2C%20back%2C%20and%20face.%20Initial%20administration%20of%20ciprofloxacin%20and%20prednisolone%20led%20to%20temporary%20and%20fluctuating%20improvement.%20Subsequent%20long-term%20self-medication%20with%20ciprofloxacin%20and%20corticosteroid%20did%20not%20heal%20the%20foul%20and%20nonhealing%20ulcers%20on%20the%20legs%20and%20under%20the%20right%20sole.%20Histopathological%20findings%20were%20compatible%20with%20lepromatous%20leprosy.%20Skin%20biopsy%20was%20positive%20for%20acid-fast%20bacilli%20and%20PCR%20assay%20confirmed%20the%20presence%20of%20a%20fluoroquinolone-resistant%20strain%20of%20Mycobacterium%20leprae%20%28gyrA%20A91V%29.%20After%206%20months%20of%20standard%20regimen%20with%20rifampicin%2C%20clofazimine%2C%20and%20dapsone%2C%20clinical%20outcome%20significantly%20improved.%20Clinical%20characteristics%20and%20possible%20epidemiological%20implications%20are%20discussed.%22%2C%22date%22%3A%222016-08-07%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1155%5C%2F2016%5C%2F4632369%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.hindawi.com%5C%2Fjournals%5C%2Fcriid%5C%2F2016%5C%2F4632369%5C%2F%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222090-6625%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-11T23%3A32%3A17Z%22%7D%7D%5D%7D
Bernard, J., Armand-Lefèvre, L., Luce, E., Mniai, A. E., Chau, F., Casalino, E., Andremont, A. and Ruppé, E. (2016). Impact of a short exposure to levofloxacin on faecal densities and relative abundance of total and quinolone-resistant Enterobacteriaceae. Clinical Microbiology and Infection 22, 646.e1-646.e4, http://doi.org/10.1016/j.cmi.2016.04.015.
Bernard, C., Aubry, A., Chauffour, A., Brossier, F., Robert, J. and Veziris, N. (2016). In vivo Mycobacterium tuberculosis fluoroquinolone resistance emergence: a complex phenomenon poorly detected by current diagnostic tests. J Antimicrob Chemother, http://doi.org/10.1093/jac/dkw344.
Brossier, F. and Aubry, A. (2016). Résistance de Mycobacterium tuberculosis aux antituberculeux. Feuillets Bio 328, 17–25, http://doi.org/10.1684/abc.2016.1132.
Brossier, F., Guindo, D., Pham, A., Reibel, F., Sougakoff, W., Veziris, N. and Aubry, A. (2016). Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains. J Clin Microbiol 54, 1573–1580, http://doi.org/10.1128/JCM.00051-16.
Brossier, F., Cambau, E., Tessier, E., Jarlier, V. and Sougakoff, W. (2016). The in vitro mechanisms of isoniazid and ethionamide resistance poorly reflect those in vivo in Mycobacterium tuberculosis. Tuberculosis 101, 144–145, http://doi.org/10.1016/j.tube.2016.09.028.
Brossier, F., Boudinet, M., Jarlier, V., Petrella, S. and Sougakoff, W. (2016). Comparative study of enzymatic activities of new KatG mutants from low- and high-level isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Tuberculosis 100, 15–24, http://doi.org/10.1016/j.tube.2016.06.002.
Chauffour, A., Robert, J., Veziris, N., Aubry, A. and Jarlier, V. (2016). Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium ulcerans Infection in Mice. PLOS Neglected Tropical Diseases 10, e0005066, http://doi.org/10.1371/journal.pntd.0005066.
Chazel, M., Marchandin, H., Keck, N., Terru, D., Carrière, C., Ponsoda, M., Jacomo, V., Panteix, G., Bouzinbi, N., Bañuls, A.-L., Choisy, M., Solassol, J., Aubry, A. and Godreuil, S. (2016). Evaluation of the SLOMYCO Sensititre® panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates. Annals of Clinical Microbiology and Antimicrobials 15, 30, http://doi.org/10.1186/s12941-016-0145-1.
Crabol, Y., Catherinot, E., Veziris, N., Jullien, V. and Lortholary, O. (2016). Rifabutin: where do we stand in 2016? J Antimicrob Chemother dkw024, http://doi.org/10.1093/jac/dkw024.
Fox, G. J., Benedetti, A., Mitnick, C. D., Pai, M., Menzies, D. and Mdr-Tb, T. C. G. for M.-A. of I. P. D. in (2016). Propensity Score-Based Approaches to Confounding by Indication in Individual Patient Data Meta-Analysis: Non-Standardized Treatment for Multidrug Resistant Tuberculosis. PLOS ONE 11, e0151724, http://doi.org/10.1371/journal.pone.0151724.
Fox, G. J., Mitnick, C. D., Benedetti, A., Chan, E. D., Becerra, M., Chiang, C.-Y., Keshavjee, S., Koh, W.-J., Shiraishi, Y., Viiklepp, P., Yim, J.-J., Pasvol, G., Robert, J., Shim, T. S., Shin, S. S., Menzies, Dick, Mdr-Tb, for the C. G. for M.-A. of I. P. D. in, Ahuja, S., Ashkin, D., Avendaño, M., Banerjee, R., Bauer, M., Burgos, M., Centis, R., Cobelens, F., Cox, H., D’Ambrosio, L., Lange, W. C. M. de, DeRiemer, K., Enarson, D., Falzon, D., Flanagan, K., Flood, J., Gandhi, N., Garcia-Garcia, L., Granich, R. M., Hollm-Delgado, M. G., Holtz, T. H., Hopewell, P., Iseman, M., Jarlsberg, L. G., Kim, H. R., Lancaster, J., Lange, C., Leimane, V., Leung, C. C., Li, J., Menzies, D., Migliori, G. B., Narita, M., Nathanson, E., Odendaal, R., O’Riordan, P., Pai, M., Palmero, D., Park, S. K., Pena, J., Pérez-Guzmán, C., Ponce-de-Leon, A., Quelapio, M. I. D., Quy, H. T., Riekstina, V., Royce, S., Salim, M., Schaaf, H. S., Seung, K. J., Shah, L., Shean, K., Sifuentes-Osornio, J., Sotgiu, G., Strand, M. J., Sung, S. W., Tabarsi, P., Tupasi, T. E., Vargas, M. H., Altena, R. van, Walt, M. van der, Werf, T. S. van der, Westenhouse, J. and Yew, W. W. (2016). Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis. Clin Infect Dis 62, 887–895, http://doi.org/10.1093/cid/ciw002.
Guglielmetti, L., Dû, D. L., Veziris, N., Caumes, E., Marigot-Outtandy, D., Yazdanpanah, Y., Robert, J. and Fréchet-Jachym, M. (2016). Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis? European Respiratory Journal 48, 582–585, http://doi.org/10.1183/13993003.00411-2016.
Henry, B., Revest, M., Dournon, N., Epelboin, L., Mellon, G., Bellaud, G., Mordant, P., Le Dû, D., Véziris, N., Bernard, C., Morel, S., Jauréguiberry, S., Michelet, C., Bricaire, F., Tattevin, P. and Caumes, É. (2016). Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014. Emerging Infectious Diseases 22, 518–521, http://doi.org/10.3201/eid2203.151130.
Lachâtre, M., Rioux, C., Dû, D. L., Fréchet-Jachym, M., Veziris, N., Bouvet, E. and Yazdanpanah, Y. (2016). Bedaquiline plus delamanid for XDR tuberculosis. Lancet Infect Dis 16, 294, http://doi.org/10.1016/S1473-3099(16)00047-5.
Lafeuille, E., Veziris, N., Sougakoff, W., Roure, F., Le Dû, D., Dournon, N., Caumes, E., Jarlier, V., Aubry, A., Robert, J. and Bernard, C. (2016). XDR-tuberculosis in France: Community transmission due to non-compliance with isolation precautions. Médecine et Maladies Infectieuses 46, 52–55, http://doi.org/10.1016/j.medmal.2015.12.008.
Lange, C., Duarte, R., Fréchet-Jachym, M., Guenther, G., Guglielmetti, L., Olaru, I. D., Oliveira, O., Rumetshofer, R., Veziris, N. and van Leth, F. (2016). Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe. Am J Respir Crit Care Med 194, 1029–1031, http://doi.org/10.1164/rccm.201606-1097LE.
Lortholary, O., Roussillon, C., Boucherie, C., Padoin, C., Chaix, M.-L., Breton, G., Rami, A., Veziris, N., Patey, O., Caumes, E., May, T., Molina, J.-M., Robert, J., Tod, M., Fagard, C. and Chêne, G. (2016). Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial. Journal of Antimicrobial Chemotherapy 71, 783–793, http://doi.org/10.1093/jac/dkv384.
Mieras, L., Anthony, R., van Brakel, W., Bratschi, M. W., van den Broek, J., Cambau, E., Cavaliero, A., Kasang, C., Perera, G., Reichman, L., Richardus, J. H., Saunderson, P., Steinmann, P. and Yew, W. W. (2016). Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy. Infectious Diseases of Poverty 5, 46, http://doi.org/10.1186/s40249-016-0140-y.
Mougari, F., Amarsy, R., Veziris, N., Bastian, S., Brossier, F., Berçot, B., Raskine, L. and Cambau, E. (2016). Standardized interpretation of antibiotic susceptibility testing and resistance genotyping for Mycobacterium abscessus with regard to subspecies and erm41 sequevar. J Antimicrob Chemother 71, 2208–2212, http://doi.org/10.1093/jac/dkw130.
Mougari, F., Guglielmetti, L., Raskine, L., Sermet-Gaudelus, I., Veziris, N. and Cambau, E. (2016). Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment. Expert Review of Anti-infective Therapy 14, 1139–1154, http://doi.org/10.1080/14787210.2016.1238304.
Pantel, A., Petrella, S., Veziris, N., Matrat, S., Bouige, A., Ferrand, H., Sougakoff, W., Mayer, C. and Aubry, A. (2016). Description of compensatory gyrA mutations restoring fluoroquinolone susceptibility in Mycobacterium tuberculosis. J Antimicrob Chemother 71, 2428–2431, http://doi.org/10.1093/jac/dkw169.
Parize, P., Hamelin, A., Veziris, N., Morand, P. C., Guillemain, R., Lortholary, O. and Dupin, N. (2016). Induction therapy with linezolid/clarithromycin combination for Mycobacterium chelonae skin infections in immunocompromised hosts. Journal of the European Academy of Dermatology and Venereology 30, 101–105, http://doi.org/10.1111/jdv.12965.
Raharolahy, O., Ramarozatovo, L. S., Ranaivo, I. M., Sendrasoa, F. A., Andrianarison, M., Andrianarivelo, M. R., Cambau, E. and Rabenja, F. R. (2016). A Case of Fluoroquinolone-Resistant Leprosy Discovered after 9 Years of Misdiagnosis. Case Reports in Infectious Diseases 2016, 4632369, http://doi.org/10.1155/2016/4632369.

Publications du CNR en 2017

1368488 2017 1 heidelberg-university-faculty-of-medicine 50 creator asc year 1 196 https://cnrmyrma.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22WWL5HK8F%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Allerberger%20et%20al.%22%2C%22parsedDate%22%3A%222017-03-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAllerberger%2C%20F.%2C%20Cambau%2C%20E.%20and%20Lange%2C%20C.%20%282017%29.%20%26lt%3Bb%26gt%3BJoint%20efforts%20urgently%20needed%20at%20times%20of%20emerging%20tuberculosis%20drug%20resistance%26lt%3B%5C%2Fb%26gt%3B.%20Clinical%20Microbiology%20and%20Infection%20%26lt%3Bi%26gt%3B23%26lt%3B%5C%2Fi%26gt%3B%2C%20129%26%23x2013%3B130%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2016.08.023%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2016.08.023%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Joint%20efforts%20urgently%20needed%20at%20times%20of%20emerging%20tuberculosis%20drug%20resistance%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Allerberger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Lange%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222017-03-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cmi.2016.08.023%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.clinicalmicrobiologyandinfection.com%5C%2Farticle%5C%2FS1198-743X%2816%2930362-7%5C%2Ffulltext%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221198-743X%22%2C%22language%22%3A%22English%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-12T09%3A40%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22W49YLEFB%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Andre%20et%20al.%22%2C%22parsedDate%22%3A%222017-03-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAndre%2C%20E.%2C%20Goeminne%2C%20L.%2C%20Cabibbe%2C%20A.%2C%20Beckert%2C%20P.%2C%20Mukadi%2C%20B.%20K.%2C%20Mathys%2C%20V.%2C%20Gagneux%2C%20S.%2C%20Niemann%2C%20S.%2C%20Ingen%2C%20J.%20V.%20and%20Cambau%2C%20E.%20%282017%29.%20%26lt%3Bb%26gt%3BConsensus%20numbering%20system%20for%20the%20rifampicin%20resistance-associated%20rpoB%20gene%20mutations%20in%20pathogenic%20mycobacteria%26lt%3B%5C%2Fb%26gt%3B.%20Clinical%20Microbiology%20and%20Infection%20%26lt%3Bi%26gt%3B23%26lt%3B%5C%2Fi%26gt%3B%2C%20167%26%23x2013%3B172%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2016.09.006%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2016.09.006%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Consensus%20numbering%20system%20for%20the%20rifampicin%20resistance-associated%20rpoB%20gene%20mutations%20in%20pathogenic%20mycobacteria%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Andre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Goeminne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Cabibbe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Beckert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%20Kabamba%22%2C%22lastName%22%3A%22Mukadi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Mathys%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Gagneux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Niemann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20Van%22%2C%22lastName%22%3A%22Ingen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Cambau%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222017-03-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cmi.2016.09.006%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.clinicalmicrobiologyandinfection.com%5C%2Farticle%5C%2FS1198-743X%2816%2930393-7%5C%2Ffulltext%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221198-743X%22%2C%22language%22%3A%22English%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-12T09%3A40%3A21Z%22%7D%7D%2C%7B%22key%22%3A%226HBGRHS2%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Appelgren%20et%20al.%22%2C%22parsedDate%22%3A%222017-06-30%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAppelgren%2C%20A.%2C%20Morquin%2C%20D.%2C%20Dufour%2C%20S.%2C%20Le%20Moing%2C%20V.%2C%20Reynes%2C%20J.%2C%20Lotth%26%23xE9%3B%2C%20A.%2C%20Parer%2C%20S.%2C%20Corbeau%2C%20C.%2C%20Aubry%2C%20A.%2C%20Sougakoff%2C%20W.%2C%20Solassol%2C%20J.%2C%20Bonzon%2C%20L.%2C%20Dumont%2C%20Y.%20and%20Godreuil%2C%20S.%20%282017%29.%20%26lt%3Bb%26gt%3BInvestigation%20of%20pre-XDR%20Beijing%20Mycobacterium%20tuberculosis%20transmission%20to%20a%20healthcare%20worker%20in%20France%2C%202016%26lt%3B%5C%2Fb%26gt%3B.%20Journal%20of%20Hospital%20Infection%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jhin.2017.06.030%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jhin.2017.06.030%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Investigation%20of%20pre-XDR%20Beijing%20Mycobacterium%20tuberculosis%20transmission%20to%20a%20healthcare%20worker%20in%20France%2C%202016%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Appelgren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Morquin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Dufour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Le%20Moing%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Reynes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Lotth%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Parer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Corbeau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Solassol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Bonzon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Y.%22%2C%22lastName%22%3A%22Dumont%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Godreuil%22%7D%5D%2C%22abstractNote%22%3A%22A%20case%20of%20occupational%20contamination%20of%20a%20healthcare%20worker%20by%20a%20pre-extensively%20drug-resistant%20%28pre-XDR%29%20Beijing%20strain%20of%20Mycobacterium%20tuberculosis%20at%20the%20University%20Hospital%20of%20Montpellier%2C%20France%20is%20reported.%20The%20index%20case%20was%20identified%20using%20genetic%20fingerprinting%20of%20isolates.%20This%20report%20underscores%20the%20risk%20of%20healthcare-associated%20contamination%20by%20pre-XDR%20tuberculosis%20%28TB%29%20in%20low-incidence%20countries%20and%20the%20importance%20of%20molecular%20tools%20for%20TB%20care.%20It%20also%20calls%20for%20increased%20vigilance%20in%20the%20management%20of%20multi-drug-resistant%5C%2FXDR%20TB%20patients.%22%2C%22date%22%3A%22June%2030%2C%202017%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jhin.2017.06.030%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0195670117303778%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220195-6701%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-09-08T16%3A22%3A51Z%22%7D%7D%2C%7B%22key%22%3A%22WURBXHFN%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Aubry%20et%20al.%22%2C%22parsedDate%22%3A%222017-04-07%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAubry%2C%20A.%2C%20Mougari%2C%20F.%2C%20Reibel%2C%20F.%20and%20Cambau%2C%20E.%20%282017%29.%20%26lt%3Bb%26gt%3BMycobacterium%20marinum%26lt%3B%5C%2Fb%26gt%3B.%20Microbiology%20Spectrum%20%26lt%3Bi%26gt%3B5%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2Fmicrobiolspec.TNMI7-0038-2016%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2Fmicrobiolspec.TNMI7-0038-2016%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mycobacterium%20marinum%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faiza%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Reibel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%5D%2C%22abstractNote%22%3A%22Mycobacterium%20marinum%20is%20a%20well-known%20pathogenic%20mycobacterium%20for%20skin%20and%20soft%20tissue%20infections%20and%20is%20associated%20with%20fishes%20and%20water.%20Among%20nontuberculous%20mycobacteria%20%28NTM%29%2C%20it%20is%20the%20leading%20cause%20of%20extrarespiratory%20human%20infections%20worldwide.%20In%20addition%2C%20there%20is%20a%20specific%20scientific%20interest%20in%20M.%20marinum%20because%20of%20its%20genetic%20relatedness%20to%20Mycobacterium%20tuberculosis%20and%20because%20experimental%20infection%20of%20M.%20marinum%20in%20fishes%20mimics%20tuberculosis%20pathogenesis.%20Microbiological%20characteristics%20include%20the%20fact%20that%20it%20grows%20in%207%20to%2014%20days%20with%20photochromogenic%20colonies%20and%20is%20difficult%20to%20differentiate%20from%20Mycobacterium%20ulcerans%20and%20other%20mycolactone-producing%20NTM%20on%20a%20molecular%20basis.%20The%20diagnosis%20is%20highly%20suspected%20by%20the%20mode%20of%20infection%2C%20which%20is%20related%20to%20the%20hobby%20of%20fishkeeping%2C%20professional%20handling%20of%20marine%20shells%2C%20or%20swimming%20in%20nonchlorinated%20pools.%20Clinics%20distinguished%20skin%20and%20soft%20tissue%20lesions%20%28typically%20sporotrichoid%20or%20subacute%20hand%20nodules%29%20and%20lesions%20disseminated%20to%20joint%20and%20bone%2C%20often%20related%20with%20the%20local%20use%20of%20corticosteroids.%20In%20clinical%20microbiology%2C%20microscopy%20and%20culture%20are%20often%20negative%20because%20growth%20requires%20low%20temperature%20%2830%5Cu00b0C%29%20and%20several%20weeks%20to%20succeed%20in%20primary%20cultivation.%20The%20treatment%20is%20not%20standardized%2C%20and%20no%20randomized%20control%20trials%20have%20been%20done.%20Therapy%20is%20a%20combination%20of%20surgery%20and%20antimicrobial%20agents%20such%20as%20cyclines%20and%20rifampin%2C%20with%20successful%20outcome%20in%20most%20of%20the%20skin%20diseases%20but%20less%20frequently%20in%20deep%20tissue%20infections.%20Prevention%20can%20be%20useful%20with%20hand%20protection%20recommendations%20for%20professionals%20and%20all%20persons%20manipulating%20fishes%20or%20fish%20tank%20water%20and%20use%20of%20alcohol%20disinfection%20after%20contact.%22%2C%22date%22%3A%222017-04-07%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2Fmicrobiolspec.TNMI7-0038-2016%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.asmscience.org%5C%2Fcontent%5C%2Fjournal%5C%2Fmicrobiolspec%5C%2F10.1128%5C%2Fmicrobiolspec.TNMI7-0038-2016%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222165-0497%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-03T22%3A21%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22TDU55DMW%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bouchet%20et%20al.%22%2C%22parsedDate%22%3A%222017-08-16%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBouchet%2C%20F.%2C%20Martin%2C%20B.%2C%20Aubry%2C%20A.%2C%20Veziris%2C%20N.%2C%20Lavigne%2C%20J.-P.%20and%20Sotto%2C%20A.%20%282017%29.%20%26lt%3Bb%26gt%3BShould%20single%20antibiotic%20therapy%20be%20avoided%20for%20nontuberculous%20mycobacteria%3F%26lt%3B%5C%2Fb%26gt%3B%20M%26%23xE9%3Bdecine%20et%20Maladies%20Infectieuses%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.medmal.2017.07.004%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.medmal.2017.07.004%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Should%20single%20antibiotic%20therapy%20be%20avoided%20for%20nontuberculous%20mycobacteria%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Bouchet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Martin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20-P.%22%2C%22lastName%22%3A%22Lavigne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Sotto%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22August%2016%2C%202017%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.medmal.2017.07.004%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0399077X17301075%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220399-077X%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-09-08T16%3A04%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22TUBJZW4P%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brossier%20and%20Sougakoff%22%2C%22parsedDate%22%3A%222017-09-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBrossier%2C%20F.%20and%20Sougakoff%2C%20W.%20%282017%29.%20%26lt%3Bb%26gt%3BMolecular%20detection%20methods%20of%20resistance%20to%20antituberculosis%20drugs%20in%20Mycobacterium%20tuberculosis%26lt%3B%5C%2Fb%26gt%3B.%20M%26%23xE9%3Bdecine%20et%20Maladies%20Infectieuses%20%26lt%3Bi%26gt%3B47%26lt%3B%5C%2Fi%26gt%3B%2C%20340%26%23x2013%3B348%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.medmal.2017.04.008%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.medmal.2017.04.008%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Molecular%20detection%20methods%20of%20resistance%20to%20antituberculosis%20drugs%20in%20Mycobacterium%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%22%2C%22lastName%22%3A%22Sougakoff%22%7D%5D%2C%22abstractNote%22%3A%22Molecular%20methods%20predict%20drug%20resistance%20several%20weeks%20before%20phenotypic%20methods%20and%20enable%20rapid%20implementation%20of%20appropriate%20therapeutic%20treatment.%20We%20aimed%20to%20detail%20the%20most%20representative%20molecular%20tools%20used%20in%20routine%20practice%20for%20the%20rapid%20detection%20of%20resistance%20to%20antituberculosis%20drugs%20among%20Mycobacterium%20tuberculosis%20strains.%20The%20molecular%20diagnosis%20of%20resistance%20to%20antituberculosis%20drugs%20in%20clinical%20samples%20or%20from%20in%20vitro%20cultures%20is%20based%20on%20the%20detection%20of%20the%20most%20common%20mutations%20in%20the%20genes%20involved%20in%20the%20development%20of%20resistance%20in%20M.%20tuberculosis%20strains%20%28encoding%20either%20protein%20targets%20of%20antibiotics%2C%20or%20antibiotic%20activating%20enzymes%29%20by%20commercial%20molecular%20kits%20or%20by%20sequencing.%20Three%20hypotheses%20could%20explain%20the%20discrepancies%20between%20the%20genotypic%20results%20and%20the%20phenotypic%20drug%20susceptibility%20testing%20results%3A%20a%20low%20percentage%20of%20resistant%20mutants%20precluding%20the%20detection%20by%20genotypic%20methods%20on%20the%20primary%20culture%3B%20a%20low%20level%20of%20resistance%20not%20detected%20by%20phenotypic%20testing%3B%20and%20other%20resistance%20mechanisms%20not%20yet%20characterized.%20Molecular%20methods%20have%20varying%20sensitivity%20with%20regards%20to%20detecting%20antituberculosis%20drug%20resistance%3B%20that%20is%20why%20phenotypic%20susceptibility%20testing%20methods%20are%20mandatory%20for%20detecting%20antituberculosis%20drug-resistant%20isolates%20that%20have%20not%20been%20detected%20by%20molecular%20methods.%20The%20questionable%20ability%20of%20existing%20phenotypic%20and%20genotypic%20drug%20susceptibility%20testing%20to%20properly%20classify%20strains%20as%20susceptible%20or%20resistant%2C%20and%20at%20what%20level%20of%20resistance%2C%20was%20raised%20for%20several%20antituberculosis%20agents.%5CnLes%20m%5Cu00e9thodes%20mol%5Cu00e9culaires%20peuvent%20pr%5Cu00e9dire%20la%20r%5Cu00e9sistance%20aux%20antituberculeux%20plusieurs%20semaines%20avant%20les%20m%5Cu00e9thodes%20ph%5Cu00e9notypiques.%20Elles%20permettent%20une%20mise%20en%20place%20rapide%20du%20traitement%20th%5Cu00e9rapeutique%20ad%5Cu00e9quat.%20Notre%20but%20%5Cu00e9tait%20de%20d%5Cu00e9tailler%20les%20outils%20mol%5Cu00e9culaires%20les%20plus%20utilis%5Cu00e9s%20en%20routine%20pour%20la%20d%5Cu00e9tection%20rapide%20de%20la%20r%5Cu00e9sistance%20aux%20antituberculeux%20chez%20Mycobacterium%20tuberculosis.%20Le%20diagnostic%20mol%5Cu00e9culaire%20de%20la%20r%5Cu00e9sistance%20aux%20antituberculeux%20dans%20les%20pr%5Cu00e9l%5Cu00e8vements%20cliniques%20ou%20les%20cultures%20s%5Cu2019appuie%20sur%20la%20d%5Cu00e9tection%20des%20mutations%20les%20plus%20fr%5Cu00e9quentes%20dans%20les%20g%5Cu00e8nes%20incrimin%5Cu00e9s%20dans%20la%20r%5Cu00e9sistance%20chez%20M.%20tuberculosis%20%28codant%20les%20prot%5Cu00e9ines%20cibles%20ou%20les%20enzymes%20activatrices%20des%20antibiotiques%29%20par%20des%20kits%20commerciaux%20et%5C%2Fou%20par%20s%5Cu00e9quen%5Cu00e7age.%20Trois%20raisons%20peuvent%20expliquer%20des%20diff%5Cu00e9rences%20entre%20les%20r%5Cu00e9sultats%20des%20tests%20de%20sensibilit%5Cu00e9%20g%5Cu00e9notypique%20et%20ph%5Cu00e9notypique%3A%20un%20faible%20pourcentage%20de%20mutants%20r%5Cu00e9sistants%20emp%5Cu00eachant%20la%20d%5Cu00e9tection%20de%20la%20r%5Cu00e9sistance%20par%20m%5Cu00e9thode%20g%5Cu00e9notypique%20sur%20la%20culture%20primaire%3B%20un%20bas%20niveau%20de%20r%5Cu00e9sistance%20non%20d%5Cu00e9tect%5Cu00e9e%20par%20test%20ph%5Cu00e9notypique%3B%20d%5Cu2019autres%20m%5Cu00e9canismes%20de%20r%5Cu00e9sistance%20non%20encore%20%5Cu00e9lucid%5Cu00e9s.%20Les%20m%5Cu00e9thodes%20mol%5Cu00e9culaires%20ont%20des%20sensibilit%5Cu00e9s%20variables%20pour%20la%20d%5Cu00e9tection%20de%20la%20r%5Cu00e9sistance%20aux%20antituberculeux%2C%20c%5Cu2019est%20pourquoi%20les%20tests%20de%20sensibilit%5Cu00e9%20ph%5Cu00e9notypiques%20restent%20obligatoires%20pour%20d%5Cu00e9tecter%20les%20souches%20r%5Cu00e9sistantes%20aux%20antituberculeux%20non%20d%5Cu00e9tect%5Cu00e9es%20par%20les%20m%5Cu00e9thodes%20g%5Cu00e9notypiques.%20La%20capacit%5Cu00e9%20des%20tests%20de%20sensibilit%5Cu00e9%20ph%5Cu00e9notypiques%20et%20g%5Cu00e9notypiques%20%5Cu00e0%20classer%20correctement%20les%20souches%20comme%20sensibles%20et%20r%5Cu00e9sistantes%2C%20et%20%5Cu00e0%20quel%20niveau%20de%20r%5Cu00e9sistance%2C%20a%20%5Cu00e9t%5Cu00e9%20soulev%5Cu00e9e%20pour%20plusieurs%20antituberculeux.%22%2C%22date%22%3A%22September%201%2C%202017%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.medmal.2017.04.008%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0399077X1730608X%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220399-077X%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-08-02T14%3A41%3A22Z%22%7D%7D%2C%7B%22key%22%3A%225CRH6I5W%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brossier%20et%20al.%22%2C%22parsedDate%22%3A%222017-02-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBrossier%2C%20F.%2C%20Pham%2C%20A.%2C%20Bernard%2C%20C.%2C%20Aubry%2C%20A.%2C%20Jarlier%2C%20V.%2C%20Veziris%2C%20N.%2C%20Sougakoff%2C%20W.%20and%20CNR-MyRMA%2C%20O.%20B.%20of%20T.%20%282017%29.%20%26lt%3Bb%26gt%3BMolecular%20Investigation%20of%20Resistance%20to%20Second-Line%20Injectable%20Drugs%20in%20Multidrug-Resistant%20Clinical%20Isolates%20of%20Mycobacterium%20tuberculosis%20in%20France%26lt%3B%5C%2Fb%26gt%3B.%20Antimicrob%20Agents%20Chemother%20%26lt%3Bi%26gt%3B61%26lt%3B%5C%2Fi%26gt%3B%2C%20e01299-16%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.01299-16%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.01299-16%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Molecular%20Investigation%20of%20Resistance%20to%20Second-Line%20Injectable%20Drugs%20in%20Multidrug-Resistant%20Clinical%20Isolates%20of%20Mycobacterium%20tuberculosis%20in%20France%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Pham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22On%20Behalf%20of%20The%22%2C%22lastName%22%3A%22CNR-MyRMA%22%7D%5D%2C%22abstractNote%22%3A%22The%20second-line%20injectable%20drugs%20%28SLID%2C%20i.e.%2C%20amikacin%2C%20kanamycin%2C%20capreomycin%29%20are%20key%20drugs%20for%20the%20treatment%20of%20multidrug-resistant%20tuberculosis.%20Mutations%20in%20rrs%20region%201400%2C%20tlyA%2C%20and%20eis%20promoter%20are%20associated%20with%20resistance%20to%20SLID%2C%20to%20capreomycin%2C%20and%20to%20kanamycin%2C%20respectively.%20In%20this%20study%2C%20the%20sequencing%20data%20of%20SLID%20resistance-associated%20genes%20were%20compared%20to%20the%20results%20of%20phenotypic%20drug%20susceptibility%20testing%20by%20the%20proportion%20method%20for%20the%20SLID%20in%20206%20multidrug-resistant%20clinical%20isolates%20of%20Mycobacterium%20tuberculosis%20collected%20in%20France.%20Among%20the%20153%20isolates%20susceptible%20to%20the%203%20SLID%2C%20145%20showed%20no%20mutation%2C%201%20harbored%20T1404C%20and%20G1473A%20mutations%20in%20rrs%2C%20and%207%20had%20an%20eis%20promoter%20mutation.%20Among%20the%2053%20strains%20resistant%20to%20at%20least%201%20of%20the%20SLID%2C%20mutations%20in%20rrs%20accounted%20for%20resistance%20to%20amikacin%2C%20capreomycin%2C%20and%20kanamycin%20for%2081%25%2C%2075%25%2C%20and%2044%25%20of%20the%20isolates%2C%20respectively%2C%20while%20mutations%20in%20eis%20promoter%20were%20detected%20in%2044%25%20of%20the%20isolates%20resistant%20to%20kanamycin.%20In%20contrast%2C%20no%20mutations%20in%20tlyA%20were%20observed%20in%20the%20isolates%20resistant%20to%20capreomycin.%20The%20discrepancies%20observed%20between%20the%20genotypic%20%28on%20the%20primary%20culture%29%20and%20phenotypic%20drug%20susceptibility%20testing%20were%20explained%20by%20%28i%29%20resistance%20to%20SLID%20with%20MICs%20close%20to%20the%20critical%20concentration%20used%20for%20routine%20DST%20and%20not%20detected%20by%20phenotypic%20testing%20%28n%20%3D%208%2C%2015%25%20of%20SLID-resistant%20strains%29%2C%20%28ii%29%20low-frequency%20heteroresistance%20not%20detected%20by%20sequencing%20of%20drug%20resistance-associated%20genes%20on%20the%20primary%20culture%20%28n%20%3D%208%2C%2015%25%20of%20SLID-resistant%20strains%29%2C%20and%20%28iii%29%20other%20resistance%20mechanisms%20not%20yet%20characterized%20%28n%20%3D%207%2C%2013%25%20of%20SLID-resistant%20strains%29.%22%2C%22date%22%3A%2202%5C%2F01%5C%2F2017%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2FAAC.01299-16%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Faac.asm.org%5C%2Fcontent%5C%2F61%5C%2F2%5C%2Fe01299-16%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220066-4804%2C%201098-6596%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-08-02T14%3A40%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22TDUI6NFB%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Delafont%20et%20al.%22%2C%22parsedDate%22%3A%222017-04-10%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BDelafont%2C%20V.%2C%20Samba-Louaka%2C%20A.%2C%20Cambau%2C%20E.%2C%20Bouchon%2C%20D.%2C%20Moulin%2C%20L.%20and%20H%26%23xE9%3Bchard%2C%20Y.%20%282017%29.%20%26lt%3Bb%26gt%3BMycobacterium%20llatzerense%2C%20a%20waterborne%20Mycobacterium%2C%20that%20resists%20phagocytosis%20by%20Acanthamoeba%20castellanii%26lt%3B%5C%2Fb%26gt%3B.%20Scientific%20Reports%20%26lt%3Bi%26gt%3B7%26lt%3B%5C%2Fi%26gt%3B%2C%2046270%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fsrep46270%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fsrep46270%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mycobacterium%20llatzerense%2C%20a%20waterborne%20Mycobacterium%2C%20that%20resists%20phagocytosis%20by%20Acanthamoeba%20castellanii%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Delafont%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ascel%22%2C%22lastName%22%3A%22Samba-Louaka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Didier%22%2C%22lastName%22%3A%22Bouchon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Moulin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yann%22%2C%22lastName%22%3A%22H%5Cu00e9chard%22%7D%5D%2C%22abstractNote%22%3A%22Nontuberculous%20mycobacteria%20%28NTM%29%20are%20environmental%20bacteria%20increasingly%20associated%20to%20public%20health%20problems.%20In%20water%20systems%2C%20free-living%20amoebae%20%28FLA%29%20feed%20on%20bacteria%20by%20phagocytosis%2C%20but%20several%20bacteria%2C%20including%20many%20NTM%2C%20are%20resistant%20to%20this%20predation.%20Thus%2C%20FLA%20can%20be%20seen%20as%20a%20training%20ground%20for%20pathogenic%20bacteria.%20Mycobacterium%20llatzerense%20was%20previously%20described%20as%20frequently%20associated%20with%20FLA%20in%20a%20drinking%20water%20network.%20The%20present%20study%20aimed%20to%20characterize%20the%20interactions%20between%20M.%20llatzerense%20and%20FLA.%20M.%20llatzerense%20was%20internalised%20by%20phagocytosis%20and%20featured%20lipid%20inclusions%2C%20suggesting%20a%20subversion%20of%20host%20resources.%20Moreover%2C%20M.%20llatzerense%20survived%20and%20even%20multiplied%20in%20presence%20of%20A.%20castellanii.%20Using%20a%20genomic-based%20comparative%20approach%2C%20twelve%20genes%20involved%20in%20phagocytosis%20interference%2C%20described%20in%20M.%20tuberculosis%2C%20were%20identified%20in%20the%20M.%20llatzerense%20genome%20sequenced%20in%20this%20study.%20Transcriptomic%20analyses%20showed%20that%20ten%20genes%20were%20significantly%20upregulated%20during%20the%20first%20hours%20of%20the%20infection%2C%20which%20could%20partly%20explain%20M.%20llatzerense%20resistance.%20Additionally%2C%20M.%20llatzerense%20was%20shown%20to%20actively%20inhibit%20phagosome%20acidification.%20In%20conclusion%2C%20M.%20llatzerense%20presents%20a%20high%20degree%20of%20resistance%20to%20phagocytosis%2C%20likely%20explaining%20its%20frequent%20occurrence%20within%20FLA%20in%20drinking%20water%20networks.%20It%20underscores%20that%20NTM%20should%20be%20carefully%20monitored%20in%20water%20networks%20to%20prevent%20human%20health%20concerns.%22%2C%22date%22%3A%222017-04-10%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1038%5C%2Fsrep46270%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fsrep46270%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222045-2322%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-03T22%3A29%3A21Z%22%7D%7D%2C%7B%22key%22%3A%227WBDJD2A%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fournier%20et%20al.%22%2C%22parsedDate%22%3A%222017-09-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BFournier%2C%20A.%2C%20Bernard%2C%20C.%2C%20Sougakoff%2C%20W.%2C%20Quelet%2C%20S.%2C%20Antoun%2C%20F.%2C%20Charlois-Ou%2C%20C.%2C%20Dormant%2C%20I.%2C%20Dufour%2C%20M.-O.%2C%20Hocine%2C%20N.%2C%20Jarlier%2C%20V.%20and%20Veziris%2C%20N.%20%282017%29.%20%26lt%3Bb%26gt%3BNeither%20genotyping%20nor%20contact%20tracing%20allow%20correct%20understanding%20of%20multidrug-resistant%20tuberculosis%20transmission%26lt%3B%5C%2Fb%26gt%3B.%20European%20Respiratory%20Journal%20%26lt%3Bi%26gt%3B50%26lt%3B%5C%2Fi%26gt%3B%2C%201700891%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.00891-2017%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.00891-2017%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Neither%20genotyping%20nor%20contact%20tracing%20allow%20correct%20understanding%20of%20multidrug-resistant%20tuberculosis%20transmission%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arthur%22%2C%22lastName%22%3A%22Fournier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvie%22%2C%22lastName%22%3A%22Quelet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fadi%22%2C%22lastName%22%3A%22Antoun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9cile%22%2C%22lastName%22%3A%22Charlois-Ou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Dormant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Odile%22%2C%22lastName%22%3A%22Dufour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nora%22%2C%22lastName%22%3A%22Hocine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22Tweetable%20abstract%20%40ERSpublications%5Cnclick%20to%20tweetEven%20combined%20contact%20tracing%20and%20genotyping%20fail%20to%20explain%20how%20MDR-TB%20transmission%20occurs%20in%20one%20third%20of%20cases%20http%3A%5C%2F%5C%2Fow.ly%5C%2F2ZKB30dRVGw%22%2C%22date%22%3A%222017%5C%2F09%5C%2F01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1183%5C%2F13993003.00891-2017%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Ferj.ersjournals.com%5C%2Fcontent%5C%2F50%5C%2F3%5C%2F1700891%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220903-1936%2C%201399-3003%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-03T22%3A43%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22E28WQ94R%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guglielmetti%20et%20al.%22%2C%22parsedDate%22%3A%222017-03-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGuglielmetti%2C%20L.%2C%20Jaspard%2C%20M.%2C%20D%26%23xFB%3B%2C%20D.%20L.%2C%20Lach%26%23xE2%3Btre%2C%20M.%2C%20Marigot-Outtandy%2C%20D.%2C%20Bernard%2C%20C.%2C%20Veziris%2C%20N.%2C%20Robert%2C%20J.%2C%20Yazdanpanah%2C%20Y.%2C%20Caumes%2C%20E.%20and%20Fr%26%23xE9%3Bchet-Jachym%2C%20M.%20%282017%29.%20%26lt%3Bb%26gt%3BLong-term%20outcome%20and%20safety%20of%20prolonged%20bedaquiline%20treatment%20for%20multidrug-resistant%20tuberculosis%26lt%3B%5C%2Fb%26gt%3B.%20European%20Respiratory%20Journal%20%26lt%3Bi%26gt%3B49%26lt%3B%5C%2Fi%26gt%3B%2C%201601799%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.01799-2016%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.01799-2016%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Long-term%20outcome%20and%20safety%20of%20prolonged%20bedaquiline%20treatment%20for%20multidrug-resistant%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Jaspard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Damien%20Le%22%2C%22lastName%22%3A%22D%5Cu00fb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Lach%5Cu00e2tre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhiba%22%2C%22lastName%22%3A%22Marigot-Outtandy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yazdan%22%2C%22lastName%22%3A%22Yazdanpanah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Caumes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathilde%22%2C%22lastName%22%3A%22Fr%5Cu00e9chet-Jachym%22%7D%5D%2C%22abstractNote%22%3A%22Bedaquiline%2C%20a%20recently%20approved%20drug%20for%20the%20treatment%20of%20multidrug-resistant%20tuberculosis%20%28MDR-TB%29%2C%20is%20recommended%20for%20a%20duration%20of%2024%20weeks.%20There%20are%20scarce%20data%20on%20patients%20treated%20with%20this%20drug%20outside%20clinical%20trials.%5CnAll%20MDR-TB%20patients%20who%20started%20treatment%20from%20January%201%2C%202011%20to%20December%2031%2C%202013%20and%20received%20%5Cu226530%20days%20of%20bedaquiline%20were%20included%20in%20a%20multicentre%20observational%20cohort.%5CnAmong%2045%20MDR-TB%20patients%2C%2053%25%20harboured%20isolates%20resistant%20to%20both%20fluoroquinolones%20and%20second-line%20injectables%2C%20and%2038%25%20harboured%20isolates%20resistant%20to%20one%20of%20these%20drug%20classes.%20Median%20bedaquiline%20treatment%20duration%20was%20361%20days%20and%2033%20patients%20%2873%25%29%20received%20prolonged%20%28%26gt%3B190%20days%29%20bedaquiline%20treatment.%20Overall%2C%2036%20patients%20%2880%25%29%20had%20favourable%20outcome%2C%20five%20were%20lost%20to%20follow-up%2C%20three%20died%2C%20and%20one%20failed%20and%20acquired%20bedaquiline%20resistance.%20No%20cases%20of%20recurrence%20were%20reported.%20Severe%20and%20serious%20adverse%20events%20were%20recorded%20in%2060%25%20and%2018%25%20of%20patients%2C%20respectively.%20Values%20of%20Fridericia-corrected%20QT%20interval%20%28QTcF%29%20%26gt%3B500%20ms%20were%20recorded%20in%2011%25%20of%20patients%2C%20but%20neither%20arrhythmias%20nor%20symptomatic%20cardiac%20side-effects%20occurred.%20Bedaquiline%20was%20discontinued%20in%20three%20patients%20following%20QTcF%20prolongation.%20No%20significant%20differences%20in%20outcomes%20or%20adverse%20events%20rates%20were%20observed%20between%20patients%20receiving%20standard%20and%20prolonged%20bedaquiline%20treatment.%5CnBedaquiline-containing%20regimens%20achieved%20favourable%20outcomes%20in%20a%20large%20proportion%20of%20patients.%20Prolonged%20bedaquiline%20treatment%20was%20overall%20well%20tolerated%20in%20this%20cohort.%5CnTweetable%20abstract%20%40ERSpublications%5Cnclick%20to%20tweetTreatment%20regimens%20including%20prolonged%20bedaquiline%20use%20are%20effective%20and%20overall%20well%20tolerated%20in%20MDR-TB%20patients%20http%3A%5C%2F%5C%2Fow.ly%5C%2Fvhtl305CYJj%22%2C%22date%22%3A%222017%5C%2F03%5C%2F01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1183%5C%2F13993003.01799-2016%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Ferj.ersjournals.com%5C%2Fcontent%5C%2F49%5C%2F3%5C%2F1601799%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220903-1936%2C%201399-3003%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-01T16%3A42%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22342DZFUU%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guglielmetti%20et%20al.%22%2C%22parsedDate%22%3A%222017-02-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGuglielmetti%2C%20L.%2C%20Hewison%2C%20C.%2C%20Avaliani%2C%20Z.%2C%20Hughes%2C%20J.%2C%20Kiria%2C%20N.%2C%20Lomtadze%2C%20N.%2C%20Ndjeka%2C%20N.%2C%20Setkina%2C%20S.%2C%20Shabangu%2C%20A.%2C%20Sikhondze%2C%20W.%2C%20Skrahina%2C%20A.%2C%20Veziris%2C%20N.%20and%20Furin%2C%20J.%20%282017%29.%20%26lt%3Bb%26gt%3BExamples%20of%20bedaquiline%20introduction%20for%20the%20management%20of%20multidrug-resistant%20tuberculosis%20in%20five%20countries%26lt%3B%5C%2Fb%26gt%3B.%20The%20International%20Journal%20of%20Tuberculosis%20and%20Lung%20Disease%20%26lt%3Bi%26gt%3B21%26lt%3B%5C%2Fi%26gt%3B%2C%20167%26%23x2013%3B174%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.16.0493%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.16.0493%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Examples%20of%20bedaquiline%20introduction%20for%20the%20management%20of%20multidrug-resistant%20tuberculosis%20in%20five%20countries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Hewison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Z.%22%2C%22lastName%22%3A%22Avaliani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Hughes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Kiria%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Lomtadze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Ndjeka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Setkina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Shabangu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%22%2C%22lastName%22%3A%22Sikhondze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Skrahina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Furin%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20For%20the%20first%20time%20in%20almost%2050%20years%2C%20there%20are%20new%20drugs%20available%20for%20the%20treatment%20of%20tuberculosis%20%28TB%29%2C%20including%20bedaquiline%20%28BDQ%29%20and%20delamanid%20%28DLM%29.%20The%20rate%20of%20introduction%2C%20however%2C%20has%20not%20kept%20pace%20with%20patient%20needs.%20It%20is%20estimated%20that%20as%20many%20as%2023%25%20of%20multidrug-resistant%20TB%20%28MDR-TB%29%20patients%20have%20an%20indication%20for%20receiving%20BDQ.%20As%20this%20is%20the%20first%20time%20the%20MDR-TB%20community%20is%20introducing%20new%20medications%2C%20it%20is%20important%20to%20understand%20how%20implementation%20can%20be%20developed%20in%20a%20variety%20of%20settings.METHODS%3A%20A%20qualitative%20assessment%20of%20country%20TB%20programs%20in%20which%20more%20than%205%25%20of%20MDR-TB%20patients%20were%20started%20on%20BDQ%20under%20program%20conditions.RESULTS%3A%20National%20TB%20programs%20in%20Belarus%2C%20France%2C%20Georgia%2C%20South%20Africa%2C%20and%20Swaziland%20all%20started%20sizeable%20cohorts%20of%20patients%20on%20BDQ%20in%202015.%20Common%20factors%20observed%20in%20these%20programs%20included%20experience%20with%20compassionate%20use%5C%2Fexpanded%20access%2C%20support%20from%20implementing%20partners%2C%20and%20adequate%20national%20or%20donor-supported%20budgets.%20Barriers%20to%20introduction%20included%20restriction%20of%20BDQ%20to%20the%20in-patient%20setting%2C%20lack%20of%20access%20to%20companion%20drugs%2C%20and%20the%20development%20of%20systems%20for%20pharmacovigilance.CONCLUSION%3A%20The%20five%20countries%20in%20this%20paper%20are%20examples%20of%20the%20introduction%20of%20new%20therapeutic%20options%20for%20the%20treatment%20of%20TB.%22%2C%22date%22%3A%222017-02-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.5588%5C%2Fijtld.16.0493%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-08-02T14%3A40%3A38Z%22%7D%7D%2C%7B%22key%22%3A%22W93AX45N%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jaspard%20et%20al.%22%2C%22parsedDate%22%3A%222017%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BJaspard%2C%20M.%2C%20Elefant-Amoura%2C%20E.%2C%20Melonio%2C%20I.%2C%20de%20Montgolfier%2C%20I.%2C%20Veziris%2C%20N.%20and%20Caumes%2C%20E.%20%282017%29.%20%26lt%3Bb%26gt%3BBedaquiline%20and%20Linezolid%20for%20Extensively%20Drug-Resistant%20Tuberculosis%20in%20Pregnant%20Woman%26lt%3B%5C%2Fb%26gt%3B.%20Emerging%20Infect%20Dis%20%26lt%3Bi%26gt%3B23%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3201%5C%2Feid2310.161398%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3201%5C%2Feid2310.161398%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Bedaquiline%20and%20Linezolid%20for%20Extensively%20Drug-Resistant%20Tuberculosis%20in%20Pregnant%20Woman%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Jaspard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Elefant-Amoura%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22I%22%2C%22lastName%22%3A%22Melonio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22I%22%2C%22lastName%22%3A%22de%20Montgolfier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Caumes%22%7D%5D%2C%22abstractNote%22%3A%22A%20woman%20with%20extremely%20drug-resistant%20tuberculosis%20treated%20with%20a%20drug%20regimen%20including%20linezolid%20and%20bedaquiline%20during%20her%20last%203%20weeks%20of%20pregnancy%20gave%20birth%20to%20a%20child%20without%20abnormalities.%20No%20fetal%20toxicities%20were%20noted%20by%202%20years%20after%20delivery.%20This%20drug%20combination%20might%20be%20safe%20during%20the%20late%20third%20trimester%20of%20pregnancy.%22%2C%22date%22%3A%222017%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.3201%5C%2Feid2310.161398%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwwwnc.cdc.gov%5C%2Feid%5C%2Farticle%5C%2F23%5C%2F10%5C%2F16-1398_article%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-03T22%3A52%3A59Z%22%7D%7D%2C%7B%22key%22%3A%2283V4AFER%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Leyer%20et%20al.%22%2C%22parsedDate%22%3A%222017-07-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLeyer%2C%20C.%2C%20Gregorowicz%2C%20G.%2C%20Mougari%2C%20F.%2C%20Raskine%2C%20L.%2C%20Cambau%2C%20E.%20and%20Briel%2C%20D.%20de%20%282017%29.%20%26lt%3Bb%26gt%3BComparison%20of%20Saramis%204.12%20and%20IVD%203.0%20Vitek%20MS%20Matrix-Assisted%20Laser%20Desorption%20Ionization%26%23x2013%3BTime%20of%20Flight%20Mass%20Spectrometry%20for%20Identification%20of%20Mycobacteria%20from%20Solid%20and%20Liquid%20Culture%20Media%26lt%3B%5C%2Fb%26gt%3B.%20Journal%20of%20Clinical%20Microbiology%20%26lt%3Bi%26gt%3B55%26lt%3B%5C%2Fi%26gt%3B%2C%202045%26%23x2013%3B2054%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.00006-17%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FJCM.00006-17%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Comparison%20of%20Saramis%204.12%20and%20IVD%203.0%20Vitek%20MS%20Matrix-Assisted%20Laser%20Desorption%20Ionization%5Cu2013Time%20of%20Flight%20Mass%20Spectrometry%20for%20Identification%20of%20Mycobacteria%20from%20Solid%20and%20Liquid%20Culture%20Media%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%22%2C%22lastName%22%3A%22Leyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guillaume%22%2C%22lastName%22%3A%22Gregorowicz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faiza%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Raskine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominique%20de%22%2C%22lastName%22%3A%22Briel%22%7D%5D%2C%22abstractNote%22%3A%22During%20the%20last%20decade%2C%20many%20investigators%20have%20studied%20matrix-assisted%20laser%20desorption%20ionization%5Cu2013time%20of%20flight%20mass%20spectrometry%20%28MALDI-TOF%20MS%29%20for%20identification%20of%20mycobacteria.%20Diverse%20and%20contradictory%20results%20indicated%20that%20optimal%20level%20for%20routine%20testing%20has%20not%20been%20reached%20yet.%20This%20work%20aimed%20to%20assess%20Vitek%20MS%20through%20two%20distinct%20versions%2C%20Saramis%20v4.12%20RUO%20and%20the%20IVD%20v3.0%2C%20under%20conditions%20close%20to%20routine%20laboratory%20practice.%20Overall%2C%20111%20mycobacterial%20isolates%20were%20subjected%20to%20protein%20extraction%20and%20same%20spectra%20were%20matched%20against%20both%20databases.%20The%20IVD%20v3.0%20database%20proved%20to%20be%20superior%20to%20Saramis%20v4.12%20and%20its%20identification%20rates%20remarkably%20increased%2C%20from%2067%25%20to%2094%25%20for%20isolates%20grown%20on%20Middlebrook%207H10%20solid%20medium%20and%20from%2062%25%20to%2091%25%20for%20isolates%20grown%20on%20mycobacterial%20growth%20indicator%20tube%20%28MGIT%29%20liquid%20medium.%20With%20this%20new%20version%2C%20IVD%20v3.0%2C%20MALDI-TOF%20MS%20might%20be%20integrated%20into%20routine%20clinical%20diagnostics%2C%20although%20molecular%20techniques%20remain%20mandatory%20in%20some%20cases.%22%2C%22date%22%3A%222017%5C%2F07%5C%2F01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2FJCM.00006-17%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjcm.asm.org%5C%2Fcontent%5C%2F55%5C%2F7%5C%2F2045%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220095-1137%2C%201098-660X%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-03T22%3A17%3A11Z%22%7D%7D%2C%7B%22key%22%3A%225Q57TTXS%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Maitre%20et%20al.%22%2C%22parsedDate%22%3A%222017-12-14%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMaitre%2C%20T.%2C%20Aubry%2C%20A.%20and%20Veziris%2C%20N.%20%282017%29.%20%26lt%3Bb%26gt%3BMolecular%20Drug-Susceptibility%20Test%20for%20Tuberculosis%26lt%3B%5C%2Fb%26gt%3B.%20New%20England%20Journal%20of%20Medicine%20%26lt%3Bi%26gt%3B377%26lt%3B%5C%2Fi%26gt%3B%2C%202403%26%23x2013%3B2404%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMc1714218%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMc1714218%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Molecular%20Drug-Susceptibility%20Test%20for%20Tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T%22%2C%22lastName%22%3A%22Maitre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22To%20the%20Editor%3A%20Xie%20et%20al.%20%28Sept.%2014%20issue%291%20present%20the%20evaluation%20of%20a%20new%20molecular%20test%20for%20the%20detection%20of%20resistance%20of%20Mycobacterium%20tuberculosis%20to%20fluoroquinolones%2C%20aminoglycosides%2C%20and%20isoniazid.%20In%20the%20Discussion%20section%2C%20the%20authors%20mention%20that%20one%20of%20the%20limitations%20of%20their%20study%20is%20that%20the%20geographic%20representation%20is%20limited%20to%20China%20and%20South%20Korea.%20The%20geographic%20origin%20of%20a%20strain%20of%20M.%20tuberculosis%20is%20of%20particular%20importance%20for%20the%20interpretation%20of%20genotypic%20testing%20for%20drug%20resistance.%20For%20example%2C%20it%20has%20been%20shown%20that%20strains%20from%20the%20Congo%20area%20can%20be%20erroneously%20interpreted%20as%20fluoroquinolone-resistant%20with%20the%20GenoType%20.%20.%20.%22%2C%22date%22%3A%22December%2014%2C%202017%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1056%5C%2FNEJMc1714218%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1056%5C%2FNEJMc1714218%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220028-4793%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-03T22%3A48%3A19Z%22%7D%7D%2C%7B%22key%22%3A%22EQSSDJFH%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Maitre%20et%20al.%22%2C%22parsedDate%22%3A%222017-08-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMaitre%2C%20T.%2C%20Petitjean%2C%20G.%2C%20Chauffour%2C%20A.%2C%20Bernard%2C%20C.%2C%20El%20Helali%2C%20N.%2C%20Jarlier%2C%20V.%2C%20Reibel%2C%20F.%2C%20Chavanet%2C%20P.%2C%20Aubry%2C%20A.%20and%20Veziris%2C%20N.%20%282017%29.%20%26lt%3Bb%26gt%3BAre%20moxifloxacin%20and%20levofloxacin%20equally%20effective%20to%20treat%20XDR%20tuberculosis%3F%26lt%3B%5C%2Fb%26gt%3B%20J%20Antimicrob%20Chemother%20%26lt%3Bi%26gt%3B72%26lt%3B%5C%2Fi%26gt%3B%2C%202326%26%23x2013%3B2333%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkx150%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkx150%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Are%20moxifloxacin%20and%20levofloxacin%20equally%20effective%20to%20treat%20XDR%20tuberculosis%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Maitre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gr%5Cu00e9goire%22%2C%22lastName%22%3A%22Petitjean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Najoua%22%2C%22lastName%22%3A%22El%20Helali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Reibel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pascal%22%2C%22lastName%22%3A%22Chavanet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20Moxifloxacin%20retains%20partial%20activity%20against%20some%20fluoroquinolone-resistant%20mutants%20of%20Mycobacterium%20tuberculosis.%20Levofloxacin%20is%20presumed%20to%20be%20as%20active%20as%20moxifloxacin%20against%20drug-susceptible%20tuberculosis%20and%20to%20have%20a%20better%20safety%20profile.Objectives%3A%20To%20compare%20the%20in%20vivo%20activity%20of%20levofloxacin%20and%20moxifloxacin%20against%20M.%20tuberculosis%20strains%20with%20various%20levels%20of%20fluoroquinolone%20resistance.Methods%3A%20BALB%5C%2Fc%20mice%20were%20intravenously%20infected%20with%20106M.%20tuberculosis%20H37Rv%20and%20three%20isogenic%20mutants%3A%20GyrA%20A90V%2C%20GyrB%20E540A%20and%20GyrB%20A543V.%20Treatment%20with%2050%20or%20100%5Cu2009mg%5C%2Fkg%20levofloxacin%20and%2060%20or%2066%5Cu2009mg%5C%2Fkg%20moxifloxacin%20was%20given%20orally%20every%206%5Cu2009h%2C%20for%204%5Cu2009weeks.Results%3A%20Levofloxacin%2050%20and%20100%5Cu2009mg%5C%2Fkg%20q6h%20and%20moxifloxacin%2060%20and%2066%5Cu2009mg%5C%2Fkg%20q6h%20generated%20AUCs%20in%20mice%20equivalent%20to%20those%20of%20levofloxacin%20750%20and%201000%5Cu2009mg%5C%2Fday%20and%20moxifloxacin%20400%20and%20800%5Cu2009mg%5C%2Fday%2C%20respectively%2C%20in%20humans.%20Moxifloxacin%2060%20and%2066%5Cu2009mg%5C%2Fkg%20q6h%20had%20bactericidal%20activity%20against%20strain%20H37Rv%20%28MIC%5Cu2009%5Cu2264%5Cu20090.25%5Cu2009mg%5C%2FL%29%20and%20mutants%20GyrB%20E540A%20and%20GyrB%20A543V%20%28MIC%5Cu2009%3D%5Cu20090.5%5Cu2009mg%5C%2FL%29.%20Against%20mutant%20GyrA%20A90V%20%28MIC%5Cu2009%3D%5Cu20092%5Cu2009mg%5C%2FL%29%2C%20moxifloxacin%2060%5Cu2009mg%5C%2Fkg%20q6h%20did%20not%20prevent%20bacillary%20growth%2C%20whereas%2066%5Cu2009mg%5C%2Fkg%20q6h%20had%20bacteriostatic%20activity.%20Levofloxacin%2050%5Cu2009mg%5C%2Fkg%20q6h%20had%20bactericidal%20activity%20against%20H37Rv%20%28MIC%5Cu2009%5Cu2264%5Cu20090.25%5Cu2009mg%5C%2FL%29%20but%20not%20against%20the%20mutant%20strains.%20Levofloxacin%20100%5Cu2009mg%5C%2Fkg%20q6h%20had%20bactericidal%20activity%20against%20H37Rv%20and%20mutants%20GyrB%20E540A%20%28MIC%5Cu2009%3D%5Cu20090.5%5Cu2009mg%5C%2FL%29%20and%20GyrB%20A543V%20%28MIC%3D%5Cu20091%5Cu2009mg%5C%2FL%29%20but%20not%20against%20mutant%20GyrA%20A90V%20%28MIC%5Cu2009%3D%5Cu20094%5Cu2009mg%5C%2FL%29.Conclusions%3A%20All%20mutations%20reduced%20fluoroquinolone%20activity%2C%20even%20those%20classified%20as%20susceptible%20according%20to%20phenotypic%20tests.%20High-dose%20levofloxacin%20is%20less%20effective%20than%20high-dose%20moxifloxacin%20against%20both%20fluoroquinolone-resistant%20and%20-susceptible%20M.%20tuberculosis%20strains%20in%20mice.%22%2C%22date%22%3A%222017%5C%2F08%5C%2F01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fjac%5C%2Fdkx150%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Facademic.oup.com%5C%2Fjac%5C%2Farticle%5C%2F72%5C%2F8%5C%2F2326%5C%2F3849381%5C%2FAre-moxifloxacin-and-levofloxacin-equally%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220305-7453%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-08-02T14%3A41%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22TF36G6J8%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Maitre%20et%20al.%22%2C%22parsedDate%22%3A%222017-02-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMaitre%2C%20T.%2C%20Aubry%2C%20A.%2C%20Jarlier%2C%20V.%2C%20Robert%2C%20J.%2C%20Veziris%2C%20N.%2C%20Bernard%2C%20C.%2C%20Sougakoff%2C%20W.%2C%20Brossier%2C%20F.%2C%20Cambau%2C%20E.%2C%20Mougari%2C%20F.%20and%20Raskine%2C%20L.%20%282017%29.%20%26lt%3Bb%26gt%3BMultidrug%20and%20extensively%20drug-resistant%20tuberculosis%26lt%3B%5C%2Fb%26gt%3B.%20M%26%23xE9%3Bdecine%20et%20Maladies%20Infectieuses%20%26lt%3Bi%26gt%3B47%26lt%3B%5C%2Fi%26gt%3B%2C%203%26%23x2013%3B10%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.medmal.2016.07.006%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.medmal.2016.07.006%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multidrug%20and%20extensively%20drug-resistant%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22Maitre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Raskine%22%7D%5D%2C%22abstractNote%22%3A%22The%20emergence%20of%20drug-resistant%20tuberculosis%20%28TB%29%20compromises%20global%20tuberculosis%20control.%20The%20incidence%20of%20multidrug-resistant%20strains%20%28MDR%29%20defined%20as%20resistant%20to%20the%20two%20main%20antituberculosis%20drugs%2C%20rifampicin%20and%20isoniazid%2C%20was%20raised%20in%20the%201990s.%20Ten%20percent%20of%20these%20strains%20have%20developed%20additional%20resistance%20to%20the%20main%20second-line%20antituberculosis%20drugs%3A%20fluoroquinolones%20and%20aminoglycosides.%20These%20strains%20are%20defined%20as%20extensively%20drug-resistant%20%28XDR%29.%20The%20prognosis%20of%20MDR-TB%20and%20XDR-TB%20is%20poor%20due%20to%20limited%20therapeutic%20resources.%20However%2C%20many%20new%20innovations%20may%20lead%20to%20a%20radical%20change%20in%20this%20field.%20Genotypic%20testing%20is%20now%20able%20to%20detect%20drug%20resistance%20within%20a%20few%20hours.%20Genotypic%20diagnosis%20of%20rifampicin%20resistance%20is%20now%20recommended%20in%20France%20for%20each%20new%20case%20of%20TB.%20The%20currently%20recommended%20treatment%20for%20MDR-TB%20is%20long%20%2818%5Cu201324%5Cu00a0months%29%20and%20toxic.%20It%20is%2C%20however%2C%20on%20the%20verge%20of%20being%20replaced%20by%20a%209-month%20treatment.%20New%20antituberculosis%20drugs%20such%20as%20bedaquiline%20and%20delamanid%20should%20also%20improve%20the%20prognosis%20of%20MDR-TB%20and%20XDR-TB.%5CnR%5Cu00e9sum%5Cu00e9%5CnL%5Cu2019%5Cu00e9mergence%20des%20tuberculoses%20%28TB%29%20%5Cu00e0%20bacilles%20r%5Cu00e9sistants%20aux%20antituberculeux%20compromet%20le%20contr%5Cu00f4le%20mondial%20de%20la%20tuberculose.%20Les%20souches%20multir%5Cu00e9sistantes%20%28MDR%29%2C%20c%5Cu2019est-%5Cu00e0-dire%20r%5Cu00e9sistantes%20%5Cu00e0%20l%5Cu2019isoniazide%20et%20%5Cu00e0%20la%20rifampicine%2C%20sont%20apparues%20dans%20les%20ann%5Cu00e9es%5Cu00a090.%20Parmi%20ces%20souches%2C%2010%5Cu00a0%25%20ont%20d%5Cu00e9velopp%5Cu00e9%20des%20m%5Cu00e9canismes%20de%20r%5Cu00e9sistance%20suppl%5Cu00e9mentaires%20aux%20principaux%20antituberculeux%20de%20deuxi%5Cu00e8me%20ligne%5Cu00a0%3A%20les%20fluoroquinolones%20et%20les%20aminosides.%20Ces%20souches%20sont%20dites%20ultrar%5Cu00e9sistantes%20%28XDR%29.%20Le%20pronostic%20de%20ces%20tuberculoses%20est%20sombre%20compte%20tenu%20du%20peu%20de%20ressources%20th%5Cu00e9rapeutiques%20disponibles.%20Toutefois%2C%20de%20nombreuses%20nouveaut%5Cu00e9s%20permettent%20d%5Cu2019envisager%20un%20changement%20radical%20dans%20la%20prise%20en%20charge%20de%20ces%20cas.%20Sur%20le%20plan%20diagnostique%2C%20les%20tests%20g%5Cu00e9notypiques%20permettent%20de%20faire%20un%20diagnostic%20des%20r%5Cu00e9sistances%20aux%20antituberculeux%20en%20quelques%20heures.%20Il%20est%20d%5Cu00e9sormais%20recommand%5Cu00e9%20de%20r%5Cu00e9aliser%20un%20diagnostic%20g%5Cu00e9notypique%20de%20r%5Cu00e9sistance%20%5Cu00e0%20la%20rifampicine%20pour%20tout%20nouveau%20cas%20de%20tuberculose.%20Sur%20le%20plan%20th%5Cu00e9rapeutique%2C%20le%20traitement%20de%20r%5Cu00e9f%5Cu00e9rence%20actuel%20pour%20les%20cas%20MDR%2C%20qui%20est%20long%20%2818%5Cu00a0%5Cu00e0%2024%5Cu00a0mois%29%20et%20toxique%2C%20est%20en%20passe%20d%5Cu2019%5Cu00eatre%20remplac%5Cu00e9%20par%20un%20traitement%20court%20de%209%5Cu00a0mois.%20Enfin%2C%20de%20nouveaux%20antituberculeux%20comme%20la%20b%5Cu00e9daquiline%20et%20le%20delamanid%20offrent%20des%20perspectives%20d%5Cu2019am%5Cu00e9lioration%20du%20traitement%20des%20tuberculoses%20MDR%20et%20XDR.%22%2C%22date%22%3A%222017-02-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.medmal.2016.07.006%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0399077X16301433%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220399-077X%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-06-03T06%3A48%3A44Z%22%7D%7D%2C%7B%22key%22%3A%22TTM3V9TD%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mazoyer%20et%20al.%22%2C%22parsedDate%22%3A%222017-03-13%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMazoyer%2C%20A.%2C%20Ycart%2C%20B.%20and%20Veziris%2C%20N.%20%282017%29.%20%26lt%3Bb%26gt%3BCorrection%3A%20Unbiased%20Estimation%20of%20Mutation%20Rates%20under%20Fluctuating%20Final%20Counts%26lt%3B%5C%2Fb%26gt%3B.%20PLOS%20ONE%20%26lt%3Bi%26gt%3B12%26lt%3B%5C%2Fi%26gt%3B%2C%20e0173143%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0173143%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0173143%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Correction%3A%20Unbiased%20Estimation%20of%20Mutation%20Rates%20under%20Fluctuating%20Final%20Counts%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrien%22%2C%22lastName%22%3A%22Mazoyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bernard%22%2C%22lastName%22%3A%22Ycart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%2213%20mars%202017%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0173143%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjournals.plos.org%5C%2Fplosone%5C%2Farticle%3Fid%3D10.1371%5C%2Fjournal.pone.0173143%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221932-6203%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-03T22%3A45%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22N2N9JDXB%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mougari%20et%20al.%22%2C%22parsedDate%22%3A%222017-06-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMougari%2C%20F.%2C%20Loiseau%2C%20J.%2C%20Veziris%2C%20N.%2C%20Bernard%2C%20C.%2C%20Bercot%2C%20B.%2C%20Sougakoff%2C%20W.%2C%20Jarlier%2C%20V.%2C%20Raskine%2C%20L.%20and%20Cambau%2C%20E.%20%282017%29.%20%26lt%3Bb%26gt%3BEvaluation%20of%20the%20new%20GenoType%20NTM-DR%20kit%20for%20the%20molecular%20detection%20of%20antimicrobial%20resistance%20in%20non-tuberculous%20mycobacteria%26lt%3B%5C%2Fb%26gt%3B.%20J%20Antimicrob%20Chemother%20%26lt%3Bi%26gt%3B72%26lt%3B%5C%2Fi%26gt%3B%2C%201669%26%23x2013%3B1677%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkx021%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fjac%5C%2Fdkx021%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Evaluation%20of%20the%20new%20GenoType%20NTM-DR%20kit%20for%20the%20molecular%20detection%20of%20antimicrobial%20resistance%20in%20non-tuberculous%20mycobacteria%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faiza%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jade%22%2C%22lastName%22%3A%22Loiseau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%5Cu00e9atrice%22%2C%22lastName%22%3A%22Bercot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Raskine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%5D%2C%22abstractNote%22%3A%22Objectives%3A%20Non-tuberculous%20mycobacteria%20%28NTM%29%20are%20emerging%20pathogens%20causing%20difficult-to-treat%20infections.%20We%20tested%20a%20new%20assay%20%28GenoType%20NTM-DR%29%20that%20detects%20natural%20and%20acquired%20resistance%20mechanisms%20to%20macrolides%20and%20aminoglycosides%20in%20frequently%20isolated%20NTM%20species.Methods%3A%20Performance%20was%20assessed%20on%20102%20isolates%20including%20reference%20strains%20%5B16%20Mycobacterium%20avium%2C%2010%20Mycobacterium%20intracellulare%2C%208%20Mycobacterium%20chimaera%2C%2015%20Mycobacterium%20chelonae%20and%2053%20Mycobacterium%20abscessus%20%28including%20subsp.%20abscessus%20isolates%2C%2018%20with%20a%20t28%20in%20erm%2841%29%20and%2010%20with%20a%20c28%2C%2013%20subsp.%20bolletii%20isolates%20and%2012%20subsp.%20massiliense%20isolates%29%5D.%20Genotypes%20were%20determined%20by%20PCR%20sequencing%20of%20erm%2841%29%20and%20rrl%20for%20clarithromycin%20resistance%20and%20of%20the%201400%5Cu20131480%20rrs%20region%20for%20aminoglycoside%20resistance.%20Phenotypes%20were%20determined%20by%20MIC%20microdilution.Results%3A%20GenoType%20NTM-DR%20yielded%20results%20concordant%20with%20Sanger%20sequencing%20for%20100%5C%2F102%20%2898%25%29%20isolates.%20The%20erm%2841%29%20genotypic%20pattern%20was%20accurately%20identified%20for%20M.%20abscessus%20isolates.%20Mutations%20in%20rrl%20were%20detected%20in%2015%20isolates%20%287%20M.%20avium%20complex%2C%205%20M.%20abscessus%20and%203%20M.%20chelonae%29%20with%20acquired%20clarithromycin%20resistance%20harbouring%20rrl%20mutations%20%28a2057c%2C%20a2058g%2C%20a2058t%20or%20a2059c%29.%20Mutations%20in%20rrs%20were%20detected%20in%20five%20isolates%20with%20amikacin%20resistance%20harbouring%20the%20rrs%20mutation%20a1408g.%20In%20two%20isolates%2C%20the%20NTM-DR%20test%20revealed%20an%20rrl%20mutation%20%28initial%20sequencing%20being%20WT%29%2C%20which%20was%20confirmed%20by%20re-sequencing.%20The%20test%20results%20were%20concordant%20with%20phenotypic%20susceptibility%20testing%20in%2096%5C%2F102%20%2894.1%25%29%20isolates%2C%20with%20four%20clarithromycin-resistant%20and%20two%20amikacin-resistant%20isolates%20not%20harbouring%20mutations.Conclusions%3A%20The%20GenoType%20NTM-DR%20test%20is%20efficient%20in%20detecting%20mutations%20predictive%20of%20antimicrobial%20resistance%20in%20M.%20avium%20complex%2C%20M.%20abscessus%20and%20M.%20chelonae.%22%2C%22date%22%3A%222017%5C%2F06%5C%2F01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fjac%5C%2Fdkx021%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Facademic.oup.com%5C%2Fjac%5C%2Farticle%5C%2F72%5C%2F6%5C%2F1669%5C%2F3058522%5C%2FEvaluation-of-the-new-GenoType-NTM-DR-kit-for-the%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220305-7453%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-08-02T14%3A40%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22U8TQ72Y2%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mougari%20et%20al.%22%2C%22parsedDate%22%3A%222017-01-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMougari%2C%20F.%2C%20Bouziane%2C%20F.%2C%20Crockett%2C%20F.%2C%20Nessar%2C%20R.%2C%20Chau%2C%20F.%2C%20Veziris%2C%20N.%2C%20Sapriel%2C%20G.%2C%20Raskine%2C%20L.%20and%20Cambau%2C%20E.%20%282017%29.%20%26lt%3Bb%26gt%3BSelection%20of%20Resistance%20to%20Clarithromycin%20in%20Mycobacterium%20abscessus%20Subspecies%26lt%3B%5C%2Fb%26gt%3B.%20Antimicrob%20Agents%20Chemother%20%26lt%3Bi%26gt%3B61%26lt%3B%5C%2Fi%26gt%3B%2C%20e00943-16%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.00943-16%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.00943-16%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Selection%20of%20Resistance%20to%20Clarithromycin%20in%20Mycobacterium%20abscessus%20Subspecies%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faiza%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Feriel%22%2C%22lastName%22%3A%22Bouziane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Flora%22%2C%22lastName%22%3A%22Crockett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachid%22%2C%22lastName%22%3A%22Nessar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7oise%22%2C%22lastName%22%3A%22Chau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guillaume%22%2C%22lastName%22%3A%22Sapriel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Raskine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%5D%2C%22abstractNote%22%3A%22Mycobacterium%20abscessus%20is%20an%20emerging%20pathogen%20against%20which%20clarithromycin%20is%20the%20main%20drug%20used.%20Clinical%20failures%20are%20commonly%20observed%20and%20were%20first%20attributed%20to%20acquired%20mutations%20in%20rrl%20encoding%2023S%20rRNA%20but%20were%20then%20attributed%20to%20the%20intrinsic%20production%20of%20the%20erm%2841%29%2023S%20RNA%20methylase.%20Since%20strains%20of%20M.%20abscessus%20were%20recently%20distributed%20into%20subspecies%20and%20erm%2841%29%20sequevars%2C%20we%20investigated%20acquired%20clarithromycin%20resistance%20mechanisms%20in%20mutants%20selected%20in%20vitro%20from%20four%20representative%20strains.%20Mutants%20were%20sequenced%20for%20rrl%2C%20erm%2841%29%2C%20whiB%2C%20rpIV%2C%20and%20rplD%20and%20studied%20for%20seven%20antibiotic%20MICs.%20For%20mutants%20obtained%20from%20strain%20M.%20abscessus%20subsp.%20abscessus%20erm%2841%29%20T28%20sequevar%20and%20strain%20M.%20abscessus%20subsp.%20bolletii%2C%20which%20are%20both%20known%20to%20produce%20effective%20methylase%2C%20rrl%20was%20mutated%20in%20only%2019%25%20%284%5C%2F21%29%20and%2032.5%25%20%2813%5C%2F40%29%20of%20mutants%2C%20respectively%2C%20at%20position%202058%20%28A2058C%2C%20A2058G%29%20or%20position%202059%20%28A2059C%2C%20A2059G%29.%20No%20mutations%20were%20observed%20in%20any%20of%20the%20other%20genes%20studied%2C%20and%20resistance%20to%20other%20antibiotics%20%28amikacin%2C%20cefoxitin%2C%20imipenem%2C%20tigecycline%2C%20linezolid%2C%20and%20ciprofloxacin%29%20was%20mainly%20unchanged.%20For%20M.%20abscessus%20subsp.%20abscessus%20erm%2841%29%20C28%20sequevar%20and%20M.%20abscessus%20subsp.%20massiliense%2C%20not%20producing%20effective%20methylase%2C%20100%25%20%2826%5C%2F26%29%20and%2097.5%25%20%2839%5C%2F40%29%20of%20mutants%20had%20rrl%20mutations%20at%20position%202058%20%28A2058C%2C%20A2058G%2C%20A2058T%29%20or%20position%202059%20%28A2059C%2C%20A2059G%29.%20The%20remaining%20M.%20abscessus%20subsp.%20massiliense%20mutant%20showed%20an%2018-bp%20repeat%20insertion%20in%20rpIV%2C%20encoding%20the%20L22%20protein.%20Our%20results%20showed%20that%20acquisition%20of%20clarithromycin%20resistance%20is%20100%25%20mediated%20by%20structural%2050S%20ribosomal%20subunit%20mutations%20for%20M.%20abscessus%20subsp.%20abscessus%20erm%2841%29%20C28%20and%20M.%20abscessus%20subsp.%20massiliense%2C%20whereas%20it%20is%20less%20common%20for%20M.%20abscessus%20subsp.%20abscessus%20erm%2841%29%20T28%20sequevar%20and%20M.%20abscessus%20subsp.%20bolletii%2C%20where%20other%20mechanisms%20may%20be%20responsible%20for%20failure.%22%2C%22date%22%3A%2201%5C%2F01%5C%2F2017%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2FAAC.00943-16%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Faac.asm.org%5C%2Fcontent%5C%2F61%5C%2F1%5C%2Fe00943-16%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220066-4804%2C%201098-6596%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-08-02T14%3A40%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22VAMXEBFX%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sch%5Cu00f6n%20et%20al.%22%2C%22parsedDate%22%3A%222017-03-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSch%26%23xF6%3Bn%2C%20T.%2C%20Miotto%2C%20P.%2C%20K%26%23xF6%3Bser%2C%20C.%20U.%2C%20Viveiros%2C%20M.%2C%20B%26%23xF6%3Bttger%2C%20E.%20and%20Cambau%2C%20E.%20%282017%29.%20%26lt%3Bb%26gt%3BMycobacterium%20tuberculosis%20drug-resistance%20testing%3A%20challenges%2C%20recent%20developments%20and%20perspectives%26lt%3B%5C%2Fb%26gt%3B.%20Clinical%20Microbiology%20and%20Infection%20%26lt%3Bi%26gt%3B23%26lt%3B%5C%2Fi%26gt%3B%2C%20154%26%23x2013%3B160%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2016.10.022%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2016.10.022%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mycobacterium%20tuberculosis%20drug-resistance%20testing%3A%20challenges%2C%20recent%20developments%20and%20perspectives%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22Sch%5Cu00f6n%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Miotto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20U.%22%2C%22lastName%22%3A%22K%5Cu00f6ser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Viveiros%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22B%5Cu00f6ttger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Cambau%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222017-03-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cmi.2016.10.022%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.clinicalmicrobiologyandinfection.com%5C%2Farticle%5C%2FS1198-743X%2816%2930511-0%5C%2Ffulltext%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221198-743X%22%2C%22language%22%3A%22English%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-12T09%3A40%3A18Z%22%7D%7D%2C%7B%22key%22%3A%226BQLWEQA%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Veziris%20et%20al.%22%2C%22parsedDate%22%3A%222017-03-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BVeziris%2C%20N.%2C%20Bernard%2C%20C.%2C%20Guglielmetti%2C%20L.%2C%20Du%2C%20D.%20L.%2C%20Marigot-Outtandy%2C%20D.%2C%20Jaspard%2C%20M.%2C%20Caumes%2C%20E.%2C%20Lerat%2C%20I.%2C%20Rioux%2C%20C.%2C%20Yazdanpanah%2C%20Y.%2C%20Tiotiu%2C%20A.%2C%20Lemaitre%2C%20N.%2C%20Brossier%2C%20F.%2C%20Jarlier%2C%20V.%2C%20Robert%2C%20J.%2C%20Sougakoff%2C%20W.%20and%20Aubry%2C%20A.%20%282017%29.%20%26lt%3Bb%26gt%3BRapid%20emergence%20of%20Mycobacterium%20tuberculosis%20bedaquiline%20resistance%3A%20lessons%20to%20avoid%20repeating%20past%20errors%26lt%3B%5C%2Fb%26gt%3B.%20European%20Respiratory%20Journal%20%26lt%3Bi%26gt%3B49%26lt%3B%5C%2Fi%26gt%3B%2C%201601719%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.01719-2016%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.01719-2016%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Rapid%20emergence%20of%20Mycobacterium%20tuberculosis%20bedaquiline%20resistance%3A%20lessons%20to%20avoid%20repeating%20past%20errors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Damien%20Le%22%2C%22lastName%22%3A%22Du%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhiba%22%2C%22lastName%22%3A%22Marigot-Outtandy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Jaspard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Caumes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Lerat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Rioux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yazdan%22%2C%22lastName%22%3A%22Yazdanpanah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angelica%22%2C%22lastName%22%3A%22Tiotiu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadine%22%2C%22lastName%22%3A%22Lemaitre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jerome%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%5D%2C%22abstractNote%22%3A%22Extract%5CnBedaquiline%20%28BDQ%29%20has%20demonstrated%20potent%20clinical%20activity%20against%20multidrug-resistant%20%28MDR%29%20and%20extensively%20drug-resistant%20%28XDR%29%20Mycobacterium%20tuberculosis%20complex%20strains%20%5B1%5Cu20133%5D.%20It%20has%20now%20been%20used%20in%20%26gt%3B50%20countries%2C%20and%20it%20is%20estimated%20that%20%5Cu223c2500%20patients%20had%20been%20treated%20with%20BDQ%20by%20the%20end%20of%202015.%20In%20spite%20of%20its%20recent%20clinical%20use%2C%20there%20are%20few%20reports%20of%20BDQ-resistant%20strains%20%5B4%2C%205%5D.%20Mutations%20in%20the%20rv0678%20gene%20encoding%20the%20MmpL5%20efflux%20pump%20repressor%20generate%20low-level%20BDQ%20resistance%20and%20clofazimine%20%28CFZ%29%20cross-resistance%20%5B6%5D.%20To%20our%20knowledge%2C%20this%20is%20the%20sole%20mechanism%20of%20BDQ%20resistance%20described%20in%20clinical%20strains%20%5B4%2C%205%5D.%20Despite%20its%20introduction%20in%20France%20in%202011%20for%20XDR-%20and%20MDR-tuberculosis%20%28TB%29%20treatment%2C%20we%20report%20herein%20four%20BDQ-resistant%20cases%2C%20and%20discuss%20strategies%20to%20avoid%20a%20surge%20of%20BDQ%20resistance.%5CnBedaquiline%20resistance%20appears%20rapidly%20both%20after%20treatment%20and%20in%20patients%20that%20have%20never%20been%20treated%20http%3A%5C%2F%5C%2Fow.ly%5C%2FmxEM30604OF%22%2C%22date%22%3A%222017%5C%2F03%5C%2F01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1183%5C%2F13993003.01719-2016%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Ferj.ersjournals.com%5C%2Fcontent%5C%2F49%5C%2F3%5C%2F1601719%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220903-1936%2C%201399-3003%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222017-08-02T14%3A46%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22WGRZSFI6%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wyplosz%20et%20al.%22%2C%22parsedDate%22%3A%222017-02-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BWyplosz%2C%20B.%2C%20Mougari%2C%20F.%2C%20Rawi%2C%20M.%20A.%2C%20Baillon%2C%20C.%2C%20Marigot-Outtandy%2C%20D.%2C%20D%26%23xFB%3B%2C%20D.%20L.%2C%20Jachym%2C%20M.%2C%20Herv%26%23xE9%3B%2C%20V.%2C%20Raskine%2C%20L.%20and%20Cambau%2C%20E.%20%282017%29.%20%26lt%3Bb%26gt%3BVisualizing%20viable%20Mycobacterium%20tuberculosis%20in%20sputum%20to%20monitor%20isolation%20measures%26lt%3B%5C%2Fb%26gt%3B.%20Journal%20of%20Infection%20%26lt%3Bi%26gt%3B74%26lt%3B%5C%2Fi%26gt%3B%2C%20207%26%23x2013%3B210%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jinf.2016.11.014%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jinf.2016.11.014%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Visualizing%20viable%20Mycobacterium%20tuberculosis%20in%20sputum%20to%20monitor%20isolation%20measures%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Wyplosz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faiza%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22May%20Al%22%2C%22lastName%22%3A%22Rawi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C%5Cu00e9line%22%2C%22lastName%22%3A%22Baillon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhiba%22%2C%22lastName%22%3A%22Marigot-Outtandy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Damien%20Le%22%2C%22lastName%22%3A%22D%5Cu00fb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathilde%22%2C%22lastName%22%3A%22Jachym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Herv%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Raskine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%5D%2C%22abstractNote%22%3A%22In%20this%20Journal%2C%20Awoniyi%20and%20colleagues%20evaluated%20cytokine%20responses%20against%20novel%5CnMtb%20antigens%20as%20diagnostic%20markers%20for%20TB%20disease.%20However%20a%20practical%20issue%20for%20physicians%5Cnlooking%20after%20patients%20with%20TB%20is%20being%20able%20to%20distinguish%20smear%20positive%5C%2Fculture%5Cnnegative%20patients%20during%20the%20early%20phases%20of%20treatment.1%20Isolation%20measures%20are%20mandatory%5Cnfor%20patients%20hospitalized%20with%20pulmonary%20tuberculosis%20%28TB%29%2C%20in%20order%20to%20prevent%20transmission.2%5CnAlthough%20the%20average%20time%20to%20culture%20conversion%20is%20one%20month%20for%20patients%20with%20drug-susceptible%5CnTB%2C3%205%25%5Cu201330%25%20cases%20require%20more%20than%20two%20months4%20and%20up%20to%206%20months%20can%20be%20required%5Cnfor%20MDR-TB.%22%2C%22date%22%3A%222017%5C%2F02%5C%2F01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jinf.2016.11.014%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.journalofinfection.com%5C%2Farticle%5C%2FS0163-4453%2816%2930313-9%5C%2Fabstract%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220163-4453%2C%201532-2742%22%2C%22language%22%3A%22English%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-03T22%3A22%3A22Z%22%7D%7D%5D%7D
Allerberger, F., Cambau, E. and Lange, C. (2017). Joint efforts urgently needed at times of emerging tuberculosis drug resistance. Clinical Microbiology and Infection 23, 129–130, http://doi.org/10.1016/j.cmi.2016.08.023.
Andre, E., Goeminne, L., Cabibbe, A., Beckert, P., Mukadi, B. K., Mathys, V., Gagneux, S., Niemann, S., Ingen, J. V. and Cambau, E. (2017). Consensus numbering system for the rifampicin resistance-associated rpoB gene mutations in pathogenic mycobacteria. Clinical Microbiology and Infection 23, 167–172, http://doi.org/10.1016/j.cmi.2016.09.006.
Appelgren, A., Morquin, D., Dufour, S., Le Moing, V., Reynes, J., Lotthé, A., Parer, S., Corbeau, C., Aubry, A., Sougakoff, W., Solassol, J., Bonzon, L., Dumont, Y. and Godreuil, S. (2017). Investigation of pre-XDR Beijing Mycobacterium tuberculosis transmission to a healthcare worker in France, 2016. Journal of Hospital Infection, http://doi.org/10.1016/j.jhin.2017.06.030.
Aubry, A., Mougari, F., Reibel, F. and Cambau, E. (2017). Mycobacterium marinum. Microbiology Spectrum 5, http://doi.org/10.1128/microbiolspec.TNMI7-0038-2016.
Bouchet, F., Martin, B., Aubry, A., Veziris, N., Lavigne, J.-P. and Sotto, A. (2017). Should single antibiotic therapy be avoided for nontuberculous mycobacteria? Médecine et Maladies Infectieuses, http://doi.org/10.1016/j.medmal.2017.07.004.
Brossier, F. and Sougakoff, W. (2017). Molecular detection methods of resistance to antituberculosis drugs in Mycobacterium tuberculosis. Médecine et Maladies Infectieuses 47, 340–348, http://doi.org/10.1016/j.medmal.2017.04.008.
Brossier, F., Pham, A., Bernard, C., Aubry, A., Jarlier, V., Veziris, N., Sougakoff, W. and CNR-MyRMA, O. B. of T. (2017). Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in France. Antimicrob Agents Chemother 61, e01299-16, http://doi.org/10.1128/AAC.01299-16.
Delafont, V., Samba-Louaka, A., Cambau, E., Bouchon, D., Moulin, L. and Héchard, Y. (2017). Mycobacterium llatzerense, a waterborne Mycobacterium, that resists phagocytosis by Acanthamoeba castellanii. Scientific Reports 7, 46270, http://doi.org/10.1038/srep46270.
Fournier, A., Bernard, C., Sougakoff, W., Quelet, S., Antoun, F., Charlois-Ou, C., Dormant, I., Dufour, M.-O., Hocine, N., Jarlier, V. and Veziris, N. (2017). Neither genotyping nor contact tracing allow correct understanding of multidrug-resistant tuberculosis transmission. European Respiratory Journal 50, 1700891, http://doi.org/10.1183/13993003.00891-2017.
Guglielmetti, L., Jaspard, M., Dû, D. L., Lachâtre, M., Marigot-Outtandy, D., Bernard, C., Veziris, N., Robert, J., Yazdanpanah, Y., Caumes, E. and Fréchet-Jachym, M. (2017). Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis. European Respiratory Journal 49, 1601799, http://doi.org/10.1183/13993003.01799-2016.
Guglielmetti, L., Hewison, C., Avaliani, Z., Hughes, J., Kiria, N., Lomtadze, N., Ndjeka, N., Setkina, S., Shabangu, A., Sikhondze, W., Skrahina, A., Veziris, N. and Furin, J. (2017). Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries. The International Journal of Tuberculosis and Lung Disease 21, 167–174, http://doi.org/10.5588/ijtld.16.0493.
Jaspard, M., Elefant-Amoura, E., Melonio, I., de Montgolfier, I., Veziris, N. and Caumes, E. (2017). Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman. Emerging Infect Dis 23, http://doi.org/10.3201/eid2310.161398.
Leyer, C., Gregorowicz, G., Mougari, F., Raskine, L., Cambau, E. and Briel, D. de (2017). Comparison of Saramis 4.12 and IVD 3.0 Vitek MS Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry for Identification of Mycobacteria from Solid and Liquid Culture Media. Journal of Clinical Microbiology 55, 2045–2054, http://doi.org/10.1128/JCM.00006-17.
Maitre, T., Aubry, A. and Veziris, N. (2017). Molecular Drug-Susceptibility Test for Tuberculosis. New England Journal of Medicine 377, 2403–2404, http://doi.org/10.1056/NEJMc1714218.
Maitre, T., Petitjean, G., Chauffour, A., Bernard, C., El Helali, N., Jarlier, V., Reibel, F., Chavanet, P., Aubry, A. and Veziris, N. (2017). Are moxifloxacin and levofloxacin equally effective to treat XDR tuberculosis? J Antimicrob Chemother 72, 2326–2333, http://doi.org/10.1093/jac/dkx150.
Maitre, T., Aubry, A., Jarlier, V., Robert, J., Veziris, N., Bernard, C., Sougakoff, W., Brossier, F., Cambau, E., Mougari, F. and Raskine, L. (2017). Multidrug and extensively drug-resistant tuberculosis. Médecine et Maladies Infectieuses 47, 3–10, http://doi.org/10.1016/j.medmal.2016.07.006.
Mazoyer, A., Ycart, B. and Veziris, N. (2017). Correction: Unbiased Estimation of Mutation Rates under Fluctuating Final Counts. PLOS ONE 12, e0173143, http://doi.org/10.1371/journal.pone.0173143.
Mougari, F., Loiseau, J., Veziris, N., Bernard, C., Bercot, B., Sougakoff, W., Jarlier, V., Raskine, L. and Cambau, E. (2017). Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria. J Antimicrob Chemother 72, 1669–1677, http://doi.org/10.1093/jac/dkx021.
Mougari, F., Bouziane, F., Crockett, F., Nessar, R., Chau, F., Veziris, N., Sapriel, G., Raskine, L. and Cambau, E. (2017). Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies. Antimicrob Agents Chemother 61, e00943-16, http://doi.org/10.1128/AAC.00943-16.
Schön, T., Miotto, P., Köser, C. U., Viveiros, M., Böttger, E. and Cambau, E. (2017). Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives. Clinical Microbiology and Infection 23, 154–160, http://doi.org/10.1016/j.cmi.2016.10.022.
Veziris, N., Bernard, C., Guglielmetti, L., Du, D. L., Marigot-Outtandy, D., Jaspard, M., Caumes, E., Lerat, I., Rioux, C., Yazdanpanah, Y., Tiotiu, A., Lemaitre, N., Brossier, F., Jarlier, V., Robert, J., Sougakoff, W. and Aubry, A. (2017). Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors. European Respiratory Journal 49, 1601719, http://doi.org/10.1183/13993003.01719-2016.
Wyplosz, B., Mougari, F., Rawi, M. A., Baillon, C., Marigot-Outtandy, D., Dû, D. L., Jachym, M., Hervé, V., Raskine, L. and Cambau, E. (2017). Visualizing viable Mycobacterium tuberculosis in sputum to monitor isolation measures. Journal of Infection 74, 207–210, http://doi.org/10.1016/j.jinf.2016.11.014.